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ABSTRACT OF THE DISSERTATION 
The Identification of Alkaloid Pathway Genes from Non-Model Plant Species in the 
Amaryllidaceae 
for Arts & Sciences Graduate Students 
by 
Matthew B. Kilgore 
Doctor of Philosophy in Biology and Biomedical Sciences 
Plant Biology 
Washington University in St. Louis, 2015 
Dr. Toni M. Kutchan, Chair 
Secondary metabolites are often restricted in their distribution to different groups of organisms. 
For this reason, attempts to study these often useful and interesting products of metabolism require 
an ability to work in a diversity of non-model species. Methods for gene discovery with low 
investment and high efficiency are needed to effectively identify the biosynthetic genes in these 
diverse pathways. During this work, a workflow for efficiently identifying biosynthetic genes was 
developed and applied to Amaryllidaceae alkaloid biosynthesis. Genes discovered during this 
work include a norbelladine 4’-O-methyltransferase, a cytochrome P450 capable of phenol-phenol 
coupling 4’-O-methylnorbelladine to noroxomaritidine, and a short-chain 
dehydrogenase/reductase capable of forming norbelladine from tyramine and 3,4-
dihydroxybenzaldehyde. These enzymatic discoveries support the future application of this 
workflow to other biosynthetic pathways and organisms. 
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Chapter 1: Introduction: The 
Amaryllidaceae Alkaloids: Biosynthesis 
and Methods for Enzyme Discovery 
This chapter is in press as a review in Phytochemistry Reviews as: 
The Amaryllidaceae alkaloids: biosynthesis and methods for enzyme discovery 
Matthew B. Kilgore1 and Toni M. Kutchan1 
 1Donald Danforth Plant Science Center, St. Louis, MO, USA  
 
Amaryllidaceae alkaloids are an example of the vast diversity of secondary metabolites with great 
therapeutic promise. The identification of novel compounds in this group with over 300 known 
structures continues to be an area of active study. The recent assembly of a transcriptome for 
Lycoris aurea highlights the potential for discovery of Amaryllidaceae alkaloid biosynthetic genes 
with new technologies. Recent technical advances of interest to studies in non-model species 
include those in enzymology, next generation sequencing, nuclear magnetic resonance 
spectroscopy (NMR), and mass spectrometry (MS). In this thesis, improvements in sequencing 
and co-expression analysis introduced in this chapter are utilized to discover three Amaryllidaceae 
alkaloid biosynthetic genes. This is done using the hypothesis that genes involved in the 
biosynthesis of particular Amaryllidaceae alkaloids are co-regulated and this leads to correlations 
between biosynthetic gene expression and corresponding end product accumulation. At the end of 
this introduction, a summary of the individual chapters in the thesis is presented. 
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1.1  Amaryllidaceae Alkaloids 
1.1.1 Amaryllidaceae Description with a Narcissus spp. Emphasis 
The Amaryllidaceae are a family of bulbous plants with leaves and flowers growing from the top 
of a bulb and roots growing from the base of the bulb (Figure 1.1A, B, and C). During this work, 
experiments were conducted on members of the Galanthus and Narcissus genera of this family 
with the majority of the enzymology on Narcissus sp. aff. pseudonarcissus proteins. Most 
Narcissus spp. bloom in the spring followed by leaf, inflorescence, and root senescence. This leads 
to a summer of primordia development inside the bulb. During the winter, the roots grow to full 
size while leaf and inflorescence tissues grow slowly. The leaf and inflorescence tissues grow 
quickly in the spring (Rees, 1969). It can take 3-8 years for a Narcissus sp. plant to reach flowering 
age from seed. Starch storage is mediated by bulb scales and old leaf bases that make up the layers 
of the bulb. Over the years, bulb depth in the soil is maintained by unbranched contractile roots 
(Rees, 1969; Gordon, 2002). The presence of mycorrhizal interactions with Narcissus sp. roots 
have been observed (Chilvers and Daft, 1981). Wild Narcissus spp. reproduction is through the 
generation of bulblets or seed. Axillary buds inside the bulb develop into bulblets, with 
approximately one initiated per year (Rees, 1969). The ability to efficiently reproduce by seed is 
limited for many commercial cultivars because they are the result of crosses between species, 
which renders them semi-sterile. These cultivars are propagated by bulb mediated bulblet 
generation or tissue culture methods for bulblet generation from bulb fragments (Chen and Ziv, 
2005). 
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Figure 1.1 Photos of Narcissus sp. aff. pseudonarcissus and Galanthus sp.(A) An herbarium sample of Narcissus sp. 
aff. pseudonarcissus collected and pressed by Megan Augustin with major organs labeled. (B) A clump of Narcissus 
sp. aff. pseudonarcissus plants in flowering in late-march. (C) Galanthus sp. flowering in early-march. 
1.1.2  Amaryllidaceae Alkaloid Introduction 
The Amaryllidaceae have a long history as medicines in the cultures throughout their natural range 
spanning the Mediterranean, Central America, South America, Europe, Asia, and Africa (Plaitakis 
and Duvoisin, 1983; Louw et al., 2002; Cabezas et al., 2003; Howes and Houghton, 2003). The 
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Amaryllidaceae alkaloids are responsible for the medicinal properties of the Amaryllidaceae and 
are largely restricted to the family Amaryllidaceae, specifically the subfamily Amaryllidoideae 
(Chase et al., 2009). A noteworthy exception is the collection of alkaloids that have been found in 
the genus Hosta that is in the order Asparagales along with Amaryllidaceae (Chase et al., 2009; Li 
et al., 2012). New Amaryllidaceae alkaloid structures and the biosynthesis of these alkaloids have 
recently been reviewed (Kornienko and Evidente, 2008; Bastida et al., 2011; Jin, 2013; Takos and 
Rook, 2013). Galanthamine is a prime example of the Amaryllidaceae alkaloids. It is one of the 
three primary drugs used for the treatment of Alzheimer’s disease. The Amaryllidaceae alkaloids 
and their derivatives have been a source of novel acetylcholine esterase inhibitors, anti-cancer 
compounds, anti-viral compounds, and antibacterial compounds with potential clinical 
applications. The last 10 years of progress in the identification of these bioactive compounds has 
recently been reviewed (He et al., 2015).  
The in planta roles of these alkaloids are not as thoroughly examined as their potential 
medicinal roles. Some potential in planta roles of these compounds can be postulated based on 
their observed biological activities in vivo and in vitro on both mammals and other plant species. 
Several Amaryllidaceae alkaloids have been shown to have anti-cancer properties including the 
following examples haemanthamine, lycorine, narciclasine, lycoricidine, pancratistatin, β-crinane 
distichamine, and narciprimine (Liu et al., 2004; Havelek et al., 2014; He et al., 2015). These 
compounds have been highlighted as potential anticancer compounds because of their preferential 
cytotoxic action on cancer cell lines over normal cells, but there is usually back-ground toxicity 
for normal cells at higher doses. So, these cytotoxic compounds could be poisonous or illness 
inducing to an herbivore if consumed in adequate quantities; for this reason, it is possible these 
compounds act as herbivore deterrents. Galanthamine, sanguinine, ungiminorine, and 1-O-
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acetyllycorine are acetylcholine esterase inhibitors (Irwin and Smith, 1960; He et al., 2015). 
Several insecticides including organophosphates and carbamates also act as acetylcholine esterase 
inhibitors and cause uncontrolled nerve firing that can lead to death (Casida, 1964). Hence, activity 
that makes these alkaloids potential Alzheimer’s treatments my serve in planta as an herbivore 
deterrent acting on the nervous system. One of the side effects of galanthamine ingestion in humans 
is an upset stomach and diarrhea supporting its role as an herbivore deterrent (Hughes et al., 2004). 
Species of Amaryllidaceae frequently have a terrible taste and cause vomiting when ingested. As 
a result, poisoning from these species is rare. Oral administration of the Amaryllidaceae species 
Boophone disticha ethanol extracts to rats in doses of 240 mg/kg or higher results in death with 
symptoms reminiscent of acetylcholinesterase poisoning (tremors, convulsions, paralysis, and 
labored breathing) demonstrating the poisonous potential of Amaryllidaceae species (Gadaga et 
al., 2011). Some Amaryllidaceae alkaloids could have a similar role in planta as proposed for the 
clinic. Several Amaryllidaceae alkaloids are documented to have antiviral (lycorine, pancratistatin, 
hippeastrine, and haemanthamine), antibacterial (lycorine, ungeremine), and antiprotozoal 
(lycorine) properties which are as pertinent to plants as to humans when exposed to these classes 
of parasites (He et al., 2015). In addition to dealing with herbivores and parasites, Amaryllidaceae 
may use some of their compounds to modulate the growth of neighboring plants through 
allelopathy or perhaps modulate their own growth. The Amaryllidaceae alkaloid narciclasine is a 
prime example of a potential allelopathy (inhibitor of surrounding plant growth) agent with well 
documented inhibition of Arabidopsis seed germination and seedling growth. The effect is partly 
due to inhibition of polar auxin transport in roots and perhaps other tissues (Na et al., 2011). 
 There are still new alkaloids being discovered in the Amaryllidaceae alkaloids and even 
novel carbon skeletons with great potential to contribute to the list of known biologically active 
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compounds. A diversity of carbon skeletons are known for this group of alkaloids including 
hostasinine, belladine, galanthamine, crinine, lycorine, galanthindole, homolycorine, galasine, 
montanine, cripowellin, cherylline, buflavine, plicamine, tazettine, graciline, augustamine, 
pancratistatin, and gracilamine (Jin, 2009). Many of these compounds are of great potential 
pharmacological significance and their production through biological means is an area of great 
interest.  
1.1.3  Prevalent Biosynthetic Gene Superfamilies 
To further the biological production of these compounds, an understanding of their biosynthetic 
genes is requisite and the majority of the reactions are reaction types that are typically catalyzed 
by a collection of characterized enzyme families. The knowledge of these families can help inform 
efforts through homology searches to identify candidate genes. When studying secondary 
metabolism, in particular Amaryllidaceae alkaloid biosynthesis, several reaction types appear 
frequently including methylation, reduction, oxidation, condensation, hydroxylation, phenol-
phenol’ coupling, and oxide bridge formation. Examples of reductions found in the 
Amaryllidaceae include reduction of ketones, aldehydes, carbon-carbon double bonds, and imines. 
Two reductase superfamilies noted for their tendency to reduce aldehydes, ketones, carbon-carbon 
double bonds, and imines include aldo-keto reductases (AKRs) and short-chain 
dehydrogenase/reductases (SDRs) (Jörnvall et al., 1995; Penning, 2015). The SDR superfamily 
consists of three families including short-chain dehydrogenase/reductases, medium-chain 
dehydrogenase/reductases (MDRs) also known as alcohol dehydrogenases (ADH), and long-chain 
dehydrogenases/reductases (LDRs) (Kavanagh et al., 2008; Penning, 2015). The common feature 
of the SDR superfamily is a “Rossmann-fold” which is involved in the binding of dinucleotide 
cofactors including NADPH or NADH (Kavanagh et al., 2008). In Chapter 4, an SDR is identified 
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with the ability to reduce norcraugsodine, an early intermediate in Amaryllidaceae alkaloid 
biosynthesis. Oxidation reactions creating these various double bonds could be catalyzed by AKRs 
and SDRs as well because of the potential of these enzyme families to drive oxidations (Porté et 
al., 2013). 2-Oxoglutarate dependent dioxygenases and cytochrome P450 enzymes are well known 
for their ability to hydroxylate substrates thus making them good candidate gene families for the 
various hydroxylases in the biosynthesis of the Amaryllidaceae alkaloids (Lester et al., 1997; 
Nelson and Werck-Reichhart, 2011). The formation of an oxide bridge from a methoxy and 
hydroxyl group is probably catalyzed by a cytochrome P450 because CYP81Q1, CYP719A1, 
CYP719A13, and CYP719A14 are enzymes shown to catalyze this type of reaction (Ikezawa et 
al., 2003; Ono et al., 2006; Díaz Chávez et al., 2011). Phenol-phenol’ coupling reactions are also 
likely catalyzed by cytochrome P450 enzymes. The cytochromes P450 CYP81Q1, CYP719A1, 
CYP719A13, and CYP719A14 have been shown to catalyze phenol-phenol coupling reactions and 
are proposed to act by a diradical mechanism (Ikezawa et al., 2003; Ono et al., 2006; Díaz Chávez 
et al., 2011). A phenol-phenol coupling cytochrome P450 forms a radical hydroxyl group on each 
of the phenol groups to be coupled. Resonance structures of these phenol radicals allow the single 
electron to be ortho or para to the initially radicalized hydroxyl. As a result, the electrons from the 
two phenol groups from a C-C bond with the possible phenol-phenol coupling possibilities of 
ortho-para, para-para, or para-ortho. In the case of the Amaryllidaceae alkaloids, a subsequent 
spontaneous nitrogen-ring closure (haemanthamine, crinine, and lycorine type) or oxygen-ring 
closure (galanthamine type) prevents the generation of a double phenol end product (Eichhorn et 
al., 1998). In other systems, however, with no further reactions or new quaternary carbons, both 
phenol groups are regenerated through rearrangement of hydrogens. In Chapter 3, CYP96T1 is 
shown to perform the para-para’ phenol-phenol coupling reaction that makes the haemanthamine 
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and crinine carbon skeletons. Other enzyme groups noted for their ability to perform phenol-
phenol’ coupling reactions are laccases and peroxidases (Schlauer et al., 1998; Constantin et al., 
2012). In the Amaryllidaceae two forms of methylation are common: O-methylation and N-
methylation. O-Methyltransferases are divided into class I and class II methyltransferases (Ibdah 
et al., 2003). It is shown in Chapter 2 that the class I O-methyltransferase, N4OMT is responsible 
for the methylation of norbelladine to 4’-O-methylnorbelladine in Amaryllidaceae alkaloid 
biosynthesis (Kilgore et al., 2014). Other O-methylation reactions in the biosynthesis of these 
compounds could be catalyzed by homologues to N4OMT or homologues to other known O-
methyltransferases including reticuline 7-O-methyltransferase, (R,S)-norcoclaurine 6-O-
methyltransferase, columbamine O-methyltransferase, chavicol O-methyltransferase, and eugenol 
O-methyltransferase (Gang et al., 2002; Morishige et al., 2002; Ounaroon et al., 2003). Examples 
of N-methyltransferases that could share homology with N-methyltransferases involved in several 
Amaryllidaceae alkaloid biosynthetic pathways include coclaurine N-methyltransferase and 
caffeine synthase (Kato et al., 2000; Choi et al., 2002). Homologues of O-methyltransferases 
would be of potential interest when looking for an N-methyltransferase as well because of the close 
homology that exists between the O- and N- methyltransferases (Raman and Rathinasabapathi, 
2003). 
1.1.4  Core Biosynthetic Pathway 
Intermediate Discovery 
The core biosynthetic pathway of the Amaryllidaceae alkaloids consists of the reactions required 
to produce 3,4-dihydroxybenzaldehyde and tyramine, the condensation and reduction of these 
precursors to norbelladine, and the subsequent methylation of norbelladine to 4’-O-
methylnorbelladine (Figure 1.2). Phenylalanine and tyrosine were shown to be precursors for 
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haemanthamine by incorporation of [3-14C]phenylalanine and [3-14C]tyramine into 
haemanthamine in Nerine bowdenii (Wildman et al., 1962b). Degradation experiments of 
haemanthamine generated from radiolabeled tyramine were used to demonstrate the placement of 
the labeled carbons on positions C11 and C12 in experiments with [2-14C]tyrosine in Sprekelia 
formosissima and [1-14C]tyrosine in Narcissus ‘Twink’ daffodil (Battersby et al., 1961a; Wildman 
et al., 1962a). [3-14C]Tyramine has also been documented to incorporate into haemanthamine, 
haemanthidine, and 6-hydroxycrinamine in Haemanthus natalensis bulbs (Jeffs, 1962). Lycorine 
and norpluviine have been shown to incorporate [2-14C]tyramine and [1-14C]tyramine in Narcissus 
“Twink” (Battersby and Binks, 1960; Battersby et al., 1961b). [14C]Phenylalanine and [3H]3,4-
dihydroxybenzaldehyde were both shown to be precursors to the aromatic half of haemanthamine 
and lycorine (Suhadolnik et al., 1962, 1963b). The pathway from phenylalanine to the intermediate 
3,4-dihydroxybenzaldehyde was determined by feeding to Narcissus pseudonarcissus [3-
14C]trans-cinnamic acid, [3-14C]4-hydroxycinnamic acid, [7-14C]benzaldehyde, [7-14C]4-
hydroxybenzaldehyde, [3H]3,4-dihydroxybenzaldehyde and [3H]threo-DL-phenylserine and 
monitoring production of haemanthamine. The precursors [3-14C]trans-cinnamic acid, [3-14C]4-
hydroxycinnamic acid, [3H]3,4-dihydroxybenzaldehyde and [7-14C]4-hydroxybenzaldehyde 
showed incorporation into haemanthamine. This led to the conclusion that the pathway for 
conversion of phenylalanine to 3,4-dihydroxybenzaldehyde is in the following sequence: 
phenylalanine, trans-cinnamic acid, 4-hydroxycinnamic acid, 3,4-dihydroxycinnamic acid or 4-
hydroxybenzaldehyde, and 3,4-dihydroxybenzaldehyde (Suhadolnik et al., 1963a). 3,4-
Dihydroxybenzaldehyde has been documented in Hydnophytum formicarum and other plants 
outside the Amaryllidaceae (Prachayasittikul et al., 2008). It is possible that the 3,4-
dihydroxybenzaldehyde pathway is more phylogenetically spread than the latter steps or 
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convergent evolution of product formation has occurred. Carbon fourteen labeled norbelladine is 
incorporated into the alkaloids lycorine, crinamine, belladine, haemanthamine, and norpluviine 
(Battersby et al., 1961b; Battersby et al., 1961a; Wildman et al., 1962c). 4’-O-Methylnorbelladine 
is a precursor of all the primary alkaloid skeletons including crinine (crinine), haemanthamine 
(vittatine, 11-hydroxyvittatine), galanthamine (galanthamine, N-demethylgalanthamine, and N-
demethylnarwedine), and lycorine (lycorine, norpluviine, and galanthine) (Kirby and Tiwari, 
1966; Bruce and Kirby, 1968; Fuganti and Mazza, 1972b, a; Fuganti, 1973; Eichhorn et al., 1998). 
4’-O-Methylnorbelladine has long been considered the direct substrate for creation of the para-
para’ and ortho-para’ carbon skeletons. 4’-O-Methylnorbelladine has recently been established 
as the direct precursor of the para-ortho’ skeleton as well (Eichhorn et al., 1998). This universal 
requirement in all phenol-phenol coupling branches for 4’-O-methylnorbelladine makes it the last 
common intermediate before a three way split in the Amaryllidaceae biosynthetic pathway. The 
three common divisions at 4’-O-methylnorbelladine are the para-para’ coupling that leads to the 
crinine and vittatine enantiomeric series, the ortho-para’ phenol coupling that is elaborated into 
the classic alkaloid lycorine, and the para-ortho’ coupling that is elaborated into the most widely 
used Amaryllidaceae alkaloid galanthamine (Figure 1.3). Most other Amaryllidaceae alkaloid 
carbon skeletons are thought to be derivatives of these four skeletons. Examples include the 
pancratistatin and tazettine carbon skeletons derived from the haemanthamine skeleton and the 
homolycorine skeleton derived from the lycorine skeleton (Figure 1.4 and 1.5). The belladine-type 
alkaloids are thought to originate by the simple methylation of norbelladine, though the order of 
methylations is not determined. The cherylline skeleton is thought to originate from hydroxylation 
at the 11-position of the norbelladine skeleton and subsequent cyclization with the dioxygenated 
phenol group (Chan, 1973). 
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Figure 1.2. Core biosynthetic pathway for Amaryllidaceae alkaloids. Phenylalanine is converted to trans-cinnamic 
acid by phenylalanine ammonia lyase (PAL) and then to 4-hydroxycinnamic acid by CYP73A1. 4-hydroxycinnamic 
acid is potentially converted to 3,4-dihydroxycinnamic acid by CYP98A3 or to 4-hydroxybenzaldehyde and then to 
3,4-dihydroxybenzaldehyde potentially by a VpVAN paralogue. Tyrosine is converted to tyramine by tyrosine 
decarboxylase. 3,4-dihyroxybenzaldehyde and tyramine are condensed to form the Schiff-base, norcraugsodine, and 
reduced by an unknown reductase into norbelladine. Norbelladine is methylated by norbelladine 4’-O-
methyltransferase (N4OMT) into 4’-O-methylnorbelladine. 
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Enzymology 
The biosynthesis of 3,4-dihydroxybenzaldehyde from phenylalanine likely involves the early 
phenylpropanoid biosynthetic pathway all the way to caffeic acid (3,4-dihydroxycinnamic acid). 
Assuming the involvement of the phenylpropanoid pathway, 3,4-dihyroxycinnamic acid is a more 
likely intermediate in the biosynthesis than 4-hydroxybenzaldehyde. This is in agreement with the 
relatively low incorporation of 4-hydroxybenzaldehyde in radiolabeling experiments (Suhadolnik 
et al., 1963a). The deamination of phenylalanine to trans-cinnamic acid is done by phenylalanine 
ammonia lyase (PAL) (Tanaka et al., 1989). LrPAL1 and LrPAL2 have been cloned from the 
Amaryllidaceae plant Lycoris radiata demonstrating the presence of this enzyme in the 
Amaryllidaceae (Jiang et al., 2011; Jiang et al., 2013). The hydroxylation of trans-cinnamic acid 
to 4-hydroxycinnamic acid is done by cinnamate 4-hydroxylase (CYP73A1) (Fahrendorf and 
Dixon, 1993; Teutsch et al., 1993). CYP98A3 has been documented to hydroxylate the 3-position 
of 4-hydroxycinnamic acid (Franke et al., 2002). However, CYP98A3 prefers the shikimic acid or 
quinic acid esters over the free 4-hydroxycinnamic acid (Schoch et al., 2001; Franke et al., 2002). 
For this reason, it is possible a detour is required through shikimic acid, quinic acid, or acyl-CoA 
esters to get hydroxylated 3,4-dihydroxycinnamic acid. The conversion 3,4-dihydroxycinnamic 
acid to 3,4-dihydroxybenzaldehyde appears very similar to the conversion of ferulic acid to 
vanillin by vanillin synthase (VpVAN), a hydratase/lyase (Gallage et al., 2014). The only 
difference is that the 3-hydroxyl is methylated in vanillin biosynthesis. Because of the substrate 
and reaction similarity, it is possible this reaction is catalyzed by an enzyme related to VpVAN. 
Interestingly, there has been debate regarding the VpVAN’s preference for ferulic acid or 4-
hydroxycinnamic acid (Havkin-Frenkel et al., 2003). If a similar enzyme in 3,4-
dihydroxybenzaldehyde biosynthesis shares the ability to perform this reaction on substrates that 
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have or have not been hydroxylated at the 3-position, it would explain some of the ambiguity 
observed in earlier radiolabeling experiments. The conversion of tyrosine to tyramine is likely 
done by a homologue to the enzyme responsible for this reaction in other systems, tyrosine 
decarboxylase (Lehmann and Pollmann, 2009). This homologue in Narcissus sp. aff. 
pseudonarcissus, KT378599, has been cloned and confirmed to have tyrosine decarboxylase 
activity (Appendix A). 
Prior to this thesis, the enzymology behind the condensation and subsequent reduction of 
3,4-dihydroxybenzaldheyde and tyramine was unknown. The formation of the predicted Schiff-
base intermediate, norcraugsodine, from tyramine and 3,4-dihydroxybenzaldehyde was possibly a 
spontaneous reaction occurring in solution, an enzymatically catalyzed condensation or both. The 
following reduction of the imine double bond to make norbelladine was potentially done by a 
reductase belonging to the AKR or SDR superfamilies. An SDR in the ADH family, 
tetrahydroalstonine synthase, from Catharanthus roseus can reduce the imine bond on strictosidine 
to form tetrahydroalstonine (Stavrinides et al., 2015). An enzyme, norcraugsodine reductase, 
capable of reducing norcraugsodine and potentially condensing 3,4-dihydroxybenzaldehyde and 
tyramine is discovered and described in Chapter 4. Several more NADPH-dependent imine 
reductases have been characterized in bacteria (Wetzl et al., 2015). After this reduction, 
norbelladine is shown in Chapter 2 to be methylated by the class I methyltransferase N4OMT in 
Narcissus sp. aff. pseudonarcissus (Kilgore et al., 2014). The three common phenol-phenol’ 
coupling reactions that follow require the same biochemistry to operate and are likely done by 
cytochrome P450 enzymes, laccases, or peroxidases (Schlauer et al., 1998; Ikezawa et al., 2003; 
Ono et al., 2006; Díaz Chávez et al., 2011; Constantin et al., 2012). 
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Figure 1.3. Primary Amaryllidaceae skeleton biosynthetic pathways with elaboration into the alkaloids 
haemanthamine, crinine, lycorine, and galanthamine. 
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Figure 1.4. Para-para’ phenol-phenol’ coupling-derived skeletons found in the Amaryllidaceae. 
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Figure 1.5. Carbon skeleton rearrangements in narciclasine, tazettine, and plicamine biosynthesis.   
1.1.5  Galanthamine-Type Alkaloid Biosynthesis 
Galanthamine is the representative alkaloid of the galanthamine type carbon skeleton. It is an 
Amaryllidaceae alkaloid used to treat the symptoms of Alzheimer’s disease (Wilcock et al., 2000). 
Because of its importance, several studies have been done with radiolabeled isotopes to determine 
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its biosynthetic pathway (Barton et al., 1961; Barton and Kirby, 1962; Eichhorn et al., 1998). Initial 
studies by Barton et al. with 4’-O-methyl-[N-methyl-14C]norbelladine, [N-methyl-
14C]norbelladine, and [4’-O-methyl-14C]norbelladine as precursors of galanthamine showed no 
incorporation of [4’-O-methyl-14C]norbelladine and a significant incorporation of 4’-O-methyl-
[N-methyl-14C]norbelladine and [N-methyl-14C]norbelladine. This lead to the conclusion that N-
methylation occurs at the norbelladine stage and subsequent O-methylation yields 4’-O-methyl-N-
methylnorbelladine. This 4’-O-methyl-N-methylnorbelladine substrate was a precursor for phenol-
phenol’ coupling to narwedine that lead to galanthamine through a subsequent reduction (Barton 
and Kirby, 1962). This view was revised by subsequent work in Leucojum aestivum where it was 
shown that 4’-O-methylnorbelladine could be used as a substrate for phenol-phenol’ coupling 
(Figure 1.3). The incorporation of 4’-O-methyl-N-methylnorbelladine was found to be one third 
the rate of incorporation of 4’-O-methylnorbelladine with an N-demethylation then occurring prior 
to conversion to galanthamine. N-Demethylgalanthamine was shown to be converted into 
galanthamine as well (Eichhorn et al., 1998). These two studies are an example of the limitations 
of conclusions drawn from negative results in radiolabeling experiments, especially considering 
the low incorporation rates observed in the initial study by Barton and Kirby (Barton and Kirby, 
1962). The subsequent experiments by Eichhorn et al. revised the pathway establishing 4’-O-
methylnorbelladine as the phenol-phenol’ coupling substrate to make N-demethylnarwedine. N-
Demethylnarwedine is reduced to N-demethylgalanthamine followed by N-methylation to make 
galanthamine (Eichhorn et al., 1998). 
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1.1.6  Haemanthamine, Pancratistatin, Gracilamine, Cripowellin, Tazettine, 
Plicamine, Hostasinine, Graciline, Augustamine, and Montanine-Type 
Alkaloid Biosynthesis 
Haemanthamine and crinine are Amaryllidaceae alkaloids with well determined biosynthetic 
pathways and are the representative alkaloids of their respective skeleton types (Figure 1.3). The 
phenol-phenol’ coupling reaction for the biosynthesis these skeletons proceeds with a para-para’ 
coupling. A transient achiral intermediate is generated. Following the phenol coupling, the 
nitrogen attacks one of two carbon double bonds to generate each of the enantiomeric carbon 
skeletons. Given the absence of the crinine skeleton in many genera that contain the 
haemanthamine skeleton, an enzyme must be guiding this ring closure. In haemanthamine 
biosynthesis, (10bR,4aS)-noroxomaritidine results from phenol coupling which is then reduced to 
normaritidine. Normaritidine is oxidized to vittatine by the formation of an oxide bridge. The same 
enzymatic reactions are required for the conversion of the (10bS,4aR)-noroxomaritidine to crinine 
with some ambiguity surrounding the order of reduction and oxide bridge formation. If reduction 
is first, macowine is the intermediate, but if oxide bridge formation is first, oxocrinine is the 
intermediate (Fuganti and Mazza, 1972b). To make haemanthamine from vittatine requires 
hydroxylation and methylation. Hydroxylation to 11-hydroxyvittatine is considered the next step 
followed by methylation to haemanthamine as indicated by the incorporation of 11-
hydroxyvittatine into haemanthidine which is a hydroxylated derivative of haemanthamine (Fales 
and Wildman, 1964; Fuganti, 1973). Since 11-hydroxyvittatine is not a catechol, this methylation 
is likely catalyzed by a homologue to a class II methyltransferase (Joshi and Chiang, 1998). A 2-
oxoglutarate dioxygenase is found to hydroxylate vittatine into one of the diastereomeric forms of 
11-hydroxyvittatine in Appendix B. 
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Radiolabeling studies with [2,4-3H2-4’-O-methyl-14C]norbelladine and [1,4a-3H2-4’-O-
methyl-14C]norbelladine as precursors have been used to demonstrate the biosynthesis of 
narciclasine, a common pancratistatin-type alkaloid, through the para-para’ phenol-coupling route 
(Figure 1.5). In corroboration, feeding of [3H]norpluviine with no significant incorporation 
demonstrated the ortho-para’ route to be an unlikely contributor to the biosynthesis of narciclasine 
(Fuganti et al., 1971). Narciclasine has been shown to be labeled from the racemic precursors 
[1,4a-3H2]noroxomaritidine, [1,3,4a-
3H3]normaritidine, and [3-
3H]vittatine in Narcissus "Twink" 
and Narcissus "Texas" plants (Fuganti and Mazza, 1971). [2,4-3H2]Crinine and [2,4-
3H2]vittatine 
were made by feeding [2, 4-3H2]4’-O-methylnorbelladine to species known for making these two 
enantiomers, Nerine bowdenii and Pancratium maritimum, respectively. When fed to Narcissus 
“Twink” and Narcissus “Texas”, [2,4-3H2]crinine was not incorporated into narciclasine and [2,4-
3H2]vittatine was incorporated. This shows the vittatine enantiomer to be the proper substrate and 
established the absolute configuration of narciclasine (Fuganti and Mazza, 1972b). [2,4-3H2]11-
Hydorxyvittatine has been shown to incorporate into narciclasine and haemanthamine (Fuganti, 
1973). 11-Hydroxyvittatine is the last theoretical common intermediate between haemanthamine 
and narciclasine. After formation of 11-hydroxyvittatine, the synthesis of narciclasine requires a 
series of reactions including a retro-Prins reaction, amine oxidation, 3 hydroxylations, and 
oxidation of a hydroxyl to a ketone. The retro-Prins reaction would result in the C2-hydroxyl, 
cleavage of the C10b-11 bond, and immigration of the C1-2 double bond to C10b-1. The amine 
oxidation to an imine between the nitrogen and C12, in addition to the retro-Prins reaction, would 
allow the release of the C11-12 carbon skeleton as glyoxal. The hydroxylations would occur at 
positions 4, 6, and 7. The hydroxyl at position 7 would subsequently be oxidized to a ketone. The 
Retro-Prins reaction has been implicated as a mechanism for germacradienol/germacrene D 
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synthase from Streptomyces coelicolor (Jiang et al., 2006). If the C2 bond is oxidized and then 
severed by hydrolysis, SDR and AKR enzymes are prime candidates due to their potential to 
perform oxidation reactions. 
Gracilamine is an unusual dinitrogenous alkaloid skeleton first discovered in 2005 (Ünver 
and Kaya, 2005). It has been proposed to be a derivative of the para-para’ phenol-phenol coupling 
reaction and leucine based on biomimetic schemes that have been devised for the total synthesis 
gracilamine from the para-para’ skeleton and leucine (Tian et al., 2012).  
The cripowellin skeleton was discovered in 1998 in Crinum powellii and resembles a 
highly oxidized version of the haemanthamine skeleton that has had the C10b-4a carbon-carbon 
bond severed and replaced with a ketone on the C4a position (Velten et al., 1998). If this is the 
pathway for generating this alkaloid, it is possible that carbon bond cleavage leading to the 
formation of a ketone is catalyzed by a cytochrome P450 similar to secologanin synthase that 
converts loganin into secologanin in an analogous manner with a ketone product (Irmler et al., 
2000).  
Tazettine biosynthesis proceeds from haemanthidine through a spontaneous ring opening 
between C6 and the nitrogen of haemanthidine forming a postulated ketone intermediate (Wildman 
and Bailey, 1969) (Figure 1.5). This is followed by the formation of a hemiacetal between the C6 
ketone and the C11 hydroxyl and N-methylation (Fales and Wildman, 1964). The resulting 
pretazettine can spontaneously convert to tazettine on exposure to basic conditions (Wildman and 
Bailey, 1967).  
Several other Amaryllidaceae skeletons are likely biosynthesized by a ring opening similar 
to the one in tazettine biosynthesis between C6 and the nitrogen, including plicamine, hostasinine, 
augustamine, and graciline. Plicamine is a dinitrogenous carbon skeleton thought to be derived 
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from a pathway similar to the tazettine skeleton with the addition of nitrogen from tyramine instead 
of the oxygen from C11 to the transient ketone intermediate as evidenced by structural similarities 
(Ünver et al., 1999) (Figure 1.5). Hostasinine is an alkaloid skeleton documented in Hosta and 
listed here because it is potentially derived from the Amaryllidaceae alkaloid haemanthidine. The 
proposed mechanism is depicted in Figure 1.6 and involves the spontaneous opening of the six 
membered nitrogen containing ring as in tazettine biosynthesis, reduction of the nitrogen C4a 
bond, formation of a carbon-carbon bond from C6 to C4, and oxidation of the nitrogen (Wang et 
al., 2007; Jin, 2009). Augustamine is potentially formed from the haemanthamine skeleton as 
shown by the presence of a direct connection of the five membered ring to carbon-10b as would 
be the case if the ether bond in the tazettine skeleton was at the C1 position and not the C11 positon 
(Machocho et al., 2004). The graciline skeleton is likely a derivative of the haemanthamine 
skeleton with the ether connected to C4a instead of C11 as in tazettine biosynthesis. 
The biosynthesis of montanine proceeds through the intermediate vittatine (Feinstein and 
Wildman, 1976). One possibility is vittatine is hydroxylated to 11-hydroxyvittatine followed by a 
ring expansion triggered by a hydroxylation at C2 with subsequent methylation at C2 (Feinstein, 
1967; Feinstein and Wildman, 1976).   
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Figure 1.6. Possible mechanism of rearrangement for hostasinine-type alkaloids from haemanthidine. The steps are 
written in this order for illustration. There is no evidence regarding the order 
1.1.7  Lycorine and Homolycorine-Type Alkaloid Biosynthesis 
Lycorine was the first Amaryllidaceae alkaloid for which a structure was determined. The ubiquity 
of lycorine in the Amaryllidaceae made it ideal for radiolabeling experiments to elucidate its 
biosynthesis. Its early biosynthesis has been determined to be equivalent to that of haemanthamine 
and galanthamine (Battersby et al., 1964). At the phenol-phenol’ coupling step, an ortho-para’ 
reaction leads to the production of noroxopluviine. After the initial phenol-phenol’ coupling, a re-
aromatization of the phenolic rings or an enolization occurs as indicated by the loss of tritium at 
the C10b-position (Kirby and Tiwari, 1966). A stereospecific carbon nitrogen bond is also formed 
to create noroxopluviine. If rearomatization or keto-enol tautomerization occurs prior to the carbon 
nitrogen bond formation, the bond will form on an achiral or racemic intermediate, respectively. 
This indicates an enzyme is involved in the closure of the nitrogen ring. This chirality may be 
dictated by the arrangement of the intermediate in the active site of the phenol-phenol’ coupling 
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enzyme or of another independent enzyme. Noroxopluviine is reduced to norpluviine (Battersby 
et al., 1964). As in haemanthamine biosynthesis, an oxide bridge is formed to make caranine 
(Battersby et al., 1964; Fuganti and Mazza, 1972a). This is followed by hydroxylation of the 2-
position to make lycorine (Battersby et al., 1964; Wildman and Heimer, 1967). Studies in 
Zephyranthes candida, Narcissus “Twink” and Narcissus “Deanna Durbin” indicate an inversion 
of configuration of the C2 hydrogen at the hydroxylation step, but a study in Clivia miniata 
indicates the configuration is retained (Wildman and Heimer, 1967; Bruce and Kirby, 1968; 
Fuganti and Mazza, 1972a). Studies in Clivia miniata, Narcissus “Twink”, and Narcissus “Deanna 
Durbin” agree that the protonation of C2 following phenol-phenol’ coupling is stereospecific with 
addition of hydrogen to the alpha side of the molecule (Bruce and Kirby, 1968; Fuganti and Mazza, 
1972a). The disagreement of the data surrounding C2 hydroxylation between these species could 
imply a difference in the mechanism of the enzyme conducting hydroxylation between these 
species (Figure 1.3). 
Homolycorine biosynthesis is thought to start with the hydroxylation of norpluviine at C6 
followed by a ring opening at the C6 nitrogen bond. This is followed by the formation of a 
hemiacetal connection between the C1 hydroxyl and the C6 ketone and methylations to form the 
known alkaloid lycorenine. The oxidation of lycorenine makes the representative alkaloid of the 
skeleton homolycorine. The exact order of the hydroxylation, ring breakage/hemiacetal formation 
and methylation reactions are poorly determined. The best evidence for order is the presence of 
lycorenine and homolycorine as products in feeding experiments for norpluviine. This indicates 
the formation of the homolycorine ester may be the last step in the pathway (Harken et al., 1976; 
Bastida et al., 2011). This reaction is done by an oxidase that could be an AKR, SDR, or a 
cytochrome P450 (Figure 1.7). 
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Figure 1.7. Formation of the homolycorine carbon skeleton from norpluviine. The order of reactions between 
norpluviine and homolycorine are not determined, but are diagramed in a sequence for illustration of the enzyme types 
that may be involved. 
1.1.8  Other Amaryllidaceae Alkaloid Biosynthesis: Cherylline, Galanthindole, 
Galasine, and Buflavine 
Cherylline-type alkaloids have been proposed to have a unique biosynthetic route that makes them 
and the belladine alkaloids the only Amaryllidaceae alkaloid skeletons to avoid the phenol-phenol 
coupling steps. This biosynthetic route involves a hydroxylation of the 2-position of 4’-O-
methylnorbelladine or 4’-O-methyl-N-methylnorbelladine followed by a cyclization reaction by 
dehydration (Figure 1.8). An N-methylation is required to make cherylline, but its placement 
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before or after the hydroxylation and cyclization is unclear (Chan, 1973). Galanthindole type 
alkaloids are indole type alkaloids that were first discovered in 2003 (Unver et al., 2003). The 
lycorine or haemanthamine skeletons are potential candidates for their origin, but studies have not 
shown a biosynthetic relation to the Amaryllidaceae alkaloids through radiolabeling or other 
means (Unver et al., 2003). The galasine alkaloid type is rare and was first isolated in 1995 (Latvala 
et al., 1995). The galasine skeleton is perhaps derived from a similar biosynthetic route as 
homolycorine except the ether bond is migrated to position 10b. Buflavine-type alkaloids, 
including buflavine and apogalanthamine, are potentially of mixed origin. If their hydroxylation 
patterns are any indication, they may originate from different phenol-coupling reactions: 
haemanthamine/lycorine in the case of buflavine or galanthamine in the case of apogalanthamine, 
but having the same end carbon skeleton. There are other Amaryllidaceae alkaloids with diverging 
carbon skeletons that do not have their own classification due to their small number. 
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Figure 1.8. The pathway for cherylline and the structures of galasine, buflavine, and apogalanthamine. R indicates an 
undetermined methyl or hydrogen group.  
1.2  Methods of Interest to Pathway Elucidation 
1.2.1  Introduction 
The themes of miniaturization and increased throughput in methods supporting secondary 
metabolism research promise to accelerate discovery of biosynthetic enzymes in these systems. 
These trends are particularly relevant because they enable studies in non-model systems with 
increased efficiency. How these methods relate to metabolomics has recently been reviewed 
(Sumner et al., 2015). In this section, advances in methods and theory of potential use to secondary 
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metabolism research in non-model species is examined including gene discovery, next generation 
sequencing technologies, NMR and MS. 
1.2.2  Gene Clusters and Co-Regulation of Biosynthetic Pathways 
Genes involved in the same biosynthetic pathway have recently been found positioned together in 
the same chromosome region in plant genomes forming gene clusters. Genes clusters have been 
observed in the secondary metabolism of Zea mays, Avena spp., Oryza sativa, Arabidopsis 
thaliana, Lotus japonicus, Sorghum bicolor, Manihot esculenta, Papaver somniferum, and 
Solanum spp. as reviewed recently (Boycheva et al., 2014; Chae et al., 2014). Current theory for 
gene cluster formation postulates that gene clusters form when a particular set of genes, or alleles 
of genes, are favored in one environment but disfavored in another and the alleles interact 
positively together or negatively apart for plant fitness (Takos and Rook, 2012). In secondary 
metabolism, biosynthetic intermediates are often chemically reactive and, thereby, toxic (Takos et 
al., 2011). The presence of the entire pathway generates a beneficial compound, but an incomplete 
pathway may lead to a loss in fitness. When looking at Amaryllidaceae alkaloid biosynthesis, 
several intermediates are catechols. Catechols can form deleterious reactive oxygen species, DNA 
adducts, protein adducts, or cause protein-protein cross-linking (Schweigert et al., 2001). 
Amaryllidaceae alkaloids are thought to function primarily as herbivore deterrents. Under low-
nitrogen and/or low-herbivore pressure conditions, the expression of the pathway would have a 
fitness cost due to use of nitrogen. Corroborating this perspective, Narcissus rupicola, one of the 
only Narcissus spp. without Amaryllidaceae alkaloids, grows on rocky soil where nutrients such 
as nitrogen may be limiting (Berkov et al., 2014). Variability in the composition of alkaloids 
between Galanthus elwesii populations has been observed; this could indicate environment-
specific benefits for selected alkaloids (Berkov et al., 2004). Considering that Amaryllidaceae 
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alkaloids are favorable in particular environments, but perhaps not in others, and that intermediates 
possess reactive functional groups, all criteria are met that favor the generation of gene clusters 
(Fisher, 1930; Takos and Rook, 2012). A sequenced genome can be used to discover new genes 
surrounding known biosynthetic genes and, assuming a gene cluster organization, these genes 
could be tested for involvement in the biosynthetic pathway (Itkin et al., 2013). Members of gene 
families with the same theoretical enzymatic mechanism for a proposed reaction are prime 
candidates for secondary metabolic pathways because evolutionary changes in substrate 
preference are more likely than changes in the underlying chemistry (Furnham et al., 2012).  
Gene clustering information could be combined with co-expression analysis to filter and 
support candidate gene lists (Itkin et al., 2013). Co-expression is when transcripts express in a 
manner similar to each other; if one transcript is high the other will probably also be high and vice 
versa. These correlations in expression are frequently scored using correlation statistics including 
the Pearson correlation or Spearman’s rank correlation (Kumari et al., 2012). The correlations can 
also exist between the transcripts of biosynthetic genes and end products of the biosynthetic 
pathway as is observed in proanthocyanidin biosynthesis and anthocyanin biosynthesis (Mellway 
et al., 2009; Ravaglia et al., 2013). The chromatin structural protein H2A.Z has been shown to 
positively correlate with gene expression in stretches of DNA enriched for this protein, and has 
been shown to be important for proper expression of these genes by analysis of gene expression in 
H2A.Z mutants in Arabidopsis thaliana. Chromatin modifications such as the content of H2A.Z 
are thought to contribute to co-expression of genes in gene clusters (Nützmann and Osbourn, 
2015). This could be one of the mechanisms for the co-expression observed for many biosynthetic 
genes in secondary metabolic pathways. Another potential mechanism is a shared transcription 
factor as noted for the transcription factors OsTGAP1 from momilactone biosynthesis, MYB134 
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from poplar in proanthocyanidin biosynthesis, and bHLH3 from Prunus persica in anthocyanin 
biosynthesis (Mellway et al., 2009; Okada et al., 2009; Ravaglia et al., 2013). Transcription factors 
can act directly by driving the expression of biosynthetic genes or indirectly by driving expression 
of other transcription factors. Sharing a transcription factor causes genes to co-express because, 
barring additional regulatory factors, the transcription factor will influence the expression of its 
downstream genes in the same way under different conditions and developmental time points. 
Modification of expression from other transcription factors, transcription factor saturation, 
chromatin modifications, or DNA modifications, however, can cause deviations from a perfect 
correlation between genes regulated by the same transcription factor (Finnegan et al., 1996; 
Kaufmann et al., 2010). 
One approach to elucidating biosynthetic pathways is to address correlation between 
metabolites or known biosynthetic genes and potential biosynthetic genes with regard to 
expression patterns, presence, absence, or pseudo gene status either within a species or between 
species. If, for example, genes that co-express with a known biosynthetic gene in multiple species 
can be found, it is more likely to be related to the function of this known biosynthetic gene than a 
gene co-expressing in only one species. However, when looking for a biosynthetic gene in this 
way, the possibility of non-homologous genes doing the same reaction should be considered and 
misannotation of the known gene should be guarded against. This is possible when considering 
the history of convergent evolution in secondary metabolism (Pichersky and Lewinsohn, 2011; 
Takos et al., 2011). This may be the case for the more derivatized Amaryllidaceae alkaloids, 
because there is not a clear correlation between phylogeny and the presence or absence of 
particular alkaloids (Rønsted et al., 2012). Due to the limitations of detection methods, however, 
the absence of these compounds in intervening lineages cannot be determined with certainty. 
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Examination of alkaloid composition in species closely related to the species in question may be 
helpful. If the biosynthetic pathway seems to be present in most common lineages as indicated by 
the presence of the end product, then there is no evidence for convergent evolution and common 
origin can be assumed in gene discovery workflows. 
1.2.3  Sequencing Technologies 
Advances in sequencing technologies show great promise to improve de novo genome and 
transcriptome assemblies in non-model systems. These improved datasets will facilitate 
identification of gene clusters, co-expression analysis, and cloning of candidate genes. Second 
generation sequencing has improved the efficiency with which genomic and transcriptomic 
sequence information can be obtained. It is of particular value when studying systems without 
previous sequencing information as is discussed in Chapter 2 (Kilgore et al., 2014). Early platforms 
for high-throughput sequencing are Roche 454 sequencing by Life sciences corporation; second 
generation MiSeq, NextSeq, HiSeq, and HiSeq X Illumina platforms; and SOLiD from life 
technologies. De novo genome assemblies can be made with second generation sequencing data 
using programs such as ALLPATHS, Velvet, ABySS, and SOAPdenovo (Zerbino and Birney, 
2008; Simpson et al., 2009; Li et al., 2010; Gnerre et al., 2011). These genomes can provide 
information for the majority of the genome including genes, intergenic space, promoters, and 
introns. If the actual transcripts or the proteins they encode are the primary interest of the study, 
then de novo transcriptome assemblies will be more practical because of the reduced level of 
information required for sequence coverage and ability to focus only on transcripts that are being 
transcribed in samples of interest. De novo transcriptome assembly can provide a combination of 
sequence information, alternative splicing, and expression information in one experiment (Wang 
et al., 2009; Liu et al., 2014). Several prominent de novo transcriptome assemblers include Trinity, 
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Oases, and Trans-ABySS (Robertson et al., 2010; Schulz et al., 2012; Haas et al., 2013). Programs 
commonly used to align reads back to the transcriptomes and obtain expression estimates in the 
form of read counts include Bowtie and BWA (Li and Durbin, 2009; Langmead, 2010). This 
combination of information allows workflows for candidate gene selection based on homology 
and co-expression to be carried out with a very manageable initial investment and no prior 
sequence information (Giddings et al., 2011; Yeo et al., 2013; Kilgore et al., 2014). Workflows of 
this nature are used to identify biosynthetic genes in Chapters 2, 3, and 4. Many transcriptomes 
have been assembled using second generation sequencing, thereby providing information on a 
genetic level to previously uncharacterized systems such as Camptotheca acuminata, 
Catharanthus roseus, Rauvolfia serpentine, Valeriana officinalis, and Veratrum californicum, 
(Góngora-Castillo et al., 2012; Yeo et al., 2013; Augustin et al., 2015). As more organisms are 
sequenced, homology-based comparisons become more meaningful because these sequences can 
be used to prepare phylogenies. When these phylogenies are combined with biochemical validation 
data for proteins contained in the phylogenies, annotations can be made more accurate through 
programs like SIFTER (Engelhardt et al., 2009).  
Second generation sequencing generates short reads that create fragmented genomes in 
non-model and model systems alike. The inability to differentiate reads from highly similar 
transcripts can make de novo transcriptome and genome assemblies prone to collapsing these 
similar sequences into one contig. Sophisticated analysis workflows have been developed to 
resolve this problem in second generation sequencing (Spannagl et al., 2013). In addition, third 
and fourth generation sequencing technologies that provide longer sequencing reads are a 
promising new tool. PacBio from pacific biosciences is an instrument that monitors the 
incorporation of fluorescently labeled bases into a DNA strand by a polymerase tethered to a pore 
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on a sequencing cell. The system is able to routinely generate sequences ~5 kb long with up to 50 
kb possible. The down side is a ~80% error rate (Lee et al., 2014). Using circular libraries, the 
polymerase used for sequencing can read the same sequence multiple times and this data can be 
processed for error reduction. This results in a tradeoff between read length and accuracy 
determined by the number of times the polymerase can make a cycle around a loop. This system 
has been used for the sequencing and distinguishing of members of the highly similar vomeronasal 
receptor class 1 gene family in the non-model lemur Microcebus murinus (Larsen et al., 2014). 
One advantage of this system is its ability to simultaneously detect DNA modifications including 
the modified bases N6-methyladenosine, 5-methylcytosine, and 5-hydroxymethylcytosine. This 
information could be of value when using genomic DNA as a template and searching for regulatory 
modifications (Flusberg et al., 2010). A fourth generation system for DNA sequencing that 
commercializes nanopore technology is the MinION system that measures changes in electrical 
conductance as a DNA strand passes through a protein pore. This instrument is produced by Oxford 
Nanopore Technologies. One of the advantages of this technology is its size, measuring only 4 
inches long and the ability to be powered by a standard USB 3.0 port making it the first highly 
portable sequencer. It has been shown to have an average read size of ~5 kb with reads reaching 
10 kb. The low accuracy of MinION has improved from ~65% to ~85% since its first appearance, 
but still makes the technology impractical when used alone (Mikheyev and Tin, 2014; Loman and 
Watson, 2015). A combination of Illumina sequencing and MinION to make accurate Nanopore 
Synthetic-long reads prior to assembly has been used, however, to generate an Acinetobacter 
baylyi assembly with 99.99% accuracy (Madoui et al., 2015). A third approach to the generation 
of long reads is Illumina TruSeq which is a variant of second generation sequencing. This 
technique shears genomes into 10 kb sections and then performs short read sequencing and 
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assembly workflow on these 10 kb sections. This has been shown to be effective in the placement 
of the highly related transposable elements within the Drosophila melanogaster genome (McCoy 
et al., 2014). The longer sequence reads from PacBio, MinION, and Illumina TruSeq will help 
improve genome assemblies and connect contigs separated by highly repetitive regions. PacBio 
and MinION should also be able to provide start to end sequencing information of transcripts 
enabling splice variant analysis. The current downside to PacBio and MinION technologies is the 
high error rate associated with the raw read data. The Illumina TruSeq technology has low error 
rates ~0.03% because its reads are built with short reads. As for MinION, the high error rate can 
be corrected in PacBio with very high coverages with circular libraries or by combining the second 
generation short reads with third generation long reads as the programs LSC, proovread, and 
LoRDEC are designed to do (Au et al., 2012; Hackl et al., 2014; Salmela and Rivals, 2014). 
1.2.4  Nuclear Magnetic Resonance Spectroscopy 
NMR techniques have become more practical for the identification of the small quantities of 
compound observed in metabolomics surveys and generated during many enzyme assays. This 
will allow more complete catalogs of compounds in plant species to determine the presence or 
absence of compounds and their associated metabolic pathways. It will also facilitate identification 
of unknown products observed in enzyme assays. The usage of solid phase extraction (SPE) to 
concentrate metabolite fractions coming out of a separation technique like HPLC and the release 
of metabolite for NMR analysis has been of great utility. This workflow enables the structural 
elucidation of compounds from complex mixtures. When used in parallel with 2D NMR 
techniques for deconvolution of co-eluting compounds chromatography issues can be avoided 
(Mahrous and Farag, 2015). Another improvement of NMR technique is the invention of 
microprobes and miniaturized coils with current volumes of 10 µl and the potential of nanoliter 
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sample sizes (Fratila and Velders, 2011). The low volumes required allow for the elucidation of 
structures with microgram quantities of compound (Aramini et al., 2007). Without these 
innovations for deconvolution and miniaturization of NMR experiments, the workflows that utilize 
NMR in high-throughput systems with LC-MS outlined in the following section would not be 
practical. 
1.2.5  Mass Spectrometry 
MS has improved in mass accuracy with the development of fourier transform mass spectrometers 
(FTMS). The increased mass accuracy of FTMS like the Orbitrap can be of immense value in 
metabolomics by providing the accuracy needed to infer the molecular formula of compounds 
(Krauss et al., 2010). Combined with MS/MS data the compounds can be searched against 
databases for the inference of structure. This is of great value in metabolomics studies and in 
enzyme product identification when the product is a characterized structure for which standard is 
lacking. Several workflows apply MSn and HPLC with SPE and NMR for the systematic structure 
elucidation of components in complex mixtures of metabolites (Castro et al., 2010; Sumner et al., 
2015). To obtain quantification of compounds, evaporative light scattering detection (ELSD) can 
be used in combination with LC-MS (LC-ELSD-MS) (Cremin and Zeng, 2002). Another example 
of a combination workflow utilizes LC-ELSD-MS detection for initial characterization of complex 
plant extracts, followed by structural elucidation of select compounds by NMR. A significant 
effect in a high-throughput screen for a biological activity of interest, such as a greater than 32% 
reduction in the cancer cell lines MCF7, NCI-H460, or SF-26, is used to prioritize compounds for 
structural elucidation with NMR (Eldridge et al., 2002). These systematic catalogs of structures 
are very useful to secondary metabolism research because the associated MSn and NMR data 
become available in databases for future analysis of enzyme products or identification of 
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metabolites from other complex mixtures in workflows lacking MSn or NMR components. In GC-
MS data analysis, the use of libraries such as just described is relatively simple because of the 
standard ionization settings and resulting reproducibility of spectra. In LC-MSn the fragmentation 
of compounds can vary greatly depending on the instrument setup and settings (Hopley et al., 
2008). To use existing LC-MSn libraries the setup and setting used for the library construction 
should be used and this can be difficult if the instruments used in library construction and available 
to the researchers are not the same. To deal with this problem there are prediction algorithms that 
utilize LC-MSn data with fragmentation rules for ion trees and algorithms for relating MSn data to 
databases with different instrument setup and settings including the Mass Frontier software from 
Thermo Scientific. 
1.2.6 Substrate Considerations 
Advances in MS, and NMR promise to lower the quantity of product required in enzyme assays. 
This also lowers the quantity of substrate required which can also be a limiting factor when 
performing enzyme assays. When trying to acquire substrates for enzyme assays the substrates can 
be bought, synthesized, or isolated from the source. Purchasing the substrate is frequently not an 
option in highly specialized pathway intermediates, so the latter two lines of inquiry become 
necessary. In the case of Amaryllidaceae alkaloids, there is a large diversity of specialized 
synthesis methods that have regularly been reviewed by Zhong Jin and can be used for production 
of various pathway intermediates (Jin, 2013). As biosynthetic genes are discovered expression of 
these genes in a heterologous system for the production of pathway intermediates that can be used 
in enzyme assays becomes possible (Augustin et al., 2015). Methods for source isolation are 
provided in the publication of a compound’s discovery but the availability of plant material can be 
a major constraint particularly for endangered species. 
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1.3  Conclusion 
In conclusion, the Amaryllidaceae alkaloids are a diverse group of alkaloids with many 
undiscovered biosynthetic enzymes. Advances in sequencing will facilitate genomic and 
transcriptomic analyses of these plants to identify candidate biosynthetic genes. In this thesis 
transcriptomes for Narcissus sp. aff. pseudonarcissus, Galanthus sp., and Galanthus elwesii are 
generated and described in Chapters 2 and 3. Previous work has generated a transcriptome for 
Lycoris aurea (Wang et al., 2013). The combination of sequencing with other methods such as 
proteomics can be a powerful approach for the identification of candidate genes. This combination 
was implemented during the discovery of VpVAN in Vanilla planifolia by selectively looking for 
transcripts and proteins highly present in the biosynthetic tissue for vanillin, inner bean pod 
(Gallage et al., 2014). Transcriptomic and genomic sequencing can also provide complementary 
information during candidate gene selection by allowing the combination of co-expression analysis 
and gene cluster searches. This combination of transcriptomic and genomic resources have become 
available in Catharanthus roseus through next generation sequencing (Kellner et al., 2015). 
Testing the candidate enzymes that will be identified through combinations of omics approaches 
including transcriptomics, proteomics, and genomics will be facilitated through more sensitive 
detection and structural elucidation of substrates and products by MS and NMR techniques either 
through plant-to-plant comparisons or direct assay of the candidate enzymes. The discovery of 
N4OMT in Chapter 2 is an example. A de novo transcriptome assembly of Narcissus sp. aff. 
pseudonarcissus provided both the sequence and expression information needed to identify a 
candidate methyltransferase. Once the methyltransferase is shown to make a methylated product 
from norbelladine with MS/MS, small volume NMR technologies are utilized to identify the 
product, 4’-O-methylnorbelladine (Kilgore et al., 2014). Another example of combining 
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transcriptomics with sensitive techniques such as small volume NMR is the discovery of the first 
6 steps of cyclopamine biosynthesis from cholesterol up to the intermediate verazine. In this study 
a de novo transcriptome assembly of Veratrum californicum is used to find candidates through co-
expression analysis. The candidates are expressed in insect cells and the various products are 
identified by a combination of MS/MS and NMR (Augustin et al., 2015). These examples of 
enzyme discovery in different species with different compound classes show these improvements 
are generally applicable to secondary metabolism in non-model systems when looking for novel 
enzymes. 
1.4  Chapter Summary 
1.4.1  Chapter 2 
In this thesis, the Amaryllidaceae alkaloid biosynthetic genes are shown to co-express in leaf, bulb 
and inflorescence tissues with the accumulation of the Amaryllidaceae alkaloid galanthamine, and 
with each other. In Chapter 2, I show that N4OMT transcript co-accumulates with galanthamine in 
Narcissus sp. aff pseudonarcissus. This is done using a de novo assembled Narcissus sp. aff 
pseudonarcissus transcriptome with associated leaf, bulb, and inflorescence expression estimates 
to find methyltransferase gene transcripts that co-accumulate with galanthamine, and then testing 
these recombinant methyltransferases for enzyme activity with putative intermediates of 
galanthamine biosynthesis. N4OMT was shown to have the ability to methylate norbelladine to 
4’-O-methylnorbelladine. The discovery of this enzyme/gene co-accumulating with galanthamine 
supports the starting hypothesis that Amaryllidaceae biosynthetic genes will co-express in a tissue–
specific pattern that reflects galanthamine accumulation in the plant. This work was done in 
collaboration with Megan M. Augustin, Courtney M. Starks, Mark O’Neil-Johnson, Gregory D. 
May, John A. Crow, and Toni M. Kutchan.   
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Previously published in PLoS One 9(7):e103223 
Cloning and characterization of a norbelladine 4’-O-methyltransferase involved in the 
biosynthesis of the Alzheimer’s drug galanthamine in Narcissus sp. aff. pseudonarcissus 
1.4.2  Chapter 3 
Chapter 3 demonstrates that co-expression is observed between Amaryllidaceae alkaloid 
biosynthetic genes and between species through the discovery of CYP96T1. CYP96T1 is a para-
para’ phenol-phenol coupling cytochrome P450 capable of forming noroxomaritidine. The gene 
was discovered by looking for cytochrome P450 transcripts that co-expressed with the N4OMT 
(discovered in Chapter 2) in Narcissus sp. aff pseudonarcissus, Galanthus sp., and Galanthus 
elwesii. When characterizing the recombinant enzyme, it was found to catalyze the formation of 
both enantiomers of noroxomaritidine. This indicates that CYP96T1 is involved in the initial para-
para’ phenol-phenol coupling to form an achiral intermediate and then releases this intermediate 
prior to a spontaneous nitrogen ring closure, thereby generating both enantiomers. This work was 
done in collaboration with Megan M. Augustin, Gregory D. May, John A. Crow, and Toni M. 
Kutchan.  
1.4.3  Chapter 4 
Chapter 4 demonstrates that the co-expression observed for N4OMT and CYP96T1 is shared with 
all of the core Amaryllidaceae alkaloid biosynthetic genes by identifying a norcraugsodine 
reductase. The discovery of this enzyme was through a similar work-flow as used in Chapter 3, 
but interrogating for oxidoreductases instead of cytochromes P450. The discovery of 
norcraugsodine reductase through co-expression analysis provides all the Amaryllidaceae alkaloid 
specific biosynthetic genes prior to the phenol-phenol coupling branch point. This enzyme was 
shown to have norcraugsodine reductase activity, and potentially facilitates the condensation of 
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tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine.  Cynthia K. Holland, Joseph 
M. Jez, and Toni M. Kutchan were key collaborators in this work.  
1.4.4  Chapter 5 
In Chapter 5, I present the major conclusions of this thesis. I address how this thesis will assist 
future research on Amaryllidaceae alkaloid biosynthesis, and on non-model species in general. 
Potential applications of the transcriptomic resources generated during my thesis research, and the 
enzymes discovered, are also discussed. The discovery of these three biosynthetic genes will 
facilitate the research on how variation in these genes and their expression leads to the observed 
variability in Amaryllidaceae alkaloid content across tissues, populations, and species. It will also 
facilitate discovery of additional biosynthetic genes for Amaryllidaceae alkaloids and regulatory 
elements, including transcription factors. These discoveries have the potential to be used for 
improved production of valuable Amaryllidaceae alkaloids and to provide experimental systems 
for clear examination of the roles these compounds play in planta and in the surrounding 
environment.  
40 
 
Chapter 2: Cloning and Characterization of 
a Norbelladine 4’-O-Methyltransferase 
Involved in the Biosynthesis of the 
Alzheimer’s Drug Galanthamine in 
Narcissus sp. aff. pseudonarcissus 
 
This chapter was previously published in PLoS One 9(7):e103223 
Cloning and characterization of a norbelladine 4’-O-methyltransferase involved in the 
biosynthesis of the Alzheimer’s drug galanthamine in Narcissus sp. aff. pseudonarcissus 
Matthew B. Kilgore1, Megan M. Augustin1, Courtney M. Starks2, Mark O’Neil-Johnson2, Gregory D. May3, 
John A. Crow3, Toni M. Kutchan1† 
1Donald Danforth Plant Science Center, St. Louis, MO, USA 
2Sequoia Sciences, St. Louis, MO, USA 
3National Center for Genome Resources, Santa Fe, NM, USA 
 
Galanthamine is an Amaryllidaceae alkaloid used to treat the symptoms of Alzheimer’s disease. 
This compound is primarily isolated from daffodil (Narcissus spp.), snowdrop (Galanthus spp.), 
and summer snowflake (Leucojum aestivum). Despite its importance as a medicine, no genes 
involved in the biosynthetic pathway of galanthamine have been identified. This absence of genetic 
information on biosynthetic pathways is a limiting factor in the development of synthetic biology 
platforms for many important botanical medicines. The paucity of information is largely due to 
the limitations of traditional methods for finding biochemical pathway enzymes and genes in non-
model organisms. A new bioinformatic approach using several recent technological improvements 
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was applied to search for genes in the proposed galanthamine biosynthetic pathway, first targeting 
methyltransferases due to strong signature amino acid sequences in the proteins. Using Illumina 
sequencing, a de novo transcriptome assembly was constructed for Narcissus sp. aff. 
pseudonarcissus. BLAST was used to identify sequences that contain signatures for plant O-
methyltransferases in this transcriptome. The program HAYSTACK was then used to identify 
methyltransferases that fit a model for galanthamine biosynthesis in leaf, bulb, and inflorescence 
tissues. One candidate gene for the methylation of norbelladine to 4’-O-methylnorbelladine in the 
proposed galanthamine biosynthetic pathway was identified. This methyltransferase cDNA was 
expressed in E. coli and the protein purified by affinity chromatography. The resulting protein was 
found to be a norbelladine 4’-O-methyltransferase (NpN4OMT) of the proposed galanthamine 
biosynthetic pathway. 
2.1  Introduction 
Amaryllidaceae alkaloids are a group of alkaloids with many documented biological activities. 
This makes them valuable potential medicines several examples are the anti-cancer compounds 
haemanthamine and lycorine and the anti-viral compound pancratistatin (Gabrielsen et al., 1992; 
Liu et al., 2004; Havelek et al., 2014). One example of an Amaryllidaceae alkaloid already used 
medically to treat Alzheimer’s disease is galanthamine. Galanthamine is an alkaloid discovered in 
1953 that is produced by members of the Amaryllidaceae family (Uyeo and Kobayashi, 1953). It 
reduces the symptoms of Alzheimer’s disease through acetylcholine esterase inhibition and 
nicotinic receptor binding. These activities are thought to compensate for reduced acetylcholine 
sensitivity in Alzheimer’s disease by increasing acetylcholine levels and perhaps increasing 
acetylcholine sensitivity (Irwin and Smith, 1960; Barik et al., 2005). Until now, no committed 
biosynthetic genes have been identified (Wilcock et al., 2000; Wilcock et al., 2003). Limited 
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enzyme kinetic characterization has been done on plant protein extracts enriched for the 
norbelladine 4’-O-methyltransferase (N4OMT) of Nerine bowdenii, but the underlying gene was 
never identified (Mann, 1963). 
The putative galanthamine biosynthetic pathway has been studied in detail and 
intermediates in the pathway have been determined. This knowledge is based on radiolabeling 
experiments. Work on other Amaryllidaceae alkaloids including lycorine and haemanthamine 
studying steps prior to 4’-O-methylnorbelladine can be applied to galanthamine biosynthesis 
because 4’-O-methylnorbelladine is a universal substrate for these alkaloids (Eichhorn et al., 
1998). The proposed pathway starts with the amino acids phenylalanine and tyrosine (Barton et 
al., 1963). In Narcissus incomparabilis phenylalanine was established as a precursor that 
contributes the catechol portion of norbelladine. This was done using radiolabeling experiments to 
trace incorporation of [3-14C]phenylalanine into lycorine and degradation experiments on the 
resulting lycorine to determine the location of the 14C label (Suhadolnik et al., 1962). Similar 
experiments with phenylalanine were performed in Nerine browdenii monitoring haemanthamine 
incorporation (Wildman et al., 1962b). As a follow up radiolabeling experiments were used to 
determine that phenylalanine probably proceeds sequentially through the intermediates trans-
cinnamic acid, p-hydroxycinnamic acid and 3,4-dihydroxycinnamic acid or p-
hydroxybenzaldehyde before conversion into 3,4-dihydroxybenzaldehyde (Suhadolnik et al., 
1963a). Tyrosine has been established as a precursor of galanthamine that in contrast to 
phenylalanine contributes only to the non-catechol half of the norbelladine intermediate. This was 
done by observing [2-14C]tyrosine incorporation into galanthamine and degradation experiments 
of galanthamine (Barton et al., 1963). Tyrosine decarboxylase converts tyrosine into tyramine and 
is well characterized in other plant families (Lehmann and Pollmann, 2009). 3,4-
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Dihydroxybenzaldehyde and tyramine condense into a Schiff-base and are reduced to form the 
first alkaloid in the proposed pathway, norbelladine. Norbelladine has been documented to 
incorporate into galanthamine and all major Amaryllidaceae alkaloid types in 14C radiolabeling 
studies (Barton et al., 1961; Battersby et al., 1961b; Battersby et al., 1961a; Barton et al., 1963). 
4’-O-Methylnorbelladine is then formed by O-methylation of norbelladine (Barton et al., 1963). 
A phenol-coupling reaction, followed by spontaneous oxide bridge formation, creates N-
demethylnarwedine, which is then reduced and N-methylated to yield galanthamine (Figure 2.1) 
(Eichhorn et al., 1998). In one study, Barton et al. fed O-methyl[1-14C]norbelladine to flower stalks 
of King Alfred daffodils, but it was not incorporated into galanthamine. The authors concluded 
that the intermediate in the pathway must be 4’-O-methyl-N-methylnorbelladine despite low 
incorporation of this compound when the equivalent experiment was conducted with 4’-O-methyl-
[N-methyl-14C]norbelladine (Barton et al., 1963). A recent revision of the proposed pathway by 
Eichhorn et al. contradicted this conclusion and placed the N-methylation step at the end of the 
proposed pathway instead of before the phenol-coupling reaction. In that study, [OC3H3]4’-O-
methylnorbelladine was applied to ovary walls of Leucojum aestivum. Incorporation into products 
indicated that the pathway produced N-demethylated intermediates up until the penultimate step 
to galanthamine. N-methylation was proposed as the final step of biosynthesis (Eichhorn et al., 
1998).  
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Figure 2.1. Proposed biosynthetic pathway for galanthamine. 3,4-Dihydroxybenzaldehyde derived from phenylalanine 
and tyramine derived from tyrosine are condensed to form norbelladine. Norbelladine is methylated by NpN4OMT to 
4’-O-methylnorbelladine. 4’-O-Methylnorbelladine is oxidized to N-demethylnarwedine. N-demethylnarwedine is 
then reduced to N-demethylgalanthamine. In the last step, N-demethylgalanthamine is methylated to galanthamine. 
 
The discovery of genes involved in metabolism is essential to metabolic engineering and 
synthetic biology. The elucidation of plant biochemical pathways can take decades. In fact, the 
biosynthesis of morphine, an important opiate analgesic, is still not completely elucidated at the 
gene level, even though the first enzyme specific to morphine biosynthesis was discovered more 
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than 20 years ago in 1993 (Gerardy and Zenk, 1993). Reports on the enzymatic activities of poppy 
extracts to describe the morphine biosynthetic pathway go even farther back to 1971 (Roberts, 
1971). After more than 40 years of enzymology and reverse genetics, the morphine biosynthetic 
pathway is still incomplete at the gene level. Traditionally, plant biochemical pathway enzymes 
have been identified either directly by purification from plant extracts or indirectly by examining 
enriched cDNA libraries and functionally expressing clones (Mann, 1963; Takeshita et al., 1995; 
Frick and Kutchan, 1999; Morishige et al., 2002; Ounaroon et al., 2003; Raman and 
Rathinasabapathi, 2003; Nomura and Kutchan, 2010; Widiez et al., 2011). To reduce pathway 
discovery from a 20+ year process to a more reasonable time frame, new methods must be 
developed and embraced. The previous work on galanthamine biosynthesis makes the prediction 
of enzyme classes involved in the proposed pathway possible, thereby rendering the galanthamine 
pathway a suitable system for development of an omic methodology for biochemical pathway 
discovery.  
In this study, using galanthamine biosynthesis as proof-of-concept, a novel workflow is 
presented to streamline the identification of biosynthetic pathway genes. A de novo transcriptome 
is created for Narcissus sp. aff. pseudonarcissus using illumina sequencing. HAYSTACK, a 
program that utilizes the Pearson correlation, is used to find genes that co-express with 
galanthamine accumulation in this transcriptome. This set of candidates is interrogated for 
homologs to methyltransferases. An OMT that converts norbelladine to 4’-O-methylnorbelladine 
(NpN4OMT) in the proposed biosynthesis of galanthamine is identified in this manner and 
characterized.  
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2.2  Materials and Methods 
2.2.1  Plant Tissue and Chemicals 
N. sp. aff. pseudonarcissus plants were collected from an outdoor plot in St. Louis, MO, with the 
GPS coordinates (38.659305, -90.410203), during peak flowering and separated into leaf, bulb, 
and inflorescence tissues. Inflorescence is considered all tissues above the spathe. The plants were 
collected with the permission of the corresponding author who is the owner of the private property. 
No endangered species were involved in this collection.  
Formic acid, potassium phosphate monobasic, potassium phosphate dibasic, 
tris(hydroxymethyl)aminomethane, glycerol, sodium acetate, sodium chloride, 
tetramethylethylenediamine, calcium chloride, magnesium chloride, and β-mercaptoethanol were 
obtained from Acros Organics. Glycine, papaverine hydrochloride, S-adenosyl methionine 
(AdoMet), cobalt chloride, zinc chloride, and manganese chloride were obtained from Fisher 
Scientific. Other chemicals include acetonitrile, JT Baker; InstaPAGE, IBI Scientific; ethanol 200 
proof, KOPTEC; Bradford reagent, Bio-Rad; S-adenosyl-L-homocysteine, Sigma-Aldrich; 
deoxynucleotide triphosphates (dNTPs), New England BioLabs, Inc. (NEB); and isopropyl β-D-
1-thiogalactopyranoside (IPTG), Gold Biotechnology. The norbelladine N-methylnorbelladine, 4’-
O-methyl-N-methylnorbelladine, and 4’-O-methylnorbelladine were synthesized previously 
(Eichhorn et al., 1998). NotI, NdeI, T4 DNA ligase, Taq DNA Polymerase, and Phusion High-
Fidelity DNA Polymerase enzymes were from NEB. M-MLV reverse transcriptase and 
RNaseOUT were obtained from Invitrogen. 
2.2.2  Alkaloid Extraction and Quantification 
N. sp. aff. pseudonarcissus leaf, bulb, and inflorescence tissues were extracted by grinding tissue 
with a mortar and pestle cooled with liquid nitrogen. Each ground sample was split into three 
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technical replicates. Two volumes of 70 % ethanol were added followed by vortexing 5 min and 
centrifuging at 14,000 xg for 10 min. The supernatant was filtered through a 0.2 µm low protein 
binding hydrophilic LCR (PTFE, millex-LG) membrane. For galanthamine quantitation, samples 
were diluted 1000 fold. Liquid chromatography samples were injected (10 µl) onto an LC-20AD 
(Shimadzu) with a Waters Nova Pak C-18 (300 X 3.9 mm 4 µm) column coupled to a 4000 QTRAP 
(AB Sciex Instruments) for MS/MS analysis. The gradient program had a flow rate of 0.8 ml/min; 
solvent A was 0.1 % formic acid in H2O and solvent B was 0.1 % formic acid in acetonitrile. At 
the beginning of the program, solvent B was held at 15 % for 2 min, followed by a linear gradient 
to 43 % B at 15 min, 90 % B at 15.1 min, 90 % B at 20 min, 15 % B at 21 min, and 15 % B at 26 
min. A Turbo Ion Spray ionization source temperature of 500 °C was used with low resolution for 
Q1 and Q3. All multiple reaction monitoring (MRM) scans were performed in positive ion mode. 
The ion fragment used for quantitation of galanthamine was 288.00 [M+H]+/213.00 [M-OH-
C3H7N]
+● m/z. Galanthamine was identified by comparison of retention time and fragmentation 
pattern to authentic galanthamine standard. The Analyst 1.5 software was used to quantitate 
galanthamine using a comparison of peak area of the unknown to authentic galanthamine. 
2.2.3  Illumina Sequencing and Transcriptome Assembly 
The transcriptome was generated via data cleaning, short read assembly, final assembly, and post 
processing steps. A modified TRIzol RNA isolation method found as protocol number 13 in 
Johnson et al. was used to obtain RNA for cDNA library preparation (Johnson et al., 2012). 
Illumina RNA-Seq was used to generate 100 base pair paired-end reads from the cDNA library. 
The resulting data was monitored for overrepresented reads. Having found no such reads, adaptor 
sequences and sections of the standard phi X genome were identified and removed. Reads were 
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then trimmed for quality using the FASTX toolkit version 0.0.8 with a Q value cutoff of 10 as is 
default for PHRAP.  
Reads were assembled in the following manner. ABySS was used to run multiple 
assemblies of the reads with a range of kmers 24≤k≤54. The resulting assemblies were assembled 
into scaffolds using ABySS scaffolder (Birol et al., 2009). Gaps in the sequences were resolved 
using GapCloser from the SOAPdenovo suit (Luo et al., 2012). A final assembly was conducted 
on the resulting synthetic ESTs using Mira in EST assembly mode (Chevreux et al., 2004). All 
sequences with over 98 % identity were considered redundant and removed using CD-Hit (Li and 
Godzik, 2006). The resulting contigs >100 base pairs long were included in the final assembly. 
Protein products for these contigs were predicted using ESTScan (Iseli et al., 1999; Lottaz et al., 
2003); all peptides over 30 amino acids were reported. Burrows-Wheeler Aligner was used to align 
the original reads to the assembled transcriptome to generate relative expression data for the 
contigs in leaf, bulb and inflorescence tissues (Li and Durbin, 2009). The N. sp. aff. 
pseudonarcissus assembly and the raw read data can be found at the MedPlant RNA Seq Database, 
http://www.medplantrnaseq.org. Anomalies in the number of reads per contig and abnormally long 
or short contigs were manually curated. To normalize for read depth, each expression value for 
each contig was divided by the total reads for the respective tissue and multiplied by 1 million.  
2.2.4  Candidate Gene Identification 
Relative expression data was compared to the levels of galanthamine in N. sp. aff. pseudonarcissus 
tissues using HAYSTACK with a background cutoff of 1, correlation cutoff 0.8, fold cutoff 4, and 
p-value 0.05 (Mockler et al., 2007). Using BLASTP, a list of known methyltransferases were 
queried against the N. sp. aff. pseudonarcissus transcriptome peptide list with an E-value of e-9 to 
identify methyltransferase homologs (Altschul et al., 1997). Accession numbers from NCBI for 
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these methyltransferases are presented in Table C.1. Overlap between the methyltransferase 
homologs and contigs that pass the HAYSTACK criteria were considered candidate genes. The 
candidate N. sp. aff. pseudonarcissus norbelladine 4’-OMT has the designation 
medp_9narc_20101112|62361 in the contigs.fa file in the Narcissus_spp.tar file on 
http://www.medplantrnaseq.org. 
2.2.5  Phylogenetic Tree 
Sequences found in Table C.2 were aligned using MUSCLE in the MEGA 5.2 software with 
default parameters (Tamura et al., 2011). For the phylogeny, this alignment was provided as input 
into the Maximum-Likelihood algorithm also found in MEGA 5.2. Default parameters were used 
except the Gaps/Missing Data treatment was set to partial deletion.  
2.2.6  PCR and Cloning 
The 5’ and 3’ ends of the NpN4OMT sequence were completed using Rapid Amplification of 
cDNA Ends (RACE) with the Invitrogen RACE kit. For gene specific primers (GSP) see Table 
C.3. The same PCR program was used for both 5’ and 3’RACE. This applies to both cycles of 
nested PCR as well. The PCR program parameters were 30 s 98 ⁰C 1 cycle; 10 s 98 ⁰C, 30 s 60 
⁰C, 1 min 72 ⁰C 30 cycles; 5 min 72 ⁰C 1 cycle. The outer-primer PCR was a mixture of 4.6 ng/µl 
RACE ready bulb cDNA, 0.3 mM dNTPs, 0.3 µM GSP primer, 0.9 µM kit provided RACE primer, 
1 U NEB Phusion High-Fidelity DNA Polymerase, and Invitrogen recommended quantity of 
buffer in a 50 µl reaction. The inner-primer PCR used the product of the outer-primer PCR as 
template with 0.2 µM of the inner RACE GSP and Invitrogen primers and 0.2 mM dNTPs. 
Amplification of the NpN4OMT open reading frame was performed with 5.1 ng/µl N. sp. 
aff. pseudonarcissus bulb oligo(dT) primed cDNA, 0.4 mM dNTPs, 0.4 µM each forward and 
reverse outer-primer, 1 UNEB Phusion High-Fidelity DNA Polymerase, and recommended buffer 
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in a 50 µl reaction. With the following PCR program parameters: 30 s 98 ⁰C 1 cycle; 10 s 98 ⁰C, 
30 s 52 ⁰C, 1 min 72 ⁰C for 30 cycles; 5 min 72 ⁰C 1 cycle. The inner-primer PCR used 1 µl of 
the outer-primer PCR product and used the inner-primers in Table C.3. The same PCR time 
program was used except the annealing temperature was increased to 53⁰C.  
NpN4OMT was cloned into the pET28a vector with the NotI and NdeI restriction sites that 
were added to the 5’ and 3’ ends of the open reading frame using the inner PCR primers. PCR 
product and pET28a were digested with NotI and NdeI enzymes, followed by gel purification and 
ligation with the T4 DNA ligase. The resulting construct was transformed into E. coli DH5α cells 
and screened on Luria-Bertani agar plates with 50 µg/ml kanamycin. Resulting colonies were 
screened by colony PCR with T7 sequencing and T7 terminator primers and Taq DNA Polymerase. 
The following cycle program was used: 3 min 94 ⁰C 1 cycle; 30 s 94 ⁰C, 30 s 52 ⁰C, 2 min 72 ⁰C 
30 cycles; 7 min 72 ⁰C 1 cycle. Plasmid minipreps were obtained using the QIAGEN QIAprep 
Spin Miniprep Kit. After Sanger sequencing of constructs (Genewiz), the desired plasmids were 
transformed into E. coli BL21(DE3) Codon Plus RIL competent cells. The sequences of the 
resulting five variants have the following accession numbers KJ584561(NpN4OMT1), 
KJ584562(NpN4OMT2), KJ584563(NpN4OMT3), KJ584564(NpN4OMT4), and 
KJ584565(NpN4OMT5). 
2.2.7  Protein Purification 
Recombinant protein production in 1 L of E. coli and purification with TALON resin followed the 
protocol found in (Higashi et al., 2010). No proteases were added to the protein extract, and 
desalting was performed with PD-10 columns from GE Healthcare. Protein quantity was 
determined according to Bradford; purity was monitored by SDS-PAGE. The E. coli cell line 
containing the hexahistidine-tagged methylthioadenosine/S-adenosylhomocysteine nucleosidase 
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(Pfs) construct from Choi-Rhee and Cronan’s work was used to purify Pfs protein (Choi-Rhee and 
Cronan, 2005). 
2.2.8  Screening Enzyme Assays 
Enzyme assays for initial testing of NpN4OMT1 contained 10 µg of pure protein with 200 µM 
AdoMet, 100 µM norbelladine, and 30 mM potassium phosphate buffer pH 8.0 in 100 µl. The 
assays were incubated for 2 hr at 30⁰C. The vector control was an E. coli extract purified with 
TALON in the same way as the methyltransferase protein. For the vector control assay, an equal 
volume of the pure vector control extract was substituted for the NpN4OMT1 protein in the 
enzyme assay. These assays were quenched by adjusting the pH to 9.5 with two volumes of sodium 
bicarbonate and extracted with two volumes ethyl acetate two times. After drying, the extracts 
were re-suspended in the initial mobile phase of the HPLC program. The HPLC separation of the 
assays was performed using a phenomenex Luna C8(2) 5 µm 250 x 4.6 mm column with solvent 
A (0.1 % formic acid in H2O) and solvent B (acetonitrile). The program started with 10 % solvent 
B and a flow rate of 0.8 ml/min, a linear gradient began at 2 min to 30 % at 15 min, 90 % at 15.1 
min, 90 % at 20 min, 10 % at 21 min, and 10 % at 28 min. Injection volume was 20 µl using a 
Waters Autosampler. Waters UV detector was set to 277 nm. 
2.2.9  Kinetic Characterization 
After optimization of the assay, the buffer was changed to 100 µM glycine at pH 8.8, with 5 mM 
of MgCl2 added and the temperature was increased to 37 ⁰C in 100 µl total reaction volume. When 
performing kinetic assays, the E. coli enzyme Pfs was added to break down SAH and prevent 
product inhibition. Product formation in kinetic experiments was quantified by comparing product 
peak area to a standard curve of the expected product or equivalent. Papaverine was used as an 
internal standard. 
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With the same solvent system as for screening enzyme assays, the HPLC program started 
with 20 % B and a flow rate of 0.8 ml/min, a linear gradient began at 2 min to 25.4 % B at 7 min, 
90 % at 7.2 min, 90 % at 9 min, 20 % at 9.1 min, and 20 % at 14 min. A 4000 QTRAP mass 
spectrometer coupled to the same LC column and time program as used in HPLC was used to 
collect all compound mass and fragmentation data. For program setting details see Table C.4. For 
norbelladine kinetics an MRM program in positive ion mode was used to monitor the following 
fragments 260.0 [M+H]+/138.0 [M-C8H9O]
+● m/z, 260.0 [M+H]+/121.0 [M-C7H8NO2]
+● m/z, 
274.0 [M+H]+/137.0 [M+H-C8H9O2]
+ m/z, 274.0 [M+H]+/122.0 [M+H-C8H10NO2]
+ m/z. The 
fragments with 260.0 [M+H]+ m/z and 274.0 [M+H]+ m/z molecular ions were replaced when 
looking at N-methylnorbelladine for 274.0 [M+H]+/152.1 [M-C8H9O]
+● m/z, 274.0 [M+H]+/121.0 
[M-C9H12NO2]
+● m/z, 288.0 [M+H]+/150.1 [M-C8H9O2]
+● m/z, and 288.2 [M+H]+/137.0 [M-
C9H12NO]
+● m/z. Papaverine internal standard was monitored with the following fragments 340.4 
[M+H]+/324.2 [M-CH3]
+● m/z and 340.4 [M+H]+/202.1 [M-C8H9O2]
+● m/z. When conducting 
dopamine kinetics, galanthamine was used as the internal standard and samples were not ethyl 
acetate extracted prior to LC/MS/MS analysis. To remove protein, two volumes of acetonitrile 
were added followed by 1 hr at -20 ⁰C and 10 min centrifugation at 16,100 xg, 4 ⁰C. The 
supernatant was dried under vacuum and re-suspended in the starting mobile phase before analysis. 
The HPLC time program was changed to start at 5 % solvent B with solution going to waste until 
3.9 min, at 5 min start linear gradient to 25 % B at 25 min, 90 % B at 9.5 min, 90 % B at 11 min, 
5 % B at 11.1 min, and 5 % B at 16 min. Ions monitored in the MRM were 168.0 [M+H]+/151.0 
[M+H-OH]+ m/z and 168.0 [M+H]+/119.0 [M-OH-OCH3]
+● m/z. AdoMet steady state kinetic 
parameters were determined with norbelladine as the saturated substrate. Product was quantitated 
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using HPLC with the 28 min program used for screening enzyme assays. Product for assays on the 
additional NpN4OMT variants was detected with this same 28 min program on HPLC.  
When conducting kinetic experiments the Km was at least five fold higher than the 
minimum concentration of substrate and fivefold lower than the maximum concentration of 
substrate tested. Km and kcat were calculated by nonlinear regression to the Michaelis-Menten 
kinetics equation with the GraphPad PRISM 5.0 software.  
2.2.10  NMR 
NMR spectra were acquired for 4’-O-methylnorbelladine in CD3OD at 600 MHz on a 
BrukerAvance 600 MHz spectrometer equipped with a BrukerBioSpin TCI 1.7 mm 
MicroCryoProbe. Proton, gCOSY, ROESY, gHSQC, and gHMBC spectra were acquired; 13C 
chemical shifts were obtained from the HSQC and HMBC spectra. Chemical shifts are reported 
with respect to the residual non-deuterated MeOD signal (H 3.31) (Figure C.1, C.2, C.3, C.4, and 
C.5). 
2.2.11 Quantitative Real Time-PCR (qRT-PCR) 
cDNA for leaf, bulb, and inflorescence tissues of N. sp. aff. pseudonarcissus were created using 1 
µg RNA from the respective tissues, random primers, and M-MLV reverse transcriptase according 
to the Invitrogen protocol. qRT-PCR was conducted with a TaqMan designed gene expression 
assay for the methyltransferase with ribosomal RNA as a reference according to manufacture 
protocol. Reactions (5 µl) were performed in quadruplicate with outlier exclusion using Applied 
Biosystems StepOnePlus Real-Time PCR system. Methyltransferase relative expression values 
were determined by calculating ∆∆CT values relative to standard ribosomal RNA and leaf tissue 
(Livak and Schmittgen, 2001).  
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2.3 Results 
The Illumina sequencing of N. sp. aff. pseudonarcissus leaf, bulb, and inflorescence tissues 
resulted in 65 million paired-end reads that were used to make the N. sp. aff. pseudonarcissus 
transcriptome assembly. The transcriptome assembly consisted of 106,450 sequences (Figure 
2.2A) with a mean length of 551 base pairs and a maximum length of 13,381 base pairs. A similar 
number of >100 base pair sequences were found in the transcriptome of Chlorophytum 
borivilianum (Kalra et al., 2013). This mean length indicates a high number of the sequences are 
long enough for homology searches and cloning work. Of these sequences, 79,980 were predicted 
to have open reading frames and were translated into peptides. After determining the reads coming 
from the three tissues, several homologs of genes with predictable expression patterns were used 
to evaluate the quality of the expression estimations. The RuBisCO large and small subunits have 
high amounts of expression in the photosynthetic leaf and inflorescence tissues compared to the 
non-photosynthetic bulb tissue. A homolog to the MADS62 floral development transcription factor 
is exclusively expressed in the inflorescence tissue as would be expected (Kwantes et al., 2012). 
The read counts were thus determined to produce expected expression patterns.  
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Figure 2.2. Identification of NpN4OMT in the N. sp. aff. pseudonarcissus transcriptome. (A) Venn diagram of all 
sequences, all OMTs, and all galanthamine correlating sequences according to HAYSTACK. (B) Accumulation level 
of galanthamine in N. sp. aff. pseudonarcissus (C) Candidate NpN4OMT expression profile in leaf, bulb, and 
inflorescence with the relative initial read estimate and qRT-PCR ∆∆Ct on the y-axis with leaf tissue set to 1. 
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The LC/MS/MS data for leaf, bulb, and inflorescence tissues resulted in a pronounced 
accumulation pattern of galanthamine. The largest concentration was found in bulb tissue, with a 
lower level found in leaf and the lowest level in inflorescence (Figure 2.2B). 
Using BLAST to seek homologs to the methyltransferases found in Table C.1 yielded 298 
methyltransferase candidate genes (Raman and Rathinasabapathi, 2003). Separately, HAYSTACK 
identified 9,505 contigs that co-express with galanthamine accumulation. A comparison of the two 
resulting lists revealed one methyltransferase NpN4OMT that fits the HAYSTACK model (Figure 
2.2A). This methyltransferase was chosen for functional analysis. After RACE, NpN4OMT was 
found to be a 239 amino acid protein with a predicted molecular weight (MW) of 27 kDa. When 
expressed using the pET28a vector, the added N-terminal Histidine tag increased the MW to 29 
kDa (Figure 2.3A). In the course of cloning, five unique clones were obtained with >96 % identity 
to each other. Due to the two-toned yellow flower color, single flower, and size, the N. sp. aff. 
pseudonarcissus variety used in this study is likely Carlton. Based on genome size estimates, 
Carlton is thought to be a domesticated form of Narcissus pseudonarcissus with a genome 
duplication event that resulted in a tetraploid (Zonneveld, 2010). A high number of paralogs is, 
therefore, expected. In addition, these bulbs have been propagated vegetatively. For these reasons, 
the existence of multiple similar sequences is not surprising. 
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Figure 2.3. Recombinant NpN4OMT1 purification, enzyme assay, and NMR structure elucidation of the 4’-O-
methylnorbelladine product. (A) SDS-PAGE gel 10 % including fractions from crude extract and the desalted protein 
prep. This is shown for vector only, NpN4OMT1, and Pfs preparations. (B) Enzyme assays (top to bottom): 
Norbelladine standard; 4’-O-Methylnorbelladine standard; Assay with E. coli vector-only crude extract added; Assay 
without AdoMet added; Complete methyltransferase assay. (C) NMR structure elucidation: proton chemical shifts are 
black, carbon chemical shifts are blue, key HMBC correlations are black arrows, and key ROESY correlations are red 
arrows. 
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Due to the high similarity of the clones, the first to be cloned was selected for thorough 
characterization. The clone selected for characterization is 92.5 % identical on the amino acid level 
to the original sequence in the transcriptome assembly (Figure 2.4). The recombinant protein was 
purified with a yield of 16.7 mg protein/L E. coli culture. SDS-PAGE analysis revealed the protein 
to be of apparent homogeneity (Figure 2.3A). Initial enzyme assays with NpN4OMT1 yielded, 
upon HPLC analysis, a peak with the retention time of 4’-O-methylnorbelladine. The vector only 
control lacks NpN4OMT1 but has all other assay components. Therefor the absence of product in 
the vector control assay excludes the possibility of a background reaction. The absence of product 
in the assay lacking AdoMet shows that the methyltransferase uses AdoMet as a co-substrate and 
cannot form product without AdoMet (Figure 2.3B). The pH optimum was found to be 8.8 and the 
temperature optimum 45 ⁰C (Figure C.6B-C). The Pfs protein, shown purified in Figure 2.3A, was 
added to prevent SAH inhibition in kinetic enzyme assays, through the Pfs catalyzed hydrolysis of 
SAH to adenine and S-ribosyl-homocysteine (Choi-Rhee and Cronan, 2005). 
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Figure 2.4. Protein sequence alignment of NpN4OMT variants. Five unique variants of the NpN4OMT sequence are 
aligned against the original sequence predicted by the de novo assembled transcriptome using CLC software. Dots are 
identical residues. 
An alternative methylation product, 3’-O-methylnorbelladine, has the same retention time 
on HPLC, the same UV profile, and MS/MS fragmentation pattern as 4’-O-methylnorbelladine. 
Thus, NMR analysis was performed to determine the regiospecificity of O-methylation. HMBC 
correlations from both the methoxyl protons (H 3.88) and H-6’ (H 6.90) to the same carbon (C 
149.9) placed the methoxyl group at C-4’.  Its location was further supported by a ROESY 
correlation from the methoxyl protons to H-5’ (H 6.98). The NMR data thus confirmed that 4’-O-
methylnorbelladine is the product of the enzyme reaction (Figure 2.3C).  
To determine the substrate specificity of this methyltransferase, several similar substrates 
were tested. Activity comparable to that found with norbelladine was observed using N-
methylnorbelladine as the substrate. Dopamine also served as a substrate. Under the assay 
conditions used, product was not detected with caffeic acid, vanillin, 3,4-dihydroxybenzaldehyde, 
and tyramine as substrates (Table 2.1). To determine if the other 4 variants show similar activity, 
they were purified, and enzymatic activity was confirmed for all variants using norbelladine as the 
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substrate. When monitoring NpN4OMT1 norbelladine assays allowed to proceed to completion, 
no sign of double methylation products were observed as expected. 
Table 2.1. Substrate specificity of NpN4OMT1 
Substrate Km (µM) kcat (1/min) kcat/Km 
(1/µM*min) 
Norbelladine 1.6±0.3 1.3±0.06 0.8 
AdoMet 28.5±1.6 4.5±0.01 0.16 
N-Methylnorbelladine 1.9±0.4 2.6±0.15 1.3 
Dopamine 7.3±2.7 3.6±0.15 0.5 
Caffeic acid ND ND ND 
Vanillin ND ND ND 
3,4-
Dihydroxybenzaldehyde 
ND ND ND 
Tyramine ND ND ND 
ND, Not detected 
±, Standard error 
Phylogenetic analysis of the NpN4OMT1 placed it in the class I OMT group (Figure 2.5). 
NpN4OMT1 has a length consistent with the 231-248 amino acid range found in class I OMTs. 
This is in contrast to other known plant catechol 4-OMTs which all group in the class II OMTs as 
their length and cofactor requirements reported in previous work would predict. All these 
methyltransferases are significantly longer than the standard class I OMTs and none are reported 
to have the characteristic divalent cation dependence of class I OMTs (Joshi and Chiang, 1998; 
Gang et al., 2002; Akashi et al., 2003; Schröder et al., 2004; Kim et al., 2005). When testing 
NpN4OMT1 for cation dependence, enzymatic activity improved upon the addition of cobalt. 
Enzymatic activity increased four-fold more with the addition of magnesium instead of cobalt 
(Figure C.6A). This preference for magnesium over other divalent cations is also to be expected 
from a class I OMT (Joshi and Chiang, 1998). It is, furthermore, consistent with previous work on 
enzyme extracts enriched for this OMT (Mann, 1963). 
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Figure 2.5. Phylogenetic analysis of NpN4OMT1. A maximum-likelihood phylogenetic tree of characterized 
methyltransferases listed in Table C.2. Alignment constructed using MUSCLE. 
 To validate the expression profiles predicted based on read counts; qRT-PCR was 
conducted with the same RNA preparation used to prepare the cDNA libraries for Illumina 
sequencing. The resulting expression profile is slightly different from that obtained from Illumina 
sequencing. The qRT-PCR expression profile has a higher quantity of inflorescence transcript 
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relative to bulb transcript (Figure 2.2C). This minor difference is potentially due to cross 
amplification, during qRT-PCR, with other close homologs in the plant. 
2.4 Discussion 
The expression pattern, product formation, and low Km for norbelladine all indicate NpN4OMT 
methylates norbelladine in the proposed galanthamine biosynthetic pathway. Two differing orders 
of methylation have been proposed for galanthamine biosynthesis (Eichhorn et al., 1998). The 
methylation of N-methylnorbelladine was tested to determine if a preference for the N-methylation 
state could be observed at O-methylation. Similar Km and kcat values for N-methylnorbelladine and 
norbelladine indicate that a preference for the N-methylation state does not occur at O-methylation. 
The results presented here support both proposed galanthamine biosynthetic pathways. Future 
work on additional enzymes in the pathway will be needed to enzymatically validate one pathway 
or the other. The lack of enzymatic activity when testing 3,4-dihydroxybenzaldehyde suggests that 
methylation does not occur prior to formation of norbelladine. The methylation of dopamine is 
expected considering structural similarity to the methylated moiety of norbelladine. Tyramine was 
not methylated; this is as expected for a class I OMT (Table 2.1). 
Several aspects of the candidate gene selection approach proved important for this 
successful identification. One is the selection of a variety of methyltransferases for the homology 
search. If only the known 4-OMTs had been used in the homology search, the gene would have 
been missed due to the large difference in sequence between known 4-OMTs and NpN4OMT. It 
has been shown that catechol 4’-OMT and catechol 3’-OMT can differ by as little as one amino 
acid (Wils et al., 2013). Because of this potential for a conversion form catechol 3’-O-methylation 
to 4’-O-methylation though evolution, OMTs of both positions were used in the homology search. 
Also, both class I and class II OMTs were used in the search because both classes are known to 
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methylate catechols. Considering the multiple branches of the N-methyltransferases in the OMT 
phylogeny, it is worth investigating enzymes that annotate as N-methyltransferases (Raman and 
Rathinasabapathi, 2003). For these reasons, the sequences used in the initial BLAST search 
consisted of representatives of known O- and N-methyltransferases of small metabolites. The 
NpN4OMT turned out to be a member of the class I OMTs. Class I OMTs show closer homology 
to human catechol OMT than to all known plant catechol 4-OMTs in class II, as demonstrated in 
Figure 2.5 (Ibdah et al., 2003). The closest known catechol 4-OMT to NpN4OMT is bacterial, has 
34 % identity to NpN4OMT, and is a class I OMT from Cyanobacterium Synechocystis sp. Strain 
PCC 6803 (SynOMT) (Kopycki et al., 2008). Many 3-OMTs show even higher homology to 
NpN4OMT than SynOMT. It is probable that the 4-OMT activity of NpN4OMT was acquired 
independently of SynOMT (Figure 2.5).  
The second selection criterion, co-expression with galanthamine accumulation, was also of 
great value. It reduced the number of candidate OMTs from hundreds to one. There are a variety 
of methods for the prioritization of candidate genes (Moreau and Tranchevent, 2012). Many of 
these methods are oriented towards species and systems for which there are extensive databases or 
prior knowledge regarding a gene involved in the pathway or process. In one study, a collection of 
~500 microarrays was used to demonstrate the co-expression of genes in the same pathway in 
Arabidopsis (Wei et al., 2006; Saito et al., 2008). However, extensive gene expression data are 
typically not available for non-model systems. There have been several studies that use co-
expression analysis to find genes in a pathway and produce promising candidate gene lists. These 
studies often lack biochemical validation of the in silico candidates (Sun et al., 2011). If a novel 
function is proposed, this type of analysis is incomplete without biochemical validation of enzyme 
activity. Enzymes that are homologous to functionally equivalent enzymes in a different species 
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can be corroborated by co-expression analysis (Sun et al., 2011). There are several studies that use 
a simple differential expression model and microarrays to find biosynthetic genes by comparing 
biosynthetically active and inactive accessions in rose and strawberry (Aharoni et al., 2000; 
Guterman et al., 2002). Differential expression analysis lacks algorithms to use data with differing 
levels of metabolism occurring in more than two samples. The Pearson correlation can compare 
data from multiple samples. Mercke et al. have used a Pearson correlation-based method to identify 
gene expression with microarrays that correlate with levels of specific terpenes in cucumber 
(Mercke et al., 2004). Illumina-based transcriptomes are, however, more sensitive to minor 
variants in the sequences and to splice variants. Illumina-based gene expression data also have a 
far greater dynamic range, limited only by sequence depth, than microarrays (Wang et al., 2009). 
Subtleties in the sequences that could be missed with microarrays can now be detected with 
Illumina sequencing. 
The use of HAYSTACK as a platform to use the Pearson correlation is ideal because it is 
designed to receive a hypothesis for gene expression and look for gene expression that correlates 
with that hypothesis. This is in contrast to an approach in which gene expression patterns are 
clustered based on similarity to each other. The search for a defined pattern in the data allows the 
number of required expression data points to be reduced compared to an approach that needs to 
define clusters of gene expression patterns based on similarity. In HAYSTACK, the shared 
expression pattern is already defined. HAYSTACK applies additional screening criteria including 
a p-value test for significance, a fold cutoff, and background cutoff. The approach chosen in our 
study used knowledge of known chemical intermediates, a transcriptome with expression profiles 
for three tissues, and metabolite levels to identify a candidate gene product to validate with in vitro 
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enzyme activity. Little prior knowledge of a pathway is required to use this approach, making this 
workflow ideal for the identification of genes in unknown biochemical pathways. 
There are several modifications to this approach that could be used to improve its power. 
It could be applied to more tissues, environmental conditions or time points to provide even greater 
statistical power to correlate co-expression of biosynthetic genes with the biosynthesis of their 
products. The method could also be modified to include analysis of multiple end products. If the 
pathway in which the enzyme participates branches, several end products could be equally 
important to co-expression analysis. This combined consideration of multiple end products could 
lead to more informative models (Yamazaki et al., 2013). Another potential source of information 
on the metabolite level could be the concentrations of intermediates made during synthesis. 
Correlations between biosynthetic gene expression, and perhaps the accumulation of metabolites 
as well, tend to decrease as distance in a pathway increases (Wei et al., 2006). Experiments that 
quantitate metabolic intermediates could be useful for finding biosynthetic genes if the flux 
through the pathway is not so high that intermediates do not accumulate. The latter would be the 
case in a pathway assembled into a metabolon. 
The discovery of this enzyme enables the future elucidation of other enzymes in the 
proposed galanthamine biosynthetic pathway and other novel pathways. Genes that co-express 
with NpN4OMT can be identified and used as candidate genes for other steps in the proposed 
galanthamine biosynthetic pathway. This will potentially be useful for earlier steps in the pathway, 
considering the tendency of expression correlations to decrease as distance in metabolic pathways 
increase (Wei et al., 2006). This enzyme discovery also validates the utility of this workflow to 
characterize metabolic pathways and provides a valuable method for pathway discovery in orphan 
species. 
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The Amaryllidaceae alkaloids are a family of amino acid derived alkaloids with many biological 
activities; examples include haemanthamine, haemanthidine, galanthamine, lycorine, and 
maritidine. Central to the biosynthesis of the majority of these alkaloids is a C-C phenol-coupling 
reaction that can have para-para’, para-ortho’, or ortho-para’ regiospecificity. Through 
comparative transcriptomics of Narcissus sp. aff. pseudonarcissus, Galanthus sp., and Galanthus 
elwesii we have identified a para-para’ C-C phenol coupling cytochrome P450, CYP96T1, 
capable of forming the products (10bR,4aS)-noroxomaritidine and (10bS,4aR)-noroxomaritidine 
from 4’-O-methylnorbelladine. CYP96T1 was also shown to catalyzed formation of the para-
ortho’ phenol coupled product, N-demethylnarwedine, as less than 1 % of the total product. 
CYP96T1 co-expresses with the previously characterized norbelladine 4’-O-methyltransferase. 
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The discovery of CYP96T1 is of special interest because it catalyzes the first major branch in 
Amaryllidaceae alkaloid biosynthesis. CYP96T1 is also the first phenol-coupling enzyme 
characterized from a monocot. 
3.1  Introduction 
The Amaryllidaceae alkaloids are produced by species of Amaryllidaceae including Narcissus spp. 
(daffodil) and Galanthus spp. (snowdrop). Alkaloids from all major structural classes of 
Amaryllidaceae alkaloids have biological activities. Some of these alkaloids have potential 
pharmaceutical applications or are already established medicines. The alkaloid skeleton types, 
haemanthamine, narciclasine, tazettine, and montanine are derived from the para-para’ C-C 
phenol coupled, (10bR,4aS)-noroxomaritidine, biosynthetic precursor (Wildman and Bailey, 1969; 
Fuganti et al., 1971; Feinstein and Wildman, 1976) (see Figure 3.1 and Figure 3.2 for 
representative structures). Specific examples of alkaloids derived from (10bR,4aS)-
noroxomaritidine include haemanthamine, maritidine, vittatine, and pretazettine. Haemanthamine 
has been shown to have antiproliferative and apoptotic effects on cancer cell lines and antioxidant 
activity in a 2,2-diphenyl-1-picrylhydrazyl scavenging assay (Oloyede et al., 2010; Van 
Goietsenoven et al., 2010; Havelek et al., 2014). Crinine and its derivatives are also derived from 
a para-para’ C-C phenol coupling, however, the phenol-coupled product is the enantiomer, 
(10bS,4aR)-noroxomaritidine. Antibacterial activities have been noted for the derivatives of the 
(10bS,4aR)-noroxomaritidine skeleton including buphanidrine and distichamine (Cheesman et al., 
2012). An example of an ortho-para’ C-C phenol-coupling product is lycorine, derived from 
noroxopluvine. Lycorine has been documented to cause apoptosis in leukemia and multiple 
myeloma cancer cell lines (Liu et al., 2004; Li et al., 2007; Liu et al., 2009). Galanthamine is a 
representative derivative of the para-ortho’ C-C phenol-coupled product N-demethylnarwedine 
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and is used as an Alzheimer’s treatment drug (Wilcock et al., 2003). It acts through acetylcholine 
esterase inhibition and nicotinic receptor binding (Irwin and Smith, 1960; Barik et al., 2005). The 
limited supply of some Amaryllidaceae alkaloids and diversity of biological activities make the 
biosynthesis of Amaryllidaceae alkaloids a topic of interest for biotechnology.  
 
Figure 3.1. Proposed biosynthetic pathways for representative Amaryllidaceae alkaloids directly derived from C-C 
phenol coupling. The previously discovered NpN4OMT, the CYP96T1 discovered in this study, and potential enzyme 
classes involved in each step of the pathways are in blue. 
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Figure 3.2. Structures of relevant compounds. 
Haemanthamine is derived from the amino acids phenylalanine and tyrosine. 
Phenylalanine was established as a precursor by incorporation of [3-14C]phenylalanine into 
haemanthamine in Nerine bowdenii (Wildman et al., 1962b). The conversion of phenylalanine to 
3,4-dihydroxybenzaldehyde in haemanthamine biosynthesis was clarified by feeding [3-14C]trans-
cinnamic acid, [3-14C]para-hydroxycinnamic acid, [7-14C]benzaldehyde, [7-14C]para-
hydroxybenzaldehyde, [3H]3,4-dihydroxybenzaldehyde, and [3H]threo-DL-phenylserine to 
Narcissus pseudonarcissus. Incorporation into haemanthamine from the precursors [3-14C]trans-
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cinnamic acid, [3-14C]para-hydroxycinnamic acid, [3H]3,4-dihydroxybenzaldehyde, and trace 
incorporation of [7-14C]para-hydroxybenzaldehyde, but not other administered compounds, lead 
to the conclusion that the pathway proceeds as follows: phenylalanine is converted to trans-
cinnamic acid, then to para-hydroxycinnamic acid, then to 3,4-dihydroxycinnamic acid or para-
hydroxybenzaldehyde followed by conversion to 3,4-dihydroxybenzaldehyde (Suhadolnik et al., 
1963a). Observation of radiolabeled [3-14C]tyrosine incorporation into haemanthamine established 
tyrosine as a precursor (Jeffs, 1962). Tyrosine was demonstrated to contribute to C11 and C12 of 
haemanthamine by feeding [β-14C]tyrosine to Sprekelia formosissima and [α-14C]tyrosine to 
Narcissus ‘Twink’ daffodil followed by haemanthamine degradation experiments (Battersby et al., 
1961a; Wildman et al., 1962a) (Figure 3.1). These results indicate tyrosine also contributes C1-4, 
C4a, and C10b because of their ring shape and proximity to the C11 and C12 of haemanthamine. 
Equivalent sections of the galanthamine and lycorine carbon skeleton also originate from tyrosine 
(Battersby and Binks, 1960; Barton et al., 1963). Tyrosine is converted into tyramine by tyrosine 
decarboxylase, a well characterized enzyme in other secondary metabolite pathways (Lehmann 
and Pollmann, 2009).  
3,4-Dihydroxybenzaldehyde and tyramine are condensed to a Schiff-base and reduced to 
norbelladine. The central role of norbelladine in Amaryllidaceae alkaloid biosynthesis was 
demonstrated by incorporation of [1-14C]norbelladine into haemanthamine, lycorine, and 
galanthamine (Barton et al., 1961; Battersby et al., 1961b; Battersby et al., 1961a). Next, 
norbelladine is methylated to 4’-O-methylnorbelladine. In 1963, crude enzyme extracts of N. 
bowdenii were used to perform a preliminary characterization of the 4’-O-methyltransferase 
conducting this methylation (Mann, 1963). This cation-dependent norbelladine 4’-O-
methyltransferase (N4OMT) was identified in Narcissus sp. aff. pseudonarcissus, and 
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enzymatically characterized by heterologous expression in E. coli in Chapter 2 (Kilgore et al., 
2014). (10bR,4aS)-Noroxomaritidine is formed from the para-para’ C-C phenol coupling of 4’-
O-methylnorbelladine. The biosynthesis of haemanthamine deviates from alkaloids with ortho-
para’ and para-ortho’ carbon skeletons at this branch point. The next step is thought to be a 
reduction of the ketone group to synthesize 8-O-demethylmaritidine followed by an oxide bridge 
formation to form vittatine. Conversion of vittatine to haemanthamine is thought to occur through 
hydroxylation followed by methylation (Figure 3.1). The conversion of vittatine to haemanthamine 
has been demonstrated by radiolabeling studies. The order of hydroxylation and methylation in 
this conversion is inferred from the presence of the hydroxylated 11-hydroxyvittatine in the N. 
bowdenii plants under investigation and the absence of the methylated (10bR,4aS)-buphanisine 
(Feinstein and Wildman, 1976). Haemanthamine accumulates in planta and is modified further to 
compounds such as haemanthidine and pretazettine in some Amaryllidaceae. The proposed 
biosynthesis of galanthamine from the ortho-para’ product N-demethylnarwedine through the 
reduced intermediate N-demethylgalanthamine has been reviewed in Chapter 1 and discussed in 
Chapter 2 (Eichhorn et al., 1998; Kilgore et al., 2014). 
Cytochrome P450 enzymes are a diverse enzyme family with numerous functions. 
Reactions catalyzed include hydroxylation, C-C and C-O phenol coupling, oxide bridge formation, 
carbon-carbon bond cleavage, demethylation, and rearrangements of carbon skeletons (Mizutani 
and Sato, 2011). Previously documented C-C phenol coupling by cytochrome P450 enzymes that 
synthesize salutaridine (CYP719A1), (S)-corytuberine (CYP80G2), and cyclodipeptide cyclo(l-
Tyr-l-Tyr) (CYP121), suggest the C-C phenol coupling reactions found in Amaryllidaceae alkaloid 
biosynthesis are cytochrome P450 dependent (Ikezawa et al., 2008; Belin et al., 2009; Gesell et 
al., 2009). C-C phenol coupling reactions have also been documented in the human cytochromes 
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P450 CYP2D6 and CYP3A4 with the substrate (R)-reticuline (Grobe et al., 2009). In addition to 
cytochromes P450 peroxidases and laccases are documented phenol-coupling enzymes (Schlauer 
et al., 1998; Davin et al., 2008; Constantin et al., 2012) 
Orphan plant species are frequently of interest due to their unique metabolism. Study of 
this metabolism is problematic due to scarcity of genetic information, limited mutant libraries, and 
lack of efficient transformation methods. In addition, secondary metabolites can be 
phylogenetically restricted. Method development for efficient metabolic pathway elucidation in 
orphan species is therefore desirable. An efficient work-flow for the identification of biosynthetic 
genes has been previously developed and applied to Amaryllidaceae alkaloid biosynthesis. 
Methyltransferase transcripts correlating with galanthamine accumulation in N. sp. aff. 
pseudonarcissus were targeted and tested for norbelladine 4’-O-methyltransferase activity, leading 
to the discovery of the biosynthetic gene N4OMT  in Chapter 2 (Kilgore et al., 2014). In this study, 
a similar work-flow is applied utilizing transcriptomic data from multiple species to identify 
cytochrome P450 genes that co-express with N4OMT. This led to the isolation and characterization 
of CYP96T1, which catalyzes formation of the para-para’ and a small quantity of the para-ortho’ 
C-C phenol couple with 4’-O-methylnorbelladine.   
3.2  Materials and Methods 
3.2.1  Plant Tissue and Chemicals 
Leaf, bulb, and inflorescence tissues were collected from adult blooming N. sp. aff. 
pseudonarcissus and Galanthus sp. plants in St. Louis, MO and Galanthus elwesii in Pullman, 
WA. Chemicals acquired from Sigma Aldrich include ammonium acetate 97 % A.C.S. reagent, 
HPLC grade ethanol, and tyramine 99 %. Other chemicals purchased include ammonium acetate 
extra pure 25 % solution in water from Acros Organics, ampicillin from GoldBio, and vanillin 
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from Merck. Several compounds were obtained previously by synthesis including: veratraldehyde, 
(R)-coclaurine, and (S)-coclaurine. Haemanthamine was previously isolated from Narcissus 
pseudonarcissus. Additional materials are as described previously in Chapter 2 and (Gesell et al., 
2009).  
3.2.2  Transcriptome Assembly and Transcript Abundance Estimation 
The transcriptomes assembled using ABySS and MIRA for Galanthus sp. and G. elwesii were 
assembled in the same manner as in Chapter 2 for the previously described ABySS and MIRA N. 
sp. aff. pseudonarcissus transcriptome (Kilgore et al., 2014), but with 50 base paired-end reads 
with leaf, bulb, and inflorescence tissues. Alternative transcriptomes were made using Trinity. For 
these transcriptomes the same raw reads were assessed using FastQC followed by trimming with 
the FASTX tool kit. The fastx_trimmer was used to remove the first 13 bases and 
fastq_quality_trimmer was used to remove all bases on the 3’ end with a Phred quality score lower 
than 28. Sequences below 30 bases or without a corresponding paired-end read were removed from 
the trimmed data set. Cleaned reads were input into the Trinity pipeline with default parameters 
for each data set (Haas et al., 2013). The unprocessed reads and Trinity assemblies were used with 
the Trinity tool RNA-Seq by Expectation-Maximization (RSEM) to obtain the transcripts per 
million mapped reads (TPM) for all transcripts in each tissue (leaf, bulb, and inflorescence) for 
each Trinity assembly. To assess quality, the following parameters were considered: the size of 
the resulting assembly and identification of homologues to the conserved genes Zea mays MADS6 
(NP_001105153.1), Arabidopsis thaliana ribulose bisphosphate carboxylase small chain 1A 
(NP_176880.1), and the Oryza sativa ribulose-1,5-bisphosphate carboxylase/oxygenase large 
subunit (AAB02583.1). Assemblies and transcript expression data are deposited in the MedPlant 
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RNA Seq Database, http://www.medplantrnaseq.org. ESTScan trained against A. thaliana open 
reading frames was used to predict peptides encoded in all Trinity assemblies (Iseli et al., 1999). 
3.2.3  Candidate Gene Identification 
BLASTP with an e-value cut off of 1 x 10-4 was used to find homologs to known cytochrome P450 
enzymes in all transcriptomes. A list of 472 unique, curated plant cytochrome P450 sequences 
from Dr. David Nelson, University of Tennessee, was used as a query against the ESTScan 
predicted peptides for each assembly (supplemental File 1). HAYSTACK was used to find 
correlations between the appropriate N4OMT expression model for each assembly (Table 3.1) and 
the transcripts in each assembly. All Galanthus models were based on the expression estimates for 
the closest NpN4OMT1 homologue in the assembly being used. The N. sp. aff. pseudonarcissus 
model was based on the RT-PCR data for NpN4OMT1 expression obtained in Chapter 2 (Kilgore 
et al., 2014). HAYSTACK parameters are as follows: correlation cutoff ≥ 0.8, background cutoff 
≥ 1, fold cutoff ≥ 4, and p-value cutoff ≤ 0.05 (Mockler et al., 2007). Homologues to annotated 
cytochrome P450 enzymes that were correlating with the N4OMT models were identified using 
BLASTN with an e-value cut off of 1 x 10-50 queried against the N4OMT co-expressing candidates 
in every other assembly. For each cytochrome P450 candidate, the total number of assemblies with 
an N4OMT co-expressing BLASTN hit were determined. Candidates present in five of the five 
comparable lists were considered top priority candidate genes and were cloned (Figure 3.3).   
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Table 3.1. Models used in HAYSTACK analysis 
Model name Leaf Inflorescence Bulb 
N N. sp. aff. pseudonarcissus N4OMT (relative units) 1 30 45 
N Galanthus sp. N4OMT (RPM) 0.01 33.34 139.79 
N Galanthus elwesii N4OMT (RPM) 2.24 22.59 71.71 
TC N. sp. aff. pseudonarcissus N4OMT (TPM) NA NA NA 
T Galanthus sp. N4OMT (TPM) 2.42 29.02 94.73 
T Galanthus elwesii N4OMT (TPM) 15.95 49.32 201.97 
N AbySS and MIRA assembly 
C homologue not found 
T Trinity assembly 
RPM=reads per million 
NA=not applicable  
3.2.4  Polymerase Chain Reaction (PCR) and Cloning 
After cloning CYP96T1, designated as narcissus-20101112|22907 in the ABySS and MIRA N. sp. 
aff. pseudonarcissus assembly, a close homologue of CYP96T1 with the designation narcissus-
20101112|13079 was identified with a complete ORF. Primers based on the 5’ sequence of 
narcissus-20101112|13079 and the 3’ sequence of CYP96T1. Design of inner primers was 
validated by sequencing (GENEWIZ Inc.) of the outer PCR product using the following primers 
CYP96T forward outer (5’-ACATCCCCCCCAAAAAAATCATAAC-3’), CYP96T reverse outer 
(5’-AGACCATCAATGTGATCACCA-3’), and CYP96T reverse sequencing (5’-
TGGTGAAATCGTTGAATTGGTTGT-3’). N. sp. aff. pseudonarcissus bulb cDNA was prepared 
as described in Chapter 2 (Kilgore et al., 2014). The outer PCR reaction contained 0.2 µM each of 
CYP96T forward outer and CYP96T reverse outer primers, 1 µl of bulb cDNA, 1X Phusion HF 
reaction buffer, 0.3 mM dNTPs, and 1 U NEB Phusion High-Fidelity DNA Polymerase in a 50 µl 
reaction. The PCR program parameters were as follows: 30 s 98 ºC 1 cycle, 15 s 98 ºC, 30 s 52 ºC, 
2 min 72 ºC 35 cycles, and 5 min 72 ºC 1 cycle. Inner PCR parameters were identical except 
primers used were CYP96T forward inner (5’-
aattGCGGCCGCATGGCCACTTCTTCTTCAGCA-3’) and CYP96T reverse inner (5’-
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aattTCTAGATCACATGACTGATCTCTTTCT-3’) adding NotI and XbaI restriction sites, 
respectively (underlined), the outer PCR reaction was added as template as opposed to cDNA, and 
the PCR cycles were reduced to 25. 
 
Figure 3.3. Work-flow for identification of candidate cytochrome P450 enzymes. Following the generation of 
transcriptome assemblies, cytochrome P450 enzymes were identified with BLASTP (Navy blue) and genes correlating 
with N4OMT were identified with HAYSTACK (Red). The genes present in both lists makeup the initial candidate 
gene list (Green). Homologues of these genes were identified in the N4OMT correlating lists of the other 
transcriptomes using BLASTN (Gray). Candidates with homologues in all five N4OMT correlating lists were cloned 
from N. sp. aff. pseudonarcissus, Narcissus sp. (light blue). The analysis for the N. sp. aff. pseudonarcissus ABySS 
and MIRA assembly is completely diagrammed to illustrate the process followed in every assembly. The number of 
transcripts selected in each step is in parentheses. The N. sp. aff. pseudonarcissus Trinity assembly is excluded from 
this work-flow due to its poor quality. 
The inner PCR product and pVL1392 vector were digested with NEB NotI and XbaI 
followed by PCR purification with the QIAquick PCR Purification Kit and ligation with NEB T4 
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DNA ligase according to manufacturer’s instructions. The resulting construct was transformed into 
DH5α E. coli chemically competent cells. Recombinant bacteria were selected on Luria-Bertani 
1.5 % agar plates with 50 µg/ml ampicillin. 
Transformants were screened by colony PCR with the following components: 0.67 µM 
polyhedrin forward (5’-AAAATGATAACCATCTCGC-3’) and polyhedrin reverse (5’-
GTCCAAGTTTCCCTGTAGA-3’) primers, ThermoPol Reaction buffer 1X, 0.2 mM dNTPs, and 
1 U of NEB Taq DNA polymerase in a volume of 20 µl. The PCR parameters were as described 
in Chapter 2 (Kilgore et al., 2014). Plasmid minipreps of 5 ml cultures in LB supplemented with 
50 µg/ml ampicillin were prepared using the QIAGEN QIAprep Spin Miniprep Kit according to 
manufacturer’s instructions and sequenced with polyhedrin forward and reverse primers by 
Eurofins genomics. All reproducible sequences were named by Dr. David Nelson, University of 
Tennessee. The closest biochemically characterized homologue to the resulting CYP96T1 clone, 
CYP96A15, was identified in the UniProt database with BLASTP. CYP97T1 (KT693311), 
CYP96T2 (KT693312), CYP96T3 (KT693313), the original CYP96T1 sequence, and CYP96A15 
were aligned with MUSCLE in the CLC main workbench version 6.9.1 (Edgar, 2004). 
3.2.5  Protein Expression 
Co-transfection of CYP96T1 in pVL1392 and Baculogold baculoviurus (BD Biosciences), viral 
amplification, protein expression, and microsome preparation in Spodoptera frugiperda Sf9 cells 
was performed as previously described (Gesell et al., 2009). Microsomes of Sf9 cells expressing 
CYP96T1 were solubilized with 0.17 % emulgen 913 at 4 ⁰C for 15 min followed by centrifugation 
(15,000 X g for 15 min) before obtaining the CO difference spectra. The resulting CYP96T1 
concentration was used to calculate concentration of CYP96T1 in all subsequent Sf9 cell cultures. 
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CYP96T1 was always co-expressed with Eschscholzia californica cytochrome P450 reductase 
(CPR) (Gesell et al., 2009). For a negative control CPR was expressed without CYP96T1. 
3.2.6  3’-O-Methylnorbelladine and 3’,4’-O-Dimethylnorbelladine Synthesis 
For the synthesis of 3’-O-methylnorbelladine sodium cyanoborohydride (48.5 mM), vanillin (5.66 
mM), and tyramine (5.15 mM) were mixed in 2.5 ml anhydrous methanol for 2 days at room 
temperature. For synthesis of 3’,4’-O-dimethylnorbelladine, sodium cyanoborohydride (65.18 
mM), veratraldehyde (9.40 mM), and tyramine (7.29 mM) were mixed in 2.5 ml anhydrous 
methanol for 2 days at room temperature. The reaction mix was then taken to dryness under N2. 
The resulting material was suspended in 200 µl of 1 M NaCO3 pH 9.5 and extracted twice with 
400 µl of ethyl acetate by vortexing for 1 min, followed by centrifugation at 16.1 x g for 2 min at 
room temperature. Ethyl acetate extractions were pooled and dried under vacuum. Extractions 
were re-suspended in 10 % acetonitrile and 0.1 % formic acid and purified by fractionation using 
a Waters fraction collector III and Waters 1525 binary HPLC pump as described in Chapter 2 
(Kilgore et al., 2014). 3’-O-methylnorbelladine was collected at 9 min for ~1 min and 3’,4’-O-
dimethylnorbelladine at 11.5 min for ~1 min. Purified compound was dried under vacuum, re-
suspended in H2O and quantified with a 4’-O-methylnorbelladine standard curve using peak area 
by HPLC with the method stated above. 
3.2.7  Enzyme Assays 
Screening assays contained 30 mM KPO4 pH 8.0, 1.25 mM NADPH, 10 µM substrate, and 70 µl 
of virus infected Sf9 cell suspension in 200 µl total volume. The assays were incubated for 2-4 hr 
at 30 ºC. 4’-O-metylnorbelladine was tested for all CYP96T variants. CYP96T1 was used for 
substrate specificity tests on norbelladine, N-methylnorbelladine, 4’-O-methyl-N-
methylnorbelladine, 3’-O-methylnorbelladine, 3’,4’-O-dimethylnorbelladine, haemanthamine, 
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(S)-coclaurine, (R)-coclaurine, and mixed (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (see 
Figure 3.1 and Figure 3.2 for chemical structures). Assays derivatized with sodium borohydride 
were incubated 2 hr at 30 ºC followed by addition of 0.5 volumes 0.5 M sodium borohydride in 
0.5 M sodium hydroxide and incubated 30 min at RT. The CYP96T1 assay resolved on a Chiral-
CBH column and assays measured with HPLC used fresh CYP96T1 and CPR expressing Sf9 cell 
protein prepared using re-amplified virus. Kinetic assays were run in the linear time range for each 
substrate in 200 mM KPO4 pH 6.5 buffer with 40 µl assays. Product for overnight enzyme assays 
of (R)-coclaurine, (S)-coclaurine, and 4’-O-methyl-N-methylnorbelladine were quantified at 277 
nm against a noroxomaritidine standard curve with the same HPLC method and setup used for 3’-
O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine isolation. These products were 
subsequently used as standards for quantifying kinetic assays. Km and kcat values were estimated 
using R version 3.2.0 with nonlinear fitting.  
3.2.8  LC-MS/MS 
Enzyme assays on all substrates were extracted as previously described and run on a QTRAP 4000 
coupled to a IL-20AC XR prominence liquid auto sampler, 20AD XR prominence liquid 
chromatograph and Phenomenex Luna 5 µm C8(2) 250 x 4.60 mm column. HPLC gradient and 
MS settings were as described in Chapter 2 (Kilgore et al., 2014). Assay specific MS/MS 
parameters are presented in Table 3.2. Multiple Reaction Monitoring (MRM) parameters for 
relative quantification of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine, N-demethylnarwedine, 
narwedine, and the two unknown compounds are presented in Table 3.3. For analysis of product 
chirality, a Chrom Tech, Inc. Chiral-CBH 100 x 4.0 mm, 5 µM column was used with a 30 min 
isocratic flow of 2.5 % HPLC grade ethanol and 10 mM ammonium acetate with pH adjusted to 
7.0 with ammonium hydroxide. Kinetic assays were quantified with an isocratic flow 20 % 
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acetonitrile and 0.08 % formic acid with the Phenomenex Luna 5 µm C8(2) 250 x 4.60 mm column 
connected to the same QTRAP 4000 setup. MRM transitions used in kinetics were 284.1/223.0 
m/z for the (S)-coclaurine and (R)-coclaurine products, 286.1/271.0 m/z for the 4’-O-methyl-N-
methylnorbelladine para-para’ product, and 272.3/229.0 m/z for noroxomaritidine. 
Table 3.2. MS/MS parameters for substrate tests 
Substrate Product specific 
parameters 
(CE)(DP)(Q1 
m/z) 
Substrate specific 
parameters 
(CE)(DP)(Q1 m/z) 
4’-O-Methylnorbelladine (35)(70)(272.30) (20)(60)(274.30) 
4’-O-Methyl-N-
methylnorbelladine 
(35)(70)(286.20) (20)(60)(288.30) 
3’-O-Methylnorbelladine (35)(70)(272.30) (35)(60)(274.30) 
3’,4’-O-Dimethylnorbelladine (35)(70)(286.20) (20)(60)(288.30) 
 
Norbelladine (35)(60)(258.00) (15)(50)(260.00) 
N-Methylnorbelladine (35)(70)(272.30) (20)(60)(274.30) 
Haemanthamine (35)(70)(300.12)/ 
(35)(70)(318.13)HO 
(35)(70)(302.14) 
(10bS,4aR)- and (10bR,4aS)-
Noroxomaritidine 
(35)(70)(270.30)/ 
(35)(70)(288.30)HO 
(35)(70)(272.30) 
Isovanillin and tyramine (20)(40)(290.30)a/ 
(20)(60)(272.20)b/ 
(35)(70)(270.20)c 
(20)(60)(138.20)/ 
(20)(50)(153.20)  
(S)-Coclaurine (35)(70)(284.30)/ 
(30)(60)(570.60)dim 
(20)(70)(286.30)  
(R)-Coclaurine (35)(70)(284.30)/ 
(30)(60)(570.60)dim 
(20)(70)(286.30)  
4’-O-Methylnorbelladine assays 
followed by sodium borohydride 
derivatization 
(20)(60)(274.30) (20)(60)(274.30) 
HO hydroxylation monitored 
dim dimer formation monitored 
a C-C phenol coupling with no amine aldehyde condensation 
b amine aldehyde condensation/amine aldehyde condensation with C-C phenol coupling and a 
reduction. 
c amine aldehyde condensation with C-C phenol coupling 
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Table 3.3. MS/MS parameters used in MRM studies 
Compound(C-C phenol coupling type) MRM parameters(CE)(DP)(Q1 m/z)(Q2 
m/z)(RT min) 
Noroxomaritidine(para’-para) (35)(70)(272.3)(229.0)(5.3) 
N-Demethylnarwedine(para’-ortho) (35)(70)(272.3)(201.0)(7.9) 
4’-O-Methyl-N-methylnorbelladine assay unknown 
1(potential para’-para product) 
(35)(70)(286.1)(271.0)(4.7) 
4’-O-Methyl-N-methylnorbelladine assay unknown 2 
(potential ortho’-para product) 
(30)(70)(286.1)(243.0)(7.5) 
Narwedine(para’-ortho) (30)(70)(286.1)(229.1)(8.1) 
3.3  Results 
3.3.1  Transcriptome Assembly and Transcript Abundance Estimation 
Key statistics for each transcriptome including total number of transcripts, maximum transcript length, and 
average transcript length are summarized in Table 3.4. ABySS and MIRA assemblies were found to have 
a high number of incomplete ORFs. This was problematic for cloning and highlighted the potential problem 
of unannotated transcripts and inaccurate expression estimates in transcripts with short assemblies. Quality 
processed reads were reassembled with Trinity to provide alternate information on the same transcripts. 
These assemblies provided additional sequence information with comparable expression estimates. The N. 
sp. aff. pseudonarcissus Trinity assembly resulted in a large number of contigs but lacked well-
characterized genes, such as ribulose bisphosphate carboxylase small chain 1A and NpN4OMT1. In 
addition, the maximum contig length was 73,933, well above the expected size range. For these reasons, 
further analysis of the N. sp. aff. pseudonarcissus Trinity assembly was abandoned. The other assemblies 
have comparable statistics regardless of assembly method. Because these assemblies are complementary to 
each other, both sets of Galanthus assembles were used for subsequent analysis (Table 3.4).  
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Table 3.4. Transcriptome statistics 
 N. sp. aff. 
pseudonarcissu
s AbySS and 
MIRA*! 
Galanthu
s sp. 
AbySS 
and 
MIRA* 
Galanthu
s elwesii 
AbySS 
and 
MIRA* 
N. sp. aff. 
pseudonarcissu
s Trinity# 
Galanthu
s sp. 
Trinity# 
Galanthu
s elwesii 
Trinity# 
Sequence
s (bp) 
106,450 143,394 224,205 608,439 103,471 97,789 
Longest 
(bp) 
13,381 15,365 19,356 40,450 13,629 13,055 
N50 (bp) 1,130 1,418 1,330 931 1,044 1,139 
Mean 
(bp) 
551 664 602 671 723 777 
Median 
(bp) 
248 271 245 430 481 528 
*assemblies were set to have a minimum cut off of 100 bp. 
#assemblies were set to have a minimum cut off of 201 bp. 
!assembly reported in Chapter 2 (Kilgore et al., 2014) 
3.3.2  Candidate Gene Identification and Cloning 
The pattern-matching algorithm HAYSTACK was used to identify transcripts that co-express with 
N4OMT. N4OMT is the only validated gene involved in Amaryllidaceae alkaloid biosynthesis to 
date. Its position in the pathway is just prior to the C-C phenol-coupling step therefore, N4OMT 
gene expression is a suitable choice to serve as a model for analysis of co-expressing transcripts 
encoding additional Amaryllidaceae alkaloid biosynthetic genes. Since the C-C phenol-coupling 
enzyme is targeted herein, BLASTP was used to find transcripts that encode putative cytochrome 
P450 enzymes. The resulting 544 N. sp. aff. pseudonarcissus cytochrome P450 protein sequences 
were compared to the list of 3,704 N4OMT co-expressing transcripts identified by HAYSTACK. 
This resulted in the identification of 18 N4OMT co-expressing cytochrome P450 transcripts in the 
N. sp. aff. pseudonarcissus assembly. The Galanthus assemblies were interrogated using these 18 
sequences to identify close homologues. This allowed for selection of the cytochrome P450 
transcripts that consistently co-expressed with N4OMT across species in all assemblies. One 
candidate (CYP96T1) co-expressed with N4OMT in all assemblies and was investigated further in 
N. sp. aff. pseudonarcissus where its correlation was 0.9995. A close homologue to CYP96T1 with 
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99 % identity in shared ORF sequence and the first 67 bases of the 3’ UTR was identified. In 
contrast to CYP96T1, this transcript was complete at the 5’ end of the ORF and contained 5’ UTR 
sequence information. This allowed the incomplete 5’ region of CYP96T1 to be predicted by 
comparison. The PCR product generated with outer primers was sequenced and the inner primer 
sequences were found not to deviate from the assembly prediction. A clone was acquired with no 
conflicts to the previously known CYP96T1 sequence and was used for functional characterization. 
Two additional variants were cloned reproducibly. The closest biochemically characterized 
homologue to CYP96T1 was CYP96A15 from A. thaliana (Q9FVS9) (Figure 3.4).  
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Figure 3.4. MUSCLE alignment of protein sequences for CYP96T1, CYP96T2, CYP96T3, the CYP96T1 sequence 
from the N. sp. aff. pseudonarcissus ABySS and MIRA assembly and CYP96A15 from A. thaliana (Q9FVS9). 
Simplified consensus motifs for cytochrome P450 enzymes are placed above the corresponding color inverted 
CYP96T1 sequence. Dots are exact matches to CYP96T1 and dashes are gaps. 
3.3.3  Enzyme Assays and Analysis by LC-MS/MS 
The concentration of CYP96T1 in Sf9 cell culture was determined to be 2.5 nM by CO-difference 
spectra. The temperature and pH optima for 4’-O-methylnorbelladine substrate were determined 
to be 30⁰C (half height ±5-10⁰C) and 6.5 (half height ±1), respectively. Testing of the CYP96T1 
enzyme demonstrated that several structurally related alkaloids were C-C phenol coupled as 
detected by LC-MS/MS. These reactions were accompanied by a background reaction catalyzed 
86 
 
by the Sf9 cells. 4’-O-Methylnorbelladine was C-C phenol coupled into N-demethylnarwedine, 
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine in CYP96T1 assays. (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine were identified by their identical liquid chromatographic retention times (Figure 
3.5A) and mass spectrometric fragmentation pattern with (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine mixed standard (Figure 3.5C and D). To determine the chirality of the 
noroxomaritidine product, 4’-O-methylnorbelladine assays with CYP96T1 were analyzed with a 
chiral-CBH column by LC-MS/MS. Chromatographic separation of (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine standards was achieved preceding MS/MS analysis. Equal amounts of each 
enantiomer were observed (Figure 3.6A). A mass spectrometric comparison of standards (Figure 
3.6B and C) and enzymatically formed (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (Figure 
3.6D and E) yielded identical MS/MS fragmentation patterns. The enzyme is, therefore, producing 
both (10bS,4aR)- and (10bR,4aS)-noroxomaritidine. A minor N-demethylnarwedine product was 
also detected in assays analyzed by HPLC on the Luna C8 column. The relative quantity of 
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine and N-demethylnarwedine formed in assays with 
CYP96T1 are quantified in Figure 3.7A and B. HPLC was used to measure the relative 
contribution of these compounds to total product. (10bS,4aR)- and (10bR,4aS)-noroxomaritidine 
account for ~99 % of the total product in CYP96T1 assays. (10bS,4aR)- and/or (10bR,4aS)-
noroxomaritidine and N-demethylnarwedine are also produced in assays containing only Sf9 cells 
and 4’-O-methylnorbelladine, but not in an enzyme-free control, indicating Sf9 cells have the 
ability to catalyze the C-C phenol couple with 4’-O-methylnorbelladine (Figure 3.5 A). In addition, 
the N-methylated form of 4’-O-methylnorbelladine, 4’-O-methyl-N-methylnorbelladine, was 
shown to produce several C-C phenol-coupled products when assayed with Sf9 cells alone, as 
indicated by the detection of products with a mass reduction of 2 m/z, including narwedine and 
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two unknown products (Figure 3.5B and 3.7D). Unknown 1 is enzymatically produced from 4’-
O-methyl-N-methylnorbelladine by CYP96T1, as indicated by the increase of product in assays 
containing CYP96T1 as compared to the CPR-only control (Figure 3.5B). Unknown 2 production 
can be explained by the endogenous activity of Sf9 cells only expressing CPR on 4’-O-
methylnorbelladine (Figure 3.7E). These observations were confirmed by an MRM-based relative 
quantification of selected transitions of these three products (Figure 3.7C, D, and E). The LC-
MS/MS fragmentation pattern of unknown 1 is a mixture of masses found in the para’-para 
products (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (165.1 m/z, 184.2 m/z, 195.0 m/z, 212.2 
m/z, 229.0 m/z) and masses +14 m/z (120.1 m/z, 149.1 m/z, 243.2 m/z, 258.1 m/z, 271.0 m/z), 
representing the addition of a methyl moiety (Figure 3.5E). For this reason, it appears the enzyme 
is capable of catalyzing formation of the para-para’ C-C phenol-couple regardless of N-
methylation state (Figure 3.7A and C). To examine the ability of CYP96T1 to C-C phenol couple 
substrates with an altered carbon linker between the phenol groups, (S)-coclaurine and (R)-
coclaurine were also tested. Assays on ether (S)-coclaurine or (R)-coclaurine yield products with 
a mass -2 m/z, which is consistent with a C-C phenol coupling. Product formation is not observed 
when norbelladine or N-methylnorbelladine is used as substrate. These results indicate the 4’-O-
methylation state of norbelladine may be important for substrate-enzyme binding. The substrates 
3’-O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine were tested to determine the relevance 
of 3’-O-methylation; products were not detected (Table 3.5).  
88 
 
 
Figure 3.5. LC-MS/MS enhanced product ion scan (EPI) monitoring the C-C phenol coupling of 4’-O-
methylnorbelladine and 4’-O-methyl-N-methylnorbelladine in CYP96T1 assays. Arrows indicate peaks unique to Sf9 
cell containing assays with substrate present. (A) Standards and assays with 4’-O-methylnorbelladine as the substrate. 
Sample runs top to bottom (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard (1 µM), CYP96T1 assay, CPR 
assay, CYP96T1 assay without 4’-O-methylnorbelladine, and assay without Sf9 cells. (B) Standards and assays with 
4’-O-methyl-N-methylnorbelladine as the substrate. Top to bottom narwedine standard, CYP96T1 assay, CPR assay, 
assay without 4’-O-methylnorbelladine, and assay without Sf9 cells. (C) EPI of the (10bR,4aS)- and (10bS,4aR)-
noroxomaritidine standard. (D) EPI of the CYP96T1 (10bR,4aS)- and (10bS,4aR)-noroxomaritidine product with 4’-
O-methylnorbelladine as substrate. E. EPI of the CYP96T1 para-para’ product (Unknown 1) with 4’-O-methyl-N-
methylnorbelladine as substrate. Red fragments indicate the addition of one methyl group, 14 m/z, relative to 
(10bR,4aS)- and (10bS,4aR)-noroxomaritidine and blue fragments indicate the same m/z as (10bR,4aS)- and 
(10bS,4aR)-noroxomaritidine fragments. Intensity is presented in counts per second (CPS). 
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Figure 3.6. Chromatographic separation and MS/MS analysis of the primary 4’-O-methylnorbelladine products 
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine. The enantiomers (10bS,4aR)- and (10bR,4aS)-noroxomaritidine were 
chromatographically separated with a chiral-CBH column and analyzed by MS/MS using an enhanced product ion 
(EPI) scan. (A) Samples, top to bottom: (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard, CYP96T1 assay, 
CPR assay, CYP96T1 assay without 4’-O-methylnorbelladine substrate and no Sf9 cells assay. (B) EPI fragmentation 
pattern for enantiomer 1 of (10bR,4aS)- and (10bS,4aR)-noroxomaritidine. (C) EPI fragmentation pattern for 
enantiomer 2 of (10bR,4aS)- and (10bS,4aR)-noroxomaritidine. (D) EPI fragmentation pattern for enantiomer 1 in the 
CYP96T1 assay with 4’-O-methylnorbelladine as substrate. (E) EPI fragmentation pattern for enantiomer 2 in the 
CYP96T1 assay with 4’-O-methylnorbelladine as substrate. Intensity is presented in counts per second (CPS).  
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Figure 3.7. Relative product formed in assays with 4’-O-methylnorbelladine (A and B) or 4’-O-methyl-N-
methylnorbelladine (C, D, and E) as substrate. Assays are performed in triplicate only expressing CPR or with CPR 
in combination with CYP96T1. (A) para-para’ ((10bR,4aS)- and (10bS,4aR)-noroxomaritidine) product. (B) para-
ortho’ (N-demethylnarwedine) product. (C) Potentially para-para’ C-C phenol coupling (unknown 1) product. (D) 
para-ortho’ (Narwedine) product. (E) Potentially ortho-para’ C-C phenol coupling (unknown 2) product. 
 The Km of (S)-coclaurine, 636.7 µM, and (R)-coclaurine, 658.8 µM, are several orders of 
magnitude higher than the Km values for 4’-O-methylnorbelladine, 1.13, and 4’-O-methyl-N-
methylnorbelladine, 3.28 (Table 3.5). Substrate inhibition was observed in 4’-O-
methylnorbelladine and 4’-O-methyl-N-methylnorbelladine with Ki values of 64.34±26.36 µM and 
173.7±140.0 µM respectively. No substrate inhibition was observed in (R)-coclaurine or (S)-
coclaurine with concentrations up to 1000 µM. The kcat of 4’-O-methylnorbelladine was higher 
than observed for 4’-O-methyl-N-methylnorbelladine, (R)-coclaurine, or (S)-coclaurine. The 
kcat/Km value 4’-O-methylnorbelladine is at least one order of magnitude larger than the 4’-O-
methyl-N-methylnorbelladine, (R)-coclaurine, or (S)-coclaurine values consistent with the role of 
4’-O-methylnorbelladine as the native substrate.   
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Table 3.5. Substrate specificity tests for CYP96T1 
Substrate Km (µM) kcat (1/min) kcat/Km 
(1/µM*m
in) 
Ki Modifications 
monitored 
4’-O-
Methylnorbelladine 
1.13±0.54 15.0±2.03 13 64.3±26.4 C-C phenol coupling 
4’-O-Methyl-N-
methylnorbelladine 
3.28±2.27 2.44±0.54 0.742 174±140 C-C phenol coupling 
(S)-Coclaurine 637±156 1.34±0.15 2.11x10-3 NA Intramolecular phenol 
coupling and Intermolecular 
coupling 
(R)-Coclaurine 659±104 2.07±0.14 3.15x10-3 NA Intramolecular phenol 
coupling and Intermolecular 
coupling 
3’-O-
Methylnorbelladine 
NA ND NA NA C-C phenol coupling 
3’,4’-O-
Dimethylnorbelladin
e 
NA ND NA NA C-C phenol coupling 
Norbelladine NA ND NA NA C-C phenol coupling 
N-
Methylnorbelladine 
NA ND NA NA C-C phenol coupling 
Haemanthamine NA ND NA NA Methoxy bridge formation 
and hydroxylation 
(10bS,4aR)- and 
(10bR,4aS)-
Noroxomaritidine 
NA ND NA NA Methoxy bridge formation 
and hydroxylation 
Isovanillin and 
tyramine 
NA ND NA NA C-C phenol coupling, 
amine-aldehyde 
condensation, amine-
aldehyde condensation, and 
C-C phenol coupling 
ND=not detected 
NA=not applicable 
3.3.4  Sodium Borohydride Assays and Analysis by LC-MS/MS 
Enzymatically formed N-demethylnarwedine from enzyme assays with CYP96T1 was converted 
to N-demethylgalanthamine by sodium borohydride reduction and detected by LC-MS/MS (Figure 
3.8A). Sodium borohydride selectively reduced the ketone group on (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine and N-demethylnarwedine to yield a stereoisomeric mixture of the 
corresponding alcohols 8-O-demethylmaritidine and N-demethylgalanthamine. Confirmation of 
N-demethylgalanthamine in these assays is demonstrated by the identical retention time (Figure 
3.8A,) and fragmentation pattern (Figure 3.8B and C) with N-demethylgalanthamine standard. 
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Another peak is also present with a different retention time (Figure 3.8A) and very similar 
fragmentation pattern (Figure 3.8D) and is likely the diastereomer epi-N-demethylgalanthamine 
formed by non-stereospecific ketone reduction. Stereoisomeric 8-O-demethylmaritidine is present 
in sodium borohydride reduced CYP96T1 4’-O-methylnorbelladine assays as the largest product 
peak (Figure 3.8A). This is validated by a comparison of the LC-MS/MS fragmentation pattern of 
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine reduced by sodium borohydride to the 
corresponding peak in the CYP96T1 assay (Figure 3.8E and F). 
 
Figure 3.8. LC-MS/MS Enhanced Product Ion (EPI) scan of sodium borohydride (NaBH4) treated CYP96T1 assays 
with 4’-O-methylnorbelladine substrate. (A) Chromatograph with the following sample runs top to bottom: N-
demethylgalanthamine standard, CYP96T1 assay, CPR assay, assay with no Sf9 cells and CYP96T1 assay without 
4’-O-methylnorbelladine. (B) EPI fragmentation pattern of the N-demethylgalanthamine standard peak eluting at 4 
min. (C) EPI fragmentation pattern of the N-demethylgalanthamine product in the CYP96T1 assay. (D) EPI 
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fragmentation pattern of epi-N-demethylgalanthamine from the CYP96T1 assay. E. EPI fragmentation pattern of 
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine standard reduced to stereoisomeric 8-O-demethylmaritidine. F. EPI 
fragmentation pattern of reduced (10bS,4aR)- and (10bR,4aS)-noroxomaritidine product from CYP96T1 assays. 
3.4  Discussion 
CYP96T1 converts 4’-O-methylnorbelladine to the products (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine indicating that this enzyme is involved in the biosynthesis of (10bR,4aS)-
noroxomaritidine-derived alkaloids such as haemanthamine. Because (10bS,4aR)-
noroxomaritidine derivatives have not been previously reported from Narcissus spp., the 
enantiomeric mixture of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine made by CYP96T1 is 
interesting. It is possible the CYP96T1 enzyme is only making the achiral intermediate that later 
spontaneously forms the different enantiomeric forms of noroxomaritidine. If this is the case the 
absence of the (10bS,4aR)-noroxomaritidine derivatives in Narcissus spp. may result from another 
enzyme perhaps associated with CYP96T1 directing the chirality of the ring closure.  
The production of N-demethylnarwedine by CYP96T1 is of interest to galanthamine 
biosynthesis. The low amount produced relative to (10bS,4aR)- and (10bR,4aS)-noroxomaritidine 
indicates that under the assay conditions used N-demethylnarwedine is not the enzyme’s primary 
product. Kinetic analysis shows a clear preference for 4’-O-methylnorbelladine over all other 
tested substrates (Table 3.5). 
 A diradical mechanism has been proposed for formation of the C-C phenol coupled product 
of (R)-reticuline and 4’-O-methylnorbelladine (Eichhorn et al., 1998; Grobe et al., 2009) (Figure 
3.9A and B). A radical is formed on a hydroxyl group ortho or para to the position for formation 
of a carbon bond. To determine if the 3’(para’) hydroxyl group is important to C-C phenol 
coupling, 3’-O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine were tested for enzymatic 
activity; product formation was not observed. The lack of activity with a methoxy group at the 
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para’ position indicates that a free hydroxyl moiety is important at this position to enable 
extraction of a hydroxyl radical by the enzyme (Figure 3.9A). These results support the proposed 
mechanism for C-C phenol coupling of 4’-O-methylnorbelladine.  
 
Figure 3.9. Proposed C-C phenol coupling mechanisms. (A) 4’-O-Methylnorbelladine para-para’ C-C phenol 
coupling mechanism followed by spontaneous nitrogen ring closure to form noroxomaritidine. (B) (R)-Reticuline 
para-ortho’ C-C phenol coupling mechanism to form salutaridine panel adapted from (Grobe et al., 2009). 
The oxygen binding and activation motif (A/G)GX(D/E)TT is substantially different 
between CYP96T1 (and its variants) when compared to cytochrome P450 enzymes that catalyze 
hydroxylation reactions. The substitutions G322Q, D324N and T326Q replace key hydrophobic, 
95 
 
acidic and alcoholic groups with neutral hydrophilic amide groups. This is consistent with the 
proposal of Mizutani and Sato that cytochrome P450 enzymes not performing hydroxylation 
reactions can have a significantly altered oxygen binding and activation site (Mizutani and Sato, 
2011). The highly conserved (387-389) EXXR, PERF (430-433) PXRX, and heme binding (464-
473) FXXGXRXCXG motifs are present (Syed and Mashele, 2014). These motifs are thought to 
have more universal functions than substrate hydroxylation including maintenance of proper 
structural integrity and heme placement in cytochrome P450 enzymes (Hasemann et al., 1995; 
Hatae et al., 1996). 
Presented herein is the first documented C-C phenol coupling cytochrome P450 enzyme in 
monocots. It is in the CYP96 family of cytochrome P450 enzymes, which falls into the CYP86 
clan. The CYP96A15 from A. thaliana has been previously documented to be a midchain alkane 
hydroxylase involved in wax synthesis (Greer et al., 2007). Previously documented members of 
the CYP86 clan have shown activity towards fatty alcohols, fatty acids, alkanes, and derivatives 
thereof (Nelson and Werck-Reichhart, 2011). This makes this phenolic alkaloid a novel substrate 
class for this clan of cytochrome P450 enzymes. All other documented C-C phenol coupling plant 
cytochrome P450 enzymes are in the CYP71 clan (Nelson and Werck-Reichhart, 2011). This 
indicates the C-C phenol coupling activity of CYP96T1 was acquired independently from other 
known C-C phenol coupling cytochrome P450 enzymes. This independent origin of C-C phenol 
coupling could help direct the search for new C-C phenol coupling cytochrome P450 enzymes. 
The independent evolution of CYP96T1 shows that future searches for novel C-C phenol coupling 
enzymes should look broadly across the cytochrome P450 families because lineages of cytochrome 
P450 enzymes responsible for these reaction activities have likely not all been identified. Other 
phenol-phenol coupling reactions potentially performed by cytochromes P450 include the 
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intramolecular coupling of 4’-O-methylnorbelladine to oxonorpluvine in lycorine biosynthesis, 
(S)-autumnaline to isoandrocymbine in colchicine biosynthesis, and the intermolecular C-C phenol 
coupling of dioncophylline A biosynthesis (Bringmann et al., 2000; Herbert, 2003). 
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Chapter 4: The Identification of a 
Noroxomaritidine/Norcraugsodine 
Reductase in the Core Amaryllidaceae 
Alkaloid Biosynthetic Pathway 
  
Amaryllidaceae alkaloids are a large group of plant natural products with over 300 documented 
structures and diverse biological activities. An approved medication from this group is the 
Alzheimer’s treatment drug galanthamine. The first committed steps in the core Amaryllidaceae 
alkaloid biosynthetic pathway are the condensation of 3,4-dihydroxybenzaldehyde and tyramine 
to form the Schiff-base norcraugsodine and subsequent reduction of the imine to norbelladine. In 
this study, oxidoreductase genes that co-express with the previously discovered norbelladine 4’-
O-methyltransferase gene in Narcissus sp. and Galanthus spp. were cloned and expressed in E. 
coli. One of these genes named noroxomaritidine/norcraugsodine reductase encodes an enzyme 
that forms norbelladine from a mixture of 3,4-dihydroxybenzaldehyde and tyramine. Considering 
the ability of norcraugsodine to form spontaneously in solution, the protein was crystallized and 
shown to bind tyramine and an analogue of 3,4-dihydroxybenzaldehyde, piperonal, individually. 
This binding indicates the enzyme may be able to facilitate norcraugsodine formation by binding 
the substrates, thereby providing a scaffold for the Schiff-base condensation prior to imine bond 
reduction. 
4.1  Introduction 
Norbelladine is an intermediate in the biosynthesis of all Amaryllidaceae alkaloids (Battersby et 
al., 1961b; Battersby et al., 1961a; Wildman et al., 1962c). norbelladine can act as a reactive 
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oxygen species scavenger and suppress enzymes associated with inflammation including CAS1, 
CAS2, and NF-ҡB making it a potential drug for mitigating the effects of obesity (Park, 2014). It 
is synthesized from the condensation and reduction of 3,4-dihydroxybenzaldehyde and tyramine 
(Figure 4.1). Tyrosine decarboxylase catalyzes the formation of tyramine from tyrosine (Lehmann 
and Pollmann, 2009). 3,4-Dihydroxybenzaldehyde is hypothesized to originate from a branch of 
the phenylpropanoid pathway with demonstrated intermediates trans-cinnamic acid, 4-
hydroxycinnamic acid, and either 3,4-dihydroxycinnamic acid or 4-hydoryxbenzaldehyde 
(Suhadolnik et al., 1963a). 3,4-Dihydroxycinnamic acid could be directly converted to 3,4-
dihydroxybenzaldehyde by a paralogue of vanillin synthase. Vanillin synthase converts ferulic 
acid to vanillin (Gallage et al., 2014). This reaction is similar to that proposed for the reduction of 
3,4-dihydroxycinnamic acid to 3,4-dihydroxybenzaldehyde by a hydratase/lyase type mechanism. 
An analogous, non-oxidative pathway is proposed for benzaldehyde biosynthesis. Reactions 
similar to the beta-oxidative and non-oxidative CoA-dependent pathways of benzaldehyde 
biosynthesis are also a possibility (Widhalm and Dudareva, 2015). The condensation to the Schiff-
base norcraugsodine is analogous to known amine-aldehyde condensing enzymes including 
norcoclaurine synthase and strictosidine synthase (Kutchan et al., 1994; Samanani and Facchini, 
2002). Considering the simple chemistry required for the formation of norcraugsodine, it is 
possible that the condensation occurs either nonenzymatically or in the active site of the same 
enzyme that reduces norcraugsodine to norbelladine. Enzyme superfamilies capable of catalyzing 
reductions similar to the reduction of norcraugsodine to norbelladine include aldo-keto reductases 
(AKRs) and short-chain dehydrogenase/reductases (SDRs) (Jörnvall et al., 1995; Penning, 2015). 
An example of an imine reductase from the alcohol dehydrogenase (ADH) branch of the SDR 
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superfamily is tetrahydroalstonine synthase from Catharanthus roseus, which reduces strictosidine 
aglycone to tetrahydroalstonine (Stavrinides et al., 2015).  
 
Figure 4.1. Amaryllidaceae alkaloid biosynthesis. Enzymes involved in the pathway are indicated in blue. 
Abbreviations phenylalanine ammonia lyase (PAL), norbelladine 4’-O-methyltransferase (N4OMT), and 
noroxomaritidine/norcraugsodine reductase (NNR). 
100 
 
Norbelladine is methylated and phenol-coupled to produce the vast diversity of 
Amaryllidaceae alkaloids, including the representative alkaloids for the primary skeletons 
haemanthamine, crinine, galanthamine, and lycorine. Several downstream Amaryllidaceae 
alkaloid biosynthetic enzymes have been characterized on a molecular level including norbelladine 
4’-O-methyltransferase (N4OMT) and CYP96T1. N4OMT is responsible for the 4’-O-methylation 
of norbelladine to 4’-O-methylnorbelladine (Kilgore et al., 2014). CYP96T1 is a para-para’ 
phenol-phenol coupling cytochrome P450 that generates an enantiomeric mixture of 
noroxomaritidine with a small quantity of N-demethylnarwedine from 4’-O-methylnorbelladine 
(Chapter 3). The two enantiomers of noroxomaritidine are further modified into haemanthamine- 
and crinine-type alkaloids. N-demethylnarwedine from CYP96T1 may contribute a small amount 
to the galanthamine type alkaloids (Figure 4.1). Several of these compounds are interesting to 
medicine including the anticancer compound haemanthamine and the Alzheimer’s disease 
treatment galanthamine (Wilcock et al., 2003; Havelek et al., 2014). These gene discoveries 
facilitate co-expression analysis to identify additional Amaryllidaceae alkaloid biosynthetic genes.  
In this study, previously described in Chapters 2 and 3 Narcissus sp. aff. pseudonarcissus, 
Galanthus sp., and Galanthus elwesii transcriptomes are interrogated for reductase genes that 
consistently co-express with the previously discovered N4OMT in 4 or more of these 
transcriptomes (Kilgore et al., 2014). These reductase cDNAs were cloned, expressed in E. coli, 
and the proteins affinity purified. Assays monitoring the formation of norbelladine from a solution 
containing 3,4-dihydroxybenzaldehyde and tyramine show formation of norbelladine with the 
SDR, which we designated noroxomaritidine/norcraugsodine reductase (NNR). Competition 
experiments and crystal structures indicate this enzyme acts directly on the 3,4-
dihydroxybenzaldhyde and tyramine and acts as a norcraugsodine synthase. In addition, the 
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enzyme reduces a carbon-carbon double bond of the Amaryllidaceae alkaloid noroxomaritidine to 
form one of the enantiomeric forms of oxomaritinamine. This enzyme is responsible for the first 
committed biosynthetic step in the Amaryllidaceae alkaloids and will be key to future biological 
production of these compounds.  
4.2  Materials and Methods 
4.2.1  Plant Tissue and Chemicals 
Plant tissue and chemicals are as described for isolation and characterization of N4OMT and 
CYP96T1 in Chapters 2 and 3 (Kilgore et al., 2014). In addition, the following chemicals were 
used: piperonal from Sigma; 8,9-O-didemethyloxomaritidine and noroxomaritidine were from our 
natural product collection; DMSO from New England BioLabs; nicotinamide adenine dinucleotide 
phosphate disodium salt (NADP+) from MP Biomedicals, Inc; citric acid anhydrous reagent ACS 
99.5% from ACROS; sodium borohydride 99% from Acros Organics; and sodium 
cyanoborohydride reagent grade 95 % from Aldrich.  
4.2.2  Candidate Gene Identification 
Candidates were selected as in the discovery of CYP96T1 (Chapter 3), but instead of a list of 
cytochromes P450, a list of oxidoreductases were used as a BLASTP query (Table D.1 and Table 
D.2). Contigs found to co-express with N4OMT in 4 or more of the 5 available Amaryllidaceae 
transcriptomes were cloned and tested for enzymatic activity (Chapter 3).  
4.2.3  cDNA Cloning and Recombinant Enzyme Purification 
cDNA was prepared as previously described in Chapter 3. The outer PCR reaction contained the 
following components: 25 ng Narcissus sp. aff. pseudonarcissus bulb cDNA, 1X Phusion HF 
reaction buffer, 1 U NEB Phusion High-Fidelity DNA polymerase, 3% DMSO, 0.4 mM dNTPs, 
0.4 µM NNR forward outer, and 0.4 µM NNR reverse outer primers (Table D.3). The parameters 
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for the PCR were 98 ⁰C 30 sec for 1 cycle, 98 ⁰C 10 sec, 50 ⁰C 30 sec, 72 ⁰C 60 sec for 35 cycles, 
72 ⁰C 5 min 1 cycle, 4 ⁰C until removed. The inner PCR solution was the same except 0.2 µM 
NNR forward inner and 0.2 µM NNR reverse inner primers were used and the outer PCR was used 
as template instead of cDNA (Table D.3). The inner PCR program had a Tm of 52 ⁰C instead of 
50 ⁰C and 25 cycles instead of 35 cycles. Primers for inner PCR have BamHI and NotI restriction 
sites appended to the start and stop sites of the open reading frame. These were used for ligation 
into pET28a and subsequent transformation into E. coli. Expression and subsequent affinity 
purification of hexahistidine-tagged protein was as for N4OMT (Chapter 2). 
4.2.4  Enzyme Assays 
Initial screening assays contained 100 mM sodium phosphate buffer pH 7.0, 1 mM NADPH, 1 
mM tyramine, 1 mM 3,4-dihydroxybenzaldehyde, and 10 µg pure protein in 100 µl. Reactions 
were incubated at 30 ⁰C for 2 hr. Assays were extracted with ethyl acetate at pH 9.5 as previously 
described (Kilgore et al., 2014). The extracts were re-suspended in mobile phase matching the 
solvent composition at the beginning of the HPLC program. Samples were run on the same LC-
MS/MS instrument and with the same program as for CYP96T1 (Chapter 3). MS/MS parameters 
used to specifically monitor norbelladine are collision energy (CE) 15, declustering potential (DP) 
50, and m/z 260.0. Other compounds screened were tested with the parameters listed in Table D.4. 
IC50 and specific activity assays were performed with 100 mM citrate buffer pH 6.0 at 35 ⁰C in 40 
µl reactions. Substrates used in specific activity assays were all 500 µM with 1 mM NADPH. For 
temperature optima and pH optima determination, the MRM parameters used to monitor 
norbelladine were m/z 260.0/138.0 and m/z 260.0/121.0 with the same CE and DP as for screening. 
For IC50 assays, oxomaritinamine was monitored with the following MRMs m/z 274.3/136.1 and 
m/z 274.3/219.1 with CE (35) and DP (70). For specific activity measurements, a QTRAP 6500 
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was used for MRM analysis with the same isocratic LC set up as previously described (Chapter 
3). The MRM parameters for specific activity measurements were norbelladine m/z 260.1/238.0 
and m/z 260.1/121.0 CE (60) and DP (10), 4’-O-methylnorbelladine m/z 274.1/137.0 and m/z 
274.1/122.0 CE (20) and DP (60), and oxomaritinamine m/z 274.1/136.1 and m/z 274.1/219.1 CE 
(30) and DP (70). Oxomaritinamine was quantified by incubating noroxomaritidine and NNR 
overnight and equating the quantity of noroxomaritidine consumed to the quantity of 
oxomaritinamine produced using the same HPLC program used to analyze enzyme assays during 
N4OMT characterization at 288 nm (Kilgore et al., 2014). This standardized oxomaritinamine was 
then used in specific activity experiments on the LC-MS/MS to determine product quantity.  
4.2.5  Substrate Synthesis 
4-(2-((1,3-Benzodioxol-5-ylmethyl)amino)ethyl)phenol, 3’-O-methylnorbelladine, and 4’-O-
methylnorbelladine were made by mixing ~100 mM sodium cyanoborohydride and ~10 mM 
tyramine with ~10 mM piperonal, vanillin, or isovanillin respectively in 2.5 ml anhydrous 
methanol. After incubation overnight at room temperature the reactions were dried to 0.5 ml with 
subsequent addition of 2 ml 1 M sodium carbonate pH 9.5 and extracted with 2 ml ethyl acetate 
two times. After drying, all extracts were dissolved in 1 ml water, diluted 1/20 and purified by 
fraction collection with the same HPLC program used to analyze enzyme assays during N4OMT 
characterization (Kilgore et al., 2014). 
4.2.6  Protein Expression and Purification for Crystallography 
NNR in pET28a was transformed into E. coli Rosetta II (DE3) cells (EMD Millipore). Cells were 
cultured in Terrific broth up to A600nm∼0.6-0.8. Induction of protein production used a final 
concentration of 1 mM IPTG overnight at 16⁰C. Cells were pelleted by centrifugation and 
resuspended in lysis buffer (50mM Tris, pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% glycerol, 
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and 1% Tween). Following sonication, cell debris were removed by centrifugation, and the 
resulting lysate was passed over a Ni2+-nitriloacetic acid (Qiagen) column equilibrated in lysis 
buffer. The column was then washed with 50 mM Tris, pH 8.0, 500 mM NaCl, 20 mM imidazole, 
and 10% glycerol. Bound His-tagged protein was eluted with 50 mM Tris pH 8.0, 500 mM NaCl, 
250 mM imidazole, and 10% glycerol. Prior to crystallization the His-tag was removed by 
overnight dialysis at 4 ⁰C using thrombin (1:2000 total protein). Dialyzed protein was loaded onto 
a mixed Benzamidine-Sepharose/Ni2+-nitrilotriacetic acid column. The flow-through was loaded 
onto a Superdex-75 26/60 HiLoad FPLC size-exclusion column (GE Healthcare) equilibrated with 
25 mM Hepes, pH 7.5, and 100 mM NaCl. Protein concentration was determined by the Bradford 
method (Protein Assay, Bio-Rad) with bovine serum albumin as a standard. 
4.2.7  Protein Crystallography 
Purified NNR was concentrated to 8 mg ml−1 and crystallized using the hanging-drop vapor-
diffusion method with a 2 μl drop (1:1 concentrated protein and crystallization buffer). Diffraction 
quality crystals of the NNR·NADP+ complex were obtained at 4 ⁰C with a crystallization buffer 
of 20% PEG-8000 and 100 mM Hepes, pH 7.5. Crystals of the NNR·tyramine complex formed at 
4 ⁰C with a crystallization buffer of 2 M ammonium sulfate, 100 mM CAPS, pH 10.5, 200 mM 
lithium sulfate, 1.5 mM NADP+, and 6 mM tyramine. For the NNR·piperonal complex, 35% MPD, 
100 mM sodium acetate, pH 4.5 and 3 mM piperonal was the crystallization buffer. Crystals were 
flash-frozen in liquid nitrogen the mother liquor supplemented with 25% glycerol as a 
cryoprotectant. Diffraction data (100 K) was collected at the Argonne National Laboratory 
Advanced Photon Source 19-ID beamline. The data were indexed, scaled, and integrated with 
HKL3000 (Minor et al., 2006). Molecular replacement implemented in PHASER (de La Fortelle 
and Bricogne, 1997) using Datura stramonium tropioine reductase-II (PDB: 2AE2; (Yamashita et 
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al., 1999) as a search model to determine the structure of the NNR·tyramine complex. Iterative 
rounds of manual model building and refinement, which included translation-libration-screen 
(TLS) models, used COOT (Emsley and Cowtan, 2004) and PHENIX (Adams et al., 2010). The 
crystal structures of NNR·NADP+ and NNR·piperonal were determined by molecular replacement 
using PHASER (de La Fortelle and Bricogne, 1997) and the NNR·tyramine structure with ligands 
removed as the search model. Data collection and refinement data are summarized in Table D.5. 
The final model of the NNR·NADP+ complex included residues Ser-16- Gly-271, the NADP+ 
ligand, and 136 waters. The final model of the NNR·tyramine complex included residues Ser-16–
Gly-271 for chain A, residues Met15–Gly-271 for chain B, residues Leu-17–Asn-270 for chain C, 
and residues Leu-17–Gly-271 for chain D, the NADP+ ligand in chains A-C, the tyrosine ligand in 
chains B and D, and 443 waters. The final model of the NNR·piperonal complex included Met-
15–Gly-271, the NADP+ ligand, the piperonal ligand in chain A, and 644 waters. 
4.3  Results 
4.3.1  Identification and Initial Characterization of NNR 
When interrogating for N4OMT co-expressing oxidoreductase homologues, 36 transcripts were 
identified in the Narcissus sp. aff. Pseudonarcissus transcriptome. Of these 36 transcripts, 
medp_9narc_20101112|58880 was found to co-express with N4OMT in the previously described 
ABySS and MIRA based assemblies for Narcissus sp. aff. pseudonarcissus, Galanthus elwesii and 
Galanthus sp. (Kilgore et al., 2014). It also co-expressed with N4OMT in the previously described 
Trinity based assembly for Galanthus sp. (Chapter 3). The medp_9narc_20101112|58880 was 
incomplete in the 3’ and 5’ regions. The medp_9narc_20101112|12438 sequence, a close 
homologue of apparent full-length, was used to design primers for PCR amplification. A clone 
with the genbank accession number KU295569 was obtained that differed from the 
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medp_9narc_20101112|58880 at four nucleic acids with one nonsynonymous change (see Figure 
D.1 for details).  
Expression in E. coli followed by affinity purification on a cobalt column resulted in a 
prominent ~31 kDa band on SDS-PAGE. When this enzyme was tested for norcraugsodine 
reductase activity, it was found to produce norbelladine (Figure 4.2A). The identity of norbelladine 
was ascertained by comparison of the MS fragmentation pattern to that of authentic standard 
(Figure 4.2B and C). The gene was therefore named noroxomaritidine/norcraugsodine reductase 
(NNR). A norbelladine background is present in all assays with 3,4-dihydroxybenzaldehyde and 
tyramine due to spontaneous formation of norcraugsodine. The enzyme was found to be NADPH 
dependent. This is consistent with the prediction that this will be a NADPH-dependent SDR based 
on the residues Lys-21, Ser-42, and Arg-43 (Kallberg et al., 2002). NADH did not serve as 
reductant for NNR. To simplify analysis quantity of enzymatic product relative to chemical 
background was maximized for pH and temperature. This maximum was found to be at pH 6.0 
and 35 ⁰C (Figure D.2 A-D).  
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Figure 4.2. LC-MS/MS enhanced product ion scan (EPI) of the enzyme assays testing 
noroxomaritidine/norcraugsodine reductase (NNR) m/z 260.0. (A) Top to bottom Norbelladine standard, functioning 
NNR assay, assay without tyramine and 3,4-dihydroxybenzaldehyde, assay without NADPH, and assay with His-tag 
purified E. coli vector control protein extract but no NNR protein. (B) EPI of norbelladine standard. (C) EPI of NNR 
product. 
4.3.2  Substrate Specificity 
Substrate specificity tests identified vanillin, isovanillin, and piperonal as substrates. These 
substrates, paired with tyramine, generated the products 3’-O-methylnorbelladine, 4’-O-
methylnorbelladine, and 4-(2-((1,3-benzodioxol-5-ylmethyl)amino)ethyl)phenol, respectively 
(Table 4.1). The structures of the enzymatic products were confirmed by comparing to the products 
produced by chemical condensation and reduction of vanillin, isovanillin, or piperonal with 
tyramine in methanol containing sodium cyanoborohydride and subsequent examination with LC-
MS/MS. The resulting LC-MS/MS spectra were identical whether the products were chemically 
or enzymatically generated. To examine the ability of NNR to operate in other points of 
Amaryllidaceae alkaloid pathways noroxomaritidine was tested for reductase activity. This 
substrate in planta is thought to be reduced at a ketone group to yield the alcohol normaritidine 
that is further modified into haemanthamine or potentially at a 1-2 carbon-carbon double bond to 
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give oxomaritinamine. Noroxomaritidine was reduced by NNR (Figure 4.3A). When 
noroxomaritidine reduced by NNR was compared to noroxomaritidine reduced with sodium 
borohydride, the fragmentation patterns were not the same (Figure 4.3B and C). Aldehyde and 
ketone double bonds are the typical substrates of sodium borohydride (Banfi et al., 2001). Carbon-
carbon double bonds can be reduced, but the ketone will be reduced as well. For this reason, the 
product generated by the sodium borohydride reduction is likely normaritidine. The 1-2 carbon-
carbon double bond is, therefore, likely reduced by NNR into oxomaritinamine. The 
noroxomaritidine substrate is an enantiomeric mixture. The enantiomers were therefore resolved 
by chiral chromatography as previously described (Chapter 3). In overnight assays only one of the 
noroxomaritidine enantiomers was notably consumed. More than half of the enantiomeric mixture 
was never consumed, indicating that the enzyme acts preferentially on one of the two enantiomers. 
Optically pure standards of known configuration are lacking, so the absolute configuration of the 
preferred substrate remains unknown. To examine the ability of NNR to take different substrates 
like noroxomaritidine the demethylated form 8,9-O-didemethyloxomaritidine was tested for 
enzymatic activity. 8,9-O-Didemethyloxomaritidine was reduced by NNR yielding a product 
highly similar to oxomaritinamine in its mass spectrum indicating that the product is also reduced 
at the carbon-carbon double bond and therefore is 9-O-demethyloxomaritinamine. Fragments that 
are identical from these two molecules include m/z 91.1, m/z 94.1, m/z 108.1, and m/z 136.1. 
Fragments that represent the presence of an additional methyl group in oxomaritinamine compared 
to 9-O-demethyloxomaritinamine are m/z 246.1 and m/z 232.1, m/z 219.1 and m/z 205.1, m/z 204.1 
and m/z 190.1, m/z 190.1 and m/z 176.1, and m/z 165.0 and m/z 151.0.  
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Table 4.1. Substrate specificity of NNR 
Substrate Product monitored Specific activity (standard 
deviation) (pmol min-1 mg-1) 
3,4-Dihydroxybenzaldehyde 
and tyramine 
Norbelladine 21.2 (1.2) 
Isovanillin and tyramine 4’-O-Methylnorbelladine 5.33 (0.21) 
Noroxomaritidine Oxomaritinamine 8600 (1250) 
Vanillin and tyramine 3’-O-Methylnorbelladine + 
Piperonal and tyramine 4-(2-((1,3-Benzodioxol-5-
ylmethyl)amino)ethyl)phenol 
+ 
8-O-,9-O-
Didemethyloxomaritidine 
9-O-Demethyloxomaritinamine + 
+product made but not quantified 
 
Figure 4.3. LC-MS/MS enhanced product ion scan (EPI) for NNR enzyme assays m/z 274.3 monitoring reduction of 
noroxomaritidine. (A) Top to bottom substrates noroxomaritidine standard, NNR assay, assay without 
noroxomaritidine, assay without NADPH, and assay with E. coli empty vector protein extract substituted for NNR 
protein. (B) EPI of NNR product. (C) EPI of noroxomaritidine reduced with NaBH4. 
An analysis of the relative reaction rates for substrates potentially involved in 
Amaryllidaceae alkaloid biosynthesis indicated several NNR preferences. Assays on 3,4-
dihydroxybenzaldehyde-tyramine or noroxomaritidine show preference for the noroxomaritidine 
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reduction by several orders of magnitude, 21.2(1.2) µmol min-1 mg-1 verses 8600(1250) µmol min-
1 mg-1 (Table 4.1). This is not surprising considering the condensation reaction that is prerequisite 
to the reduction of norcraugsodine. The specific activity for the isovanillin-tyramine reaction, 
5.33(0.21) µmol min-1 mg-1, was determined to be about 4-fold less than 3,4-
dihydroxybenzaldehyde-tyramine. This difference supports the proposed pathway with 3,4-
dihydroxybenzaldehyde as the substrate for condensation and reduction with subsequent 
methylation by N4OMT to 4’-O-methylnorbelladine. 
4.3.3  Inhibition of Noroxomaritidine Reduction 
The reduction of noroxomaritidine provided the opportunity to test the occupancy of the active site 
of NNR by 3,4-dihydroxybenzaldehyde and tyramine. If the enzyme active site binds these 
substrates, it could facilitate the formation of norcraugsodine prior to reduction to norbelladine. 
Also, if the enzyme binds these substrates then the individual components could act as competitive 
inhibitors for the reduction of noroxomaritidine. If previously formed norcraugsodine is the 
substrate NNR acts on than this inhibition would not be expected. The IC50 values of tyramine, 
3,4-dihydroxybenzaldehyde, and piperonal are greater than 300 µM (Table 4.2). Piperonal has a 
lower IC50 value (330 µM) than 3,4-dihydroxybenzaldehyde (1,050 µM). This could result from 
the increased stability of piperonal relative to 3,4-dihydroxybenzaldehyde or a stronger binding to 
the active site. These values are high, however, strictosidine synthase has been shown to have a 
Km of even greater magnitude Km ~4 mM for tryptamine and secologanin (Hampp and Zenk, 1988). 
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Table 4.2. NNR noroxomaritidine reduction inhibition 
Inhibitor IC50 (µM) 
Tyramine 1,050 
3,4-Dihydroxybenzaldehyde 3,870 
Piperonal 330 
4.3.4  Structure of NNR 
The crystal structures of Narcissus sp. aff. pseudonarcissus NNR complexed with NADP+, NADP+ 
and tyramine, and NADP+ and piperonal were determined to 1.7 Å, 1.8 Å and 1.5 Å, respectively. 
NNR can be classified as a classical short-chain dehydrogenase reductase (SDR), containing the 
conserved dinucleotide binding motif TGxxxGxG at the N-terminus (Persson and Kallberg, 2013). 
NNR is a tetramer with each chain being 271 amino acids in length and contains the classic 
Rossmann fold typical of the SDR enzyme family (Rossmann et al., 1975). An alternating α/β 
structure formed by seven parallel β-sheets sandwiched between two layers of three α-helices 
shapes the NADPH binding domain (Figure 4.4A). NNR uses NADPH as an electron donor to 
catalyze the reduction of norcraugsodine to norbelladine. NADPH binds the active site pocket of 
NNR through polar interactions and nonpolar interactions (Figure 4.4B). The adenine ring, which 
is in the anti conformation, interacts with the side chain carboxylate of Val-83 through its exocyclic 
N6 and a terminal hydroxyl group of Asp-82 through hydrogen bonding with N1. The 2′-phosphate 
of the adenine ribose interacts with Arg-57 through hydrogen bonds to 1N and N of the side 
chain and to the backbone amide-nitrogen. Additionally, the adenine ribose phosphate interacts 
with the hydroxyl side chain of Ser-56. These interactions are key structural features that 
distinguish the NADPH SDRs from the NADH-specific enzymes (Deacon et al., 2000; Filling et 
al., 2002). The adenine binding pockets of all SDRs are stabilized by a highly conserved DxxD 
motif (Filling et al., 2002). The nicotinamide ribose has the C3′-endo conformation, and its C3 
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hydroxyl group hydrogen bonds to the Thr-34 hydroxyl. The 2′-hydroxyl of the nicotinamide 
ribose interacts with Tyr-175, a key residue for substrate recognition, and the 3′-hydroxyl of the 
nicotinamide ribose interacts with another key substrate-recognition residue, Lys-199, and the 
carboxylate of Asn-110. A water molecule is responsible for hydrogen bonding to two of the 
nicotinamide ribose phosphate oxygens, while a third hydrogen bond forms between an oxygen on 
the first nicotinamide ribose phosphate and Thr-210. The syn conformation of the nicotinamide 
ring is stabilized by a hydrogen bond involving the nicotinamide carboxamide group to the 
backbone amide-nitrogen Ile-208. The A-face of the nicotinamide ring packs against several 
aliphatic side chains (Ile-208, Pro-225, Gly-226, and Ala-227) and directs the B-face toward the 
binding pocket for the imine substrate. The NNR·NADP+ complex was intended to be an apo 
enzyme but the binding affinity of NADP+ to the NNR active site prevented its removal during 
purification from E. coli. 
 
Figure 4.4. Crystal structure of NNR. (A) Ribbon diagram of the NNR tetramer complexed with NADP+ and tyramine. 
(B) Polar contacts between NADP+ and NNR. (C) Tyramine co-crystallized with NNR. (D) Piperonal co-crystallized 
with NNR. 
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 Tyramine and piperonal were co-crystallized with NNR with NADP+ (Figure 4.4C and D). 
These crystals demonstrate that these two compounds can bind to the NNR active site prior to 
condensation into a Schiff-base. In the context of the noroxomaritidine reduction both these 
compounds were demonstrated to inhibit the reduction and this is consistent with their position in 
the active site (Table 4.2). Both compounds interact with residues Tyr-175 and Lys-179, blocking 
the transfer of the hydride from C4 of the nicotinamide ring, and would prevent the reduction 
reaction of noroxomaritidine. The amine group of tyramine hydrogen bonds to Tyr-175 at a 
distance of 3.2 Å, while the distance between tyramine and C4 of the nicotinamide is 3.36 Å.  
4.4  Discussion 
NNR belongs to the SDR superfamily. It is closely related to the tropinone reductase-like 
reductases that are frequently involved in the metabolism of secondary metabolites (Brock et al., 
2008; Reinhardt et al., 2014). This is the second example of a member of the SDR superfamily in 
plants reducing an imine functional group (Stavrinides et al., 2015). This makes SDRs promising 
candidates to target for identifying additional imine reductase activities. 
NNR shows two separate enzymatic activities. One is the formation of norbelladine from 
a mixture of tyramine and 3,4-dihydroxybenzaldehyde. The norbelladine forming reaction is one 
of the first committed steps in Amaryllidaceae alkaloid biosynthesis. The reaction consists of two 
steps: condensation of tyramine and 3,4-dihydroxybenzaldehyde to an imine, and subsequent 
reduction of the imine. NNR was shown to have norcraugsodine reductase activity, and potentially 
facilitates the condensation of tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine.  
The competition experiments designed to determine the enzyme’s ability to bind 3,4-
dihydroxybenzaldehyde and tyramine alone resulted in high IC50 values. However, actual 
concentrations of tyramine can be 3 mM in bulb tissue of Narcissus sp. aff. pseudonarciss. In 
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addition, enzymes for secondary metabolism can have high Km values, such as that for strictosidine 
synthase (Hampp and Zenk, 1988). Crystal structures also showed binding of the individual 
components tyramine and piperonal to the NNR active site. This confirms the binding of these 
uncondensed molecules to the active site. 
A second activity of the enzyme is the reduction of one of the enantiomeric forms of 
noroxomaritidine to oxomaritinamine. Depending on the enantiomer being reduced, this second 
activity could contribute to the biosynthesis of maritinamine or elwesine (Boit and Döpke, 1961; 
Pabuççuoglu et al., 1989). The double bond is reduced in both maritinamine or elwesine, but are 
derived from (10bR,4aS)-noroxomaritidine and (10bS,4aR)-noroxomaritidine, respectively. 
When using co-expression analysis to search for additional Amaryllidaceae alkaloid 
biosynthetic genes individual genes will vary in their expression pattern over diverse 
environmental, developmental, tissue, and time points. Because of these differences the addition 
of NNR to a co-expression analysis with N4OMT and CYP96T1 in systems other than what was 
initially used to identify them will enrich efforts to identify additional biosynthetic genes and 
provide a deeper understanding of the relationships between Amaryllidaceae alkaloid biosynthesis 
and accumulation of participating enzymes. 
The discovery of NNR now makes it possible to produce Amaryllidaceae alkaloids through 
bioengineering. Tyrosine decarboxylase, a well-known enzyme in other systems, has been 
identified in Narcissus sp. aff. pseudonarcissus and the recombinant enzyme has been 
biochemically validated to have tyrosine decarboxylase activity (Appendix A). While some 
aspects of 3,4-dihydroxybenzaldehyde synthesis remain unknown, a synthetic biology system for 
the production of vanillin produces 3,4-dihydroxybenzaldehyde as an intermediate (Hansen et al., 
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2009). It is possible that the addition of tyrosine decarboxylase, the enzymes required for 3,4-
dihydroxybenzaldehyde production, and NNR to a heterologous system would be sufficient for the 
production of norbelladine. Even if the synthase activity is not sufficient in NNR to drive the 
condensation reaction, a heterologous system may make sufficient quantities of the two substrates 
that the spontaneous condensation proceeds and NNR can mediate reduction. The previously 
discovered N4OMT and CYP96T1 could also be added to the system to potentially obtain 
haemanthamine, crinine, and some galanthamine skeleton derivatives (Kilgore et al., 2014). This 
could provide a more efficient production system for these anticancer compounds and Alzheimer’s 
disease treatments (Wilcock et al., 2003; Havelek et al., 2014).  
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Chapter 5: Conclusions and Perspectives 
5.1  Thesis Conclusions 
This thesis examines how Amaryllidaceae alkaloids are biosynthesized using an effective workflow 
for identifying pathway genes in non-model systems. The hypothesis from which this workflow 
evolved is that genes involved in the biosynthesis of particular Amaryllidaceae alkaloids are co-
regulated and this leads to correlations between biosynthetic gene expression and corresponding 
end-product accumulation. The discovery of the Amaryllidaceae alkaloid biosynthetic genes 
norbelladine 4’-O-methyltransferase (N4OMT), CYP96T1, and noroxomaritidine/norcraugsodine 
reductase (NNR) in Chapters 2, 3, and 4 through correlations with galanthamine accumulation 
(N4OMT) and co-expression with N4OMT (CYP96T1 and NNR) confirms this underlying 
hypothesis. The confirmation of this hypothesis is in keeping with previous work demonstrating 
co-expression of other pathways with end metabolites and their biosynthetic genes (Augustin et al., 
2015). These core pathway enzyme discoveries also provide biosynthetic information relevant to 
many biologically active Amaryllidaceae alkaloids, including the Alzheimer’s treatment 
galanthamine and the anti-cancer compound haemanthamine (Wilcock et al., 2003; Havelek et al., 
2014).  
 The three newly discovered enzymes were found to have the following activities: NNR 
reduces norcraugsodine to norbelladine, N4OMT methylates norbelladine to 4’-O-
methylnorbelladine, and CYP96T1 phenol-phenol couples 4’-O-methylnorbelladine to 
noroxomaritidine. When characterizing N4OMT, CYP96T1, and NNR, previously unknown 
aspects of Amaryllidaceae alkaloid biosynthesis were discovered. N4OMT and CYP96T1 were 
both shown to accept N-methylated versions of norbelladine and 4’-O-methylnorbelladine as 
substrate. Detailed radiolabeling experiments by Eichhorn et al. have placed the N-methylation of 
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galanthamine-type alkaloids after phenol-phenol coupling (Eichhorn et al., 1998). Prior to these 
experiments, it was thought that N-methylation occurred prior to phenol-phenol coupling due to 
radiolabeling experiments of Barton and Kirby (Barton and Kirby, 1962). The ability of N4OMT 
and CYP96T1 to accept substrates with and without N-methylation may explain incorporation of 
4’-O-methyl-N-methylnorbelladine in earlier work.  
 CYP96T1 generated the enantiomeric mixture (+)-noroxomaritidine when using 4’-O-
methylnorbelladine as substrate. This could indicate a role of this cytochrome P450 in formation of 
both the haemanthamine series of compounds and the crinine series. The presence or absence of 
derivatives from one or the other enantiomer in different Amaryllidaceae species could be a result 
of degradation pathways, a stereospecific version of this enzyme, or chiral directing of the achiral 
intermediate by another enzyme in planta.  
 NNR was shown to have norcraugsodine reductase activity, and potentially facilitates the 
condensation of tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine.  It was also 
shown to be multifunctional with the ability to reduce the carbon-carbon double bond on one of the 
enantiomers of noroxomaritidine. The potential involvement of NNR in all these reactions will be 
informative to future work on these reactions. 
5.2  Application of Minimalist and Extensive Workflows 
This thesis demonstrates that a simple workflow consisting of RNA-seq on only a few well-
determined tissues and quantification of a limited number of metabolites can be used to discover 
biosynthetic genes in species and pathways for which previous genetic knowledge is lacking. This 
is a practical alternative workflow to methods that take a metabolomics approach with substantial 
expression data (Saito et al., 2008). The extensive approach has better statistical power, but can be 
cost and labor prohibitive in non-model species without available omic data. The extensive 
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approach is particularly problematic if the plant tissue being analyzed comes from a rare plant, 
which is sometimes the case in secondary metabolism research (Augustin et al., 2015). However, 
the minimalist approach is limited statistically, due to the low sample number, causing small 
correlations to be undetectable. Also, experimental conditions with strong correlations between 
genes may be lacking from the dataset. Because of the resulting danger of false negatives when 
using a minimalist approach, the ability to test for multiple enzymes in a pathway can be vital. If 
one enzyme in the pathway is not observed to co-express with another under tested conditions a 
third enzyme in the pathway may be co-expressing and discoveries can be made without 100 % 
success for every enzymatic activity tested.  
 The CYP96T1 work demonstrates the ability to identify biosynthetic genes by comparing 
co-expression across species in the Amaryllidaceae. In a rare species, this could be applied to 
identify shared biosynthetic genes using data from closely related common species with similar 
alkaloids, forming the basis for the identification of the unique biosynthetic genes in the rare 
species. Interspecies comparisons are useful when applied to species with extensive information in 
relation to a species with limited information. Homology, along with a few expression data points, 
can be used to link one of these well-studied species with an orphan species of interest. Using 
known genes along with the unique properties of non-model species, new insights can be obtained 
by just adding a few more data points to the well-characterized system. The co-expression of 
transcripts in Amaryllidaceae alkaloid biosynthesis and co-accumulation of alkaloids with these 
transcripts opens the door for future co-expression studies in Amaryllidaceae alkaloids. It also 
validates the use of co-expression analysis as a starting point when studying secondary metabolism 
in non-model species. 
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5.3 Future Directions for Amaryllidaceae Alkaloid 
Biosynthesis  
The discovery of more biosynthetic genes in the pathways for Amaryllidaceae alkaloids is an area 
of future interest because of their medicinal potential and importance to Amaryllidaceae biology. 
Many of the biosynthetic steps leading to compounds like haemanthamine and galanthamine remain 
undiscovered. These uncharacterized genes likely belong to established biosynthetic gene 
superfamilies. Given the co-expression observed between the discovered biosynthetic genes, it is 
likely several of these uncharacterized genes will also co-express. For this reason, the application 
of co-expression coupled with homology to superfamilies with the same underlying chemistry will 
likely result in the discovery of additional biosynthetic genes. Steps of particular interest include 
the reduction of N-demethylnarwedine to N-demethylgalanthamine, which is likely catalyzed by an 
AKR or an SDR superfamily member. While this gene was not found to co-express with N4OMT 
in ≥ 4 of the transcriptomes in Chapter 4, it is likely present in the ≥ 3 or the ≥ 2 lists. These genes 
were observed during the discovery of the NNR, but were assigned a lower priority than the genes 
co-expressing in 4 transcriptomes. The same applies to the reductase responsible for the reduction 
of noroxomaritidine to normaritidine. These reductases would be of particular biotechnological 
interest because they are directly downstream of the enzymatically characterized core biosynthetic 
genes and could prove useful for the production of these compounds in heterologous systems. Also 
of interest are the N-methyltransferase that converts N-demethylgalanthamine to galanthamine, the 
oxidase (probably a cytochrome P450) responsible for the oxide bridge formation in the 
normaritidine to vittatine conversion, the hydroxylase (possibly a cytochrome P450 or a 2-
oxoglutarate-dependent dioxygenase) that converts vittatine to 11-hydroxyvittatine, and the 
methyltransferase that converts 11-hydroxyvittatine to haemanthamine. A cytochrome P450 that 
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yields more N-demethylnarwedine than CYP96T1 may yet be discovered, given the high content 
of galanthamine type alkaloids in some Amaryllidaceae.   
 In addition to biosynthetic genes transcription factors regulating their biosynthesis could be 
discovered through co-expression analysis, examination of transcription factor binding motifs on 
the promoters of known genes, or proximity on gene clusters. The discovery of these transcription 
factors could enable an understanding of the biosynthetic regulation of these compounds and help 
identify other plant pathways that may share these transcription factors and therefore experience 
similar regulation. The resulting understanding of this regulation could assist efforts to boost the 
content of specific Amaryllidaceae alkaloids in members of the Amaryllidaceae and provide insight 
into other co-regulated pathways that may work with Amaryllidaceae alkaloid biosynthesis to 
achieve goals such as deterring herbivores.  
 A potential expansion of the work would be to sequence more members of the 
Amaryllidaceae. Sequencing projects have already been performed on the closely related bulbs 
Allium cepa (onion), Allium sativum (garlic), Allium fistulosum (bunching onion), and Allium 
tuberosum (chinese chive) (Kamenetsky et al., 2015; Rajkumar et al., 2015; Tsukazaki et al., 2015). 
A cross comparison of additional species could make phylogenetic sense of the distribution of 
Amaryllidaceae alkaloids across the Amaryllidaceae. Searching for the characterized genes in 
additional species and in the neighboring alliums could yield information regarding their origin. In 
addition, the sequencing of species with unique metabolites such as Crinum spp. would facilitate 
the discovery of the enzymes that lead to these unique products. These studies on the diversity of 
Amaryllidaceae alkaloids would provide key information for attempts to tailor Amaryllidaceae 
alkaloid pathways, in heterologous systems and members of the Amaryllidaceae, for optimal 
alkaloid production or the absence of these frequently poisonous alkaloids. 
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 The discovery of additional biosynthetic genes may require a more extensive collection of 
conditions and tissues to use for co-expression analysis.  Because some biosynthetic genes differ in 
regulation (modulated for example through differing transcription factors) depending on tissue, 
time in development, and stress some genes may require data sets with diverse tissues, time points, 
and environmental conditions to identify co-expression. To determine how consistently these 
discovered biosynthetic genes co-express, a finer organ or cell type level than leaf, bulb, and 
inflorescence could be monitored with qRT-PCR. Effects of environmental conditions and variation 
over the course of a year could also be monitored. This data could help identify the level of 
variability between known biosynthetic genes providing a baseline for unknown biosynthetic genes. 
Problematic tissues, time points, and conditions with little correlation between the known 
biosynthetic genes could be observed and perhaps excluded in co-expression experiments, or 
examined more thoroughly to determine the cause of the discrepancy between the expression 
patterns.   
 A cell type by cell type analysis of known-gene expression and the alkaloid end products 
could help determine if the Amaryllidaceae alkaloid biosynthesis is cell type specific or if transport 
occurs as in the biosynthesis of vindoline in Catharanthus roseus. In vindoline biosynthesis 
different cell types are required for early and late biosynthetic steps (St-Pierre et al., 1999). When 
transport of intermediates between cell types is required for the biosynthesis of secondary 
metabolites this other cell type could be next to the original cell or in a completely different organ 
of the plant. Potential reasons for the transport of intermediates include regulation of the 
biosynthetic process through prevention of undesired side reactions or a simpler evolutionary route 
where transport rather than alteration of ancestral biosynthetic gene promoters allow for cell type 
co-expression. An example of specialized cells for secondary metabolite production is the secretory 
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cells on the glandular trichomes of Mentha piperita. These cells secrete monoterpenoids into a 
central subcuticular cavity that stores the toxic terpenoids for protection of the leaf from herbivore 
attack (McCaskill et al., 1992). The need for a specialized cavity to store the toxic monoterpenoids 
is what drives cell type specific production in Mentha piperita. In addition to minimizing toxicity 
through specialized structures these cells may produce these metabolites to spare other cells from 
the associated metabolic load.    
 In addition to measuring transcript level, measuring changes in alkaloid content during the 
above experiments could provide information on the expression of unknown biosynthetic genes 
responsible for the elaboration of these alkaloids. For example, if 11-hydroxyvittatine is present but 
not haemanthamine in one tissue, while haemanthamine and not 11-hydroxvittatine is present in 
another tissue this would be an indication that the methyltransferase that methylates 11-
hydroxyvittatine to haemanthamine is present in the latter tissue but not the former. Such 
discoveries would help with the detection of the corresponding enzyme by incorporating new 
information into the co-expression analysis. 
 The examination of the proteome during any of these experiments could provide the actual 
levels of the enzymes of interest in different tissues. The correlation of the transcriptome to the 
proteome can be moderate (Ghazalpour et al., 2011). Discrepancies between transcript levels and 
active protein levels can be due to protein degradation, protein inactivation by redox signaling, a 
phosphorylation requirement, or other regulatory modification. These changes can be detected 
through proteomic analysis (Zhang and Ge, 2011). The ability of proteomic analysis to detect these 
changes could enable the identification of changes in active protein content and identify candidates 
correlating with the biosynthesis of Amaryllidaceae alkaloids on the protein level but not on the 
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transcript level. The proteome would also serve as an independent validation of sequences in the 
transcriptome that frequently align to peptides. 
 Another route to discover more biosynthetic genes is to place candidate genes under more 
biologically relevant conditions for enzyme assays. The temperature and pH used in screening 
assays are slightly higher than biological 30 ⁰C verses 20-25 ⁰C and the pH is approximately 7.5-
8.0 which may not mimic biological conditions if enzymes are compartmentalized in locations such 
as the vacuole with a reported pH of 5.5 (Mathieu et al., 1989). If the Amaryllidaceae alkaloids are 
biosynthesized in a complex of enzymes that facilitates biosynthesis through shuttling of the 
intermediates or a localized increase in intermediates, then some enzymes in the pathway may only 
function effectively in the context of this complex. It has been observed that when chorismate 
mutase and 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase, two biosynthetic enzymes in 
aromatic amino acid biosynthesis, in Mycobacterium tuberculosis interact their allosteric properties 
are extended and enzymatic activity is enhanced (Blackmore et al., 2015). If some Amaryllidaceae 
alkaloid biosynthetic enzymes require this physical interaction to function, then some enzyme 
activates may not be identifiable through an enzyme assay approach until a better understanding of 
this potential complex and its components is achieved. 
5.4 Potential Applications to Biotechnology and 
Amaryllidaceae Basic Science 
In addition to interrogating metabolomics, transcriptomic, and genomic datasets for other 
biosynthetic genes, several experiments could be done using the three genes characterized in this 
thesis. These genes can be used for the production of noroxomaritidine and some N-
demethylnarwedine in a heterologous expression system such as yeast or Camelina. The 
biosynthesis of 3,4-dihydroxybenzaldehyde in the Amaryllidaceae has at least one uncharacterized 
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enzyme, but a synthetic system for the creation of this compound has already been described using 
3-dehydroshikimate dehydratase from Podospora pauciseta and an aromatic carboxylic acid 
reductase from Nocardia sp. that could be used in these heterologous systems (Hansen et al., 2009). 
To create a system for the production of galanthamine in yeast or in planta will require 2-3 enzymes 
in addition to the 3 discovered (if you count CYP96T1) and the 3 required for 3,4-
dihydroxybenzaldehdye and tyramine production. CYP96T1 will make some N-
demethylnarwedine but an enzyme with a higher specificity for this product would be desirable. 
The reductase for the N-demethylnarwedine to N-demethylgalanthamine conversion and the N-
methyltransferase for the N-demethylgalanthamine to galanthamine conversion would also be 
required. A system producing haemanthamine will require the discovery of a reductase, an oxide 
bridge forming enzyme, and a methyltransferase. A hydroxylase is also required for the conversion 
of vittatine to 11-hydorxyvittatine in haemanthamine biosynthesis but the 2-oxoglutarate-dependent 
dioxygenase described in Appendix B would provide this activity if the chirality of the product is 
appropriate for haemanthamine biosynthesis.  
 Although many Amaryllidaceae alkaloids can be made chemically, this process can require 
toxic catalysts and many of the chemical synthesis protocols are not efficient or scalable for 
commercial production. The ability to produce these compounds with low cost inputs and low 
toxicity outputs using biological systems including members of the Amaryllidaceae, yeast, or a fast 
growing plant such as Camelina is appealing. The discovery of the missing enzymes for 
galanthamine or haemanthamine biosynthesis would enable experiments aimed at improving their 
production in biological systems. The need to discover biosynthetic genes in valuable secondary 
metabolite pathways from non-model systems for improved production of these compounds is a 
general need to achieve the goal of more affordable healthcare. The development of generally 
125 
 
applicable workflows, such as the ones utilized in this thesis featuring technologies such as next 
generation sequencing, will enable the future discovery of these valuable biosynthetic genes.  
 Amaryllidaceae alkaloid biosynthetic gene knock-out cultivars with resulting altered 
alkaloid profiles could prove ideal systems for ecological tests of the effects of Amaryllidaceae 
alkaloids on plant fitness and species interactions. An Amaryllidaceae plant with a knockout 
mutation for N4OMT or NNR could be devoid of Amaryllidaceae alkaloids and a comparison of 
this plant to wild type under stresses including herbivore challenge would enable a direct testing of 
the proposed roles of these alkaloids in planta as described in section 1.1.2. The knockout of 
CYP96T1 would potentially result in a deficiency of haemanthamine type alkaloids but not others 
like galanthamine. The importance of the small quantity of galanthamine type alkaloid phenol-
phenol coupling made by CYP96T1 could be determined by the presence or absence of 
galanthamine derivatives in the CYP96T1 mutant. If galanthamine type alkaloids are not 
significantly reduced in this mutant, then another enzyme may be primarily responsible for this 
reaction and the resulting plant may provide a cleaner alkaloid extract when preparing galanthamine 
commercially. CRISPR/Cas technology enables the creation of these knockout mutants in these 
genes and their close paralogues in various Amaryllidaceae plants through precise gene editing 
(Sander and Joung, 2014).  
 The transcriptomic resources are also useful for CRISPR/Cas guided mutagenesis of other 
genes not necessarily related to Amaryllidaceae alkaloid biosynthesis, including genes for plant 
development, floral morphology, and floral color. These traits are of particular interest to the floral 
industry and using CRISPR/Cas with the transcriptomes in this way could lead to more desirable 
cultivars. It could also be used for answering basic biology questions regarding bulb development. 
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Due to the slow turnaround of the tissue culture and transformation protocol previously reported in 
Narcissus tazzeta var. chinensis, these projects would be long-term (Lu et al., 2007). 
5.5  Summary 
In summary, this thesis confirmed the hypothesis that genes involved in the biosynthesis of selected 
Amaryllidaceae alkaloids are co-regulated and that this leads to correlations between biosynthetic 
gene expression and corresponding end-product accumulation. Biosynthetic genes that were either 
co-accumulating with the Amaryllidaceae alkaloid galanthamine or were co-expressing with the 
biosynthetic gene N4OMT were thereby discovered. During the subsequent characterization of 
these enzymes, hypotheses on how Amaryllidaceae alkaloids are made were tested. The discovery 
of these enzymes validates a simple workflow for biosynthetic gene discovery in Amaryllidaceae 
and provides tools in the form of transcriptomes and validated enzymes. These tools can be used 
for further study of Amaryllidaceae alkaloid biosynthesis and regulation, general molecular biology 
questions relating to members of the Amaryllidaceae including bulb development, and 
biotechnology applications. This could lead to better production systems for medicinal compounds 
such as the Alzheimer’s treatment galanthamine and anticancer compound haemanthamine and to 
a better understanding of this plant family.  
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Appendix A: The Identification and 
Confirmation of the Narcissus sp. aff. 
pseudonarcissus Tyrosine Decarboxylase 
A.1  Introduction, Results, and Discussion 
Tyrosine decarboxylase (TyrDC) is the enzyme responsible for the conversion of tyrosine to 
tyramine in an early stage of the Amaryllidaceae alkaloid biosynthetic pathway. This enzyme was 
previously discovered in other plants (Lehmann and Pollmann, 2009). To confirm the presence of 
a similar enzyme in Narcissus, homologues to a previously characterized TyrDC from Arabidopsis 
thaliana were identified and tested for enzymatic activity. A TyrDC homologue was found to 
encode an enzyme with tyrosine decarboxylase as shown in Figure A.1 and is deposited in 
GenBank under the Accession Number KT378599.     
A.2  Methods 
A.2.1  PCR and Cloning 
Nested PCR reactions were used to amplify the TyrDC as in as for N4OMT in Chapter 2 except 
TyrDC specific primers were used for outer and inner PCR, the outer PCR consisted of 30 cycles 
with a Tm of 52 ⁰C, and the inner PCR consisted of 30 cycles with a Tm of 54 ⁰C. Digestion with 
NotI and BamHI with subsequent ligation into pET28a and transformation into DH5a for plasmid 
amplification are also as in Chapter 2. The resulting plasmid was purified, sequenced, and 
transformed into BL21 Rosetta cells as in Chapter 2. 
A.2.2  Protein Purification, Enzyme Assays, and HPLC 
The protein was purified by inducing the transformed E. coli overnight at 16 ⁰C with 1 mM IPTG 
and subsequent His-tag purification as in Chapter 2. The protein concentration was determined by 
the Bradford assay and the purity evaluated with SDS-PAGE as in Chapter 2. The enzyme assays 
are based on the work of Lehmann and Pollmann with 100 mM potassium phosphate pH 7.5, 5 µg 
pure TyrDC, 2 mM pyridoxal 5’-phosphate, and 200 µM tyrosine at 30 ⁰C for 2 hr (Lehmann and 
Pollmann, 2009). The assays were extracted by adjusting the pH to 10 with the addition of two 
volumes 1 M NaCO2 and extracting with two volumes ethyl acetate two times as in Chapter 2. 
Samples were analyzed using the same HPLC system and program as described in Chapter 2. 
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Figure A.1. Production of tyramine by tyrosine decarboxylase monitored at 288 nm on HPLC. Top to bottom; blank, 
tyramine, tyrosine, functioning assay with TyrDC, no substrate control, and no enzyme control. 
A.3  References 
Lehmann, T., and Pollmann, S. (2009). Gene expression and characterization of a stress-induced 
tyrosine decarboxylase from Arabidopsis thaliana. FEBS Lett. 583, 1895-1900. 
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Appendix B: The Identification of a 2-
Oxoglutarate Dependent Dioxygenase 
Capable of Hydroxylating Vittatine into 
One of the Two Diastereomeric Forms of 
11-Hydroxvittatine. 
B.1  Introduction, Results, and Discussion 
The biosynthesis of the haemanthamine-type alkaloids involves the hydroxylation of vittatine to 
11-hydroxyvittatien as discussed in detail in Chapter 1.1.5. During the research described in this 
thesis, a 2-oxoglutarate dioxygenase was found to co-express with N4OMT in all the Galanthus 
spp. assemblies described in Chapter 3. This cDNA was expressed in Sf9 cells and the recombinant 
enzyme tested for the ability to hydroxylate vittatine. It was found to hydroxylate vittatine with a 
fragmentation pattern and retention time identical to one of the two peaks produced by the 
diastereomeric mixture present in the reference compound (Figure B.1A-C), however, the absolute 
configuration of the product is unknown. The enzyme clearly only makes one diastereomer (Figure 
B.1A). The cDNA sequence of vittatine 11-hydroxylase has been deposited in GenBank under the 
accession number KT985905. 
B.2  Methods 
B.2.1  Reagents 
Reagents were as described in Chapters 2, 3, and 4. Vittatine and 11-hydroxyvittatine were 
synthesized previously. Reagents unique to this study were sodium ascorbate and α-ketoglutaric 
acid potassium salt (2-oxoglutarate) from Sigma-Aldrich and ferrous sulfate from Fisher 
Scientific. 
B.2.2  Candidate Gene Selection 
As a part of the search for oxidoreductases in Chapter 4, Galanthus-20120814-25202 (vittatine 11-
hydroxylase), a homologue of the Pisum sativum 2-oxoglutarate-dependent dioxygenase 
(O24648), was found to co-express with N4OMT in both the ABySS and MIRA and the Trinity 
based assemblies for Galanthus sp. and Galanthus elwesii (Lester et al., 1997). Its co-expression 
with four of the five available transcriptomes prompted further study. 
B.2.3  PCR 
Vittatine 11-hydroxylase had a complete open reading frame in the Galanthus sp. ABySS and 
MIRA assembly. Nested PCR was used to generate this ORF, followed by cloning and expression 
in insect cells as in Chapter 3 (see Table B.1 for primers). When sequenced, several assembly 
errors were identified with several substitutions and an insertion of nucleotides at both the 3’- and 
[151] 
 
5’ end. These changes corrected several frame shifts predicted by the assembly that would have 
resulted in a truncated protein.   
B.2.4  Enzyme assays 
Enzyme assays were incubated at 30 ⁰C for 4 hr and consisted of 100 µM Tris pH 7.5, 500 µM 
ferrous sulfate, 500 µM sodium ascorbate, 500 µM 2-oxoglutarate, 35 % Sf9 cell suspension, and 
10 µM vittatine. Assays were extracted with EtOAc, resuspended, and run on the same LC-MS/MS 
hardware set-up as in Chapter 3. Specific parameters for vittatine monitoring were m/z 272.1, 
declustering potential (70), and collision energy (35). The product 11-hydroxyvittatine was 
monitored at m/z 288.1, declustering potential (70), and collision energy (35). 
 
Figure B.1. Assays for the vittatine 11-hydroxylase. (A) Top to bottom 11-hydroxyvittatine, assay with vittatine 11-
hydroxylase expressing Sf9 cells, assay with no Sf9 cells, assay with no vittatine substrate, and Sf9 cells expressing 
CPR instead of vittatine 11-hydroxylase. (B) Fragmentation pattern of 11-hydroxyvittatine. (C) Fragmentation pattern 
of vittatine 11-hydroxylase product. 
 
Table B.1. Primers used 
Primer name  Primer sequence 
Ga25202_FW_o TCAAGCAAAGACACCCATTCT 
Ga25202_FW_i aattGGATCCATGGGTTCCGATGTCAAATCA 
Ga25202_RV_o CTTGTTCCAAACACATTACAACA 
Ga25202_RV_i aattGCGGCCGCTTACACGATTCGTTTCTGCCA 
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B.3  References 
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encodes a gibberellin 3 beta-hydroxylase. Plant Cell 9, 1435-1443. 
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Appendix C: Supplementary Material for 
Chapter 2 
C.1 Figures and Tables 
Table C.1. Methyltransferases used in BLAST search 
Accession 
number 
Substrate specificity Reference 
AAQ01669.1  (R,S)-Norcoclaurine, (R)-norprotosinomenine, (S)-
norprotosinomenine, (R,S)-isoorientaline,  
(Ounaroon et al., 2003) 
AAQ01670.1  unpublished 
AAQ01668.1 Guaiacol, isovanillic acid, (R)-reticuline, (S)-reticuline, 
(R,S)-orientaline, (R)-protosinomenine, (R,S)-
laudanidine 
(Ounaroon et al., 2003) 
BAI79244.1 (1S)-N-Deacetylisoipecoside, (1R)-N-deacetylipecoside, 
(13aR)-demethylalangiside, (11bS)-7′-O-
demethylcephaeline, (13aS)-redipecamine, (1R,S)-
isococlaurine, (1R,S)-norcoclaurine, (1R,S)-
isoorientaline, oripavine 
(Nomura and Kutchan, 
2010) 
BAI79245.1 (13aS)-3-O-Methylredipecamine, (1S)-coclaurine, 
(1R,S)-N-methylcoclaurine, (1R,S)-4′-O-
methylcoclaurine, (1R,S)-6-O-methyllaudanosoline, 
(1R,S)-nororientaline, (1S)-norreticuline, (1S)-reticuline, 
(13aS)-coreximine 
(Nomura and Kutchan, 
2010) 
BAI79243.1 (1S)-N-Deacetylisoipecoside, (1S)-7-O-methyl-N-
deacetylisoipecoside, (11bS)-cephaeline, (1R,S)-
isococlaurine, (1R,S)-norcoclaurine, (1S)-4′-O-
methyllaudanosoline, (1R,S)-nororientaline, (1R,S)-
isoorientaline, (1S)-norprotosinomenine, (1R)-
norprotosinomenine, (1R,S)-protosinomenine 
(Nomura and Kutchan, 
2010) 
BAA06192.1 (R,S)-Scoulerine (Takeshita et al., 1995) 
AAD29843.1 See reference (Frick and Kutchan, 1999) 
AAD29841.1 See reference (Frick and Kutchan, 1999) 
AAD29845.1 See reference (Frick and Kutchan, 1999) 
AAD29842.1 See reference (Frick and Kutchan, 1999) 
AAD29844.1 See reference (Frick and Kutchan, 1999) 
BAC22084.1 Columbamine, 
tetrahydrocolumbamine, (S)-scoulerine, 2,3,9,10-
tetrahydroxyprotoberberine 
 
ACV50428.1 Homology with caffeoyl-CoA O-methyltransferase 
described in (Day et al., 2009) 
(Eswaran et al., 2010) 
AAN61072.1 Quercetin, 7-O-methylquercetin, quercetin-3-O-
glucoside, quercetagetin, 3-O-methylquercetagetin 6-O-
methylquercetagetin, 6-hydroxykaempferol, myricetin, 
luteolin, caffeoyl-CoA 
(Ibdah et al., 2003) 
AAR02420.1 Eriodictyol, homoeriodictyol, kaempferol, quercetin, 
isorhamnetin, chrysoeriol 
(Schröder et al., 2004) 
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Table C.2. Methyltransferases used in phylogeny 
Accession 
number 
Short name Species Substrate specificity Reference 
AAQ01669.1  PsN6OMT Papaver 
somniferum 
(R,S)-Norcoclaurine, (R)-norprotosinomenine, 
(S)-norprotosinomenine, (R,S)-isoorientaline,  
(Ounaroon et 
al., 2003) 
AAQ01670.1 PsCOMT Papaver 
somniferum 
 Unpublished 
AAQ01668.1 PsR7OMT Papaver 
somniferum 
Guaiacol, isovanillic acid, (R)-reticuline, (S)-
reticuline, (R,S)-orientaline, (R)-
protosinomenine, (R,S)-laudanidine 
(Ounaroon et 
al., 2003) 
BAI79244.1 PiOMT2 Psychotria 
ipecacuanha 
(1S)-N-Deacetylisoipecoside, (1R)-N-
deacetylipecoside, (13aR)-demethylalangiside, 
(11bS)-7′-O-demethylcephaeline, (13aS)-
redipecamine, (1R,S)-isococlaurine, (1R,S)-
norcoclaurine, (1R,S)-isoorientaline, oripavine 
(Nomura and 
Kutchan, 
2010) 
BAI79243.1 PiOMT1 Psychotria 
ipecacuanha 
(1S)-N-Deacetylisoipecoside, (1S)-7-O-methyl-
N-deacetylisoipecoside, (11bS)-cephaeline, 
(1R,S)-Isococlaurine, (1R,S)-norcoclaurine, (1S) 
4′O-methyllaudanosoline, (1R,S)-
nororientaline, (1R,S)-isoorientaline, (1S)-
norprotosinomenine, (1R)-norprotosinomenine, 
(1R,S)-protosinomenine 
(Nomura and 
Kutchan, 
2010) 
BAA06192.1 CjS9OMT Coptis 
japonica 
(R,S)-Scoulerine (Takeshita et 
al., 1995) 
AAD29843.1 TtCOMT3 Thalictrum 
tuberosum 
See reference (Frick and 
Kutchan, 
1999) 
AAD29841.1 TtCOMT1 Thalictrum 
tuberosum 
See reference (Frick and 
Kutchan, 
1999) 
AAD29845.1 TtCOMT5 Thalictrum 
tuberosum 
See reference (Frick and 
Kutchan, 
1999) 
AAD29842.1 TtCOMT2 Thalictrum 
tuberosum 
See reference (Frick and 
Kutchan, 
1999) 
AAD29844.1 TtCOMT4 Thalictrum 
tuberosum 
See reference (Frick and 
Kutchan, 
1999) 
BAC22084.1 CjCOMT Coptis 
japonica 
Columbamine, 
tetrahydrocolumbamine, (S)-scoulerine, 
2,3,9,10-tetrahydroxyprotoberberine 
(Morishige 
et al., 2002) 
ACV50428.1 JcCCoAOMT Jatropha 
curcas 
Homology with caffeoyl-CoA O-
methyltransferase described in (Day et al., 2009) 
(Eswaran et 
al., 2010) 
AAR02420.1 CrF4OMT Catharanthus 
roseus 
Eriodictyol, homoeriodictyol, kaempferol, 
quercetin, isorhamnetin, chrysoeriol 
(Schröder et 
al., 2004) 
Q9C5D7.1 AtCCoAOMT Arabidopsis 
thaliana 
Not determined (Ibrahim et 
al., 1998) 
C7AE94.1 VvAOMT Vitis vinifera Cyanidin 3-glucoside, delphinidin 3-glucoside, 
quercetin 3-glucoside, cyanidin, quercetin, 
myricetin, pelargonidin 3-glucoside, catechin, 
epicatechin  
(Hugueney 
et al., 2009) 
ADZ76153.1 VpOMT4 Vanilla 
planifolia 
Tricetin, 5-hydroxyferulic acid ethyl ester, 5-
hydroxyferulic acid, myricetin, 3,4-
(Widiez et 
al., 2011) 
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dihydroxybenzaldehyde, quercetin, 5-
hydroxyconiferaldehyde, caffeoyl CoA, caffeic 
acid ethyl ester, caffeoylaldehyde, caffeic acid 
ADZ76154.1 VpOMT5 Vanilla 
planifolia 
Tricetin, 5-hydroxyferulic acid ethyl ester, 5-
hydroxyferulic acid, myricetin, 3,4-
dihydroxybenzaldehyde, quercetin, 5-
hydroxyconiferaldehyde, caffeoyl CoA, caffeic 
acid ethyl ester, caffeoylaldehyde, caffeic acid 
(Widiez et 
al., 2011) 
Q84KK6 GeI4OMT Glycyrrhiza 
echinata 
2,7,4'-Trihydroxyisoflavanone, medicarpin (Akashi et 
al., 2003) 
C6TAY1 GmF4OMT Glycine max Apigenin, daidzein, genistein, quercetin, 
naringenin 
(Kim et al., 
2005) 
AAY89237.1 LuCCoA3O
MT 
Linum 
usitatissimum 
 (Apuya et 
al., 2008) 
3C3Y|A McPFOMT Mesembryant
hemum 
crystallinum 
 
Quercetin, quercetagetin, caffeic acid, CoA, 
caffeoyl glucose 
(Kopycki et 
al., 2008a) 
62361_DF6 NpN4OMT1 Narcissus sp. 
aff. 
pseudonarcis
sus 
Norbelladine, N-methylnorbelladine, dopamine this study 
BAB71802.1 CjCNMT Coptis 
japonica 
(R)-Coclaurine, (S)-coclaurine, (R,S)-
norreticuline, (R,S)-norlaudanosoline, (R,S)-6-
O-methylnorlaudanosoline, 6,7-dimethoxyl-
1,2,3,4-tetrahydroisoquinoline, 1-methyl-6,7-
dihydroxy-1,2,3,4-tetrahydroisoquinolinne 
(Choi et al., 
2002) 
BAB12278.1 CsCNMT Camellia 
sinensis 
 
7-Methylxanthine, 3-methylxanthine, 1-
methylxanthine, theobromine, theophylline, 
paraxanthine 
(Kato et al., 
2000) 
Q93WU3 ObCV4OMT Ocimum 
basilicum 
 
Chavicol, phenol, eugenol, t-isoeugenol, t-anol (Gang et al., 
2002) 
Q8WZ04 HsCOMT 
 
Homo sapiens A catechol  
3CBG|A SynOMT Cyanobacteri
um 
Synechocystis 
sp. strain PCC 
6803 
 
Hydroxyferulic acid, caffeic acid, caffeoyl-
CoA, caffeoylglucose, 3,4,5-
trihydorxycinnamic acid, tricetin, 3,4-
dihydroxybenzoic acid 
(Kopycki et 
al., 2008b) 
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Table C.3. Primers used in RACE, cloning, and colony PCR 
Primer name  Primer sequence 
62361_5’_RACE_outer TCCACCTCATCTTCCGGACGAA 
62361_5’_RACE_inner ACTTCCGTTCCAGAGCGTGTT 
62361_3’_RACE_outer AGAAGACCTGTACGACCATGCAT 
62361_3’_RACE_inner ACGAGCGATTAGTGAAGCTCGTCA 
62361_forward_outer CTTCACTTGTGTCAAGTTCAAT 
62361_reverse_outer CCRATAGATAGCATGCAGAATCT 
62361_forward_inner a,baattCATATGGGTGCTAGCATAGATGATT 
62361_reverse_inner a,baattGCGGCCGCTCAATAAAGACGTCGGCAAATAGT 
qRT-PCR_forward_62361 ATTGGTGTGTACACCGGCTATT 
qRT-PCR_reverse_62361 TTCCATCTTCCGGTAAAGCCAAA 
qRT-PCR_probe_62361 CTCTGCTCACAACTGC 
T7 sequencing TAATACGACTCACTATA 
T7 terminator GCTAGTTATTGCTCAGCGG 
 
Table C.4. Parameters used for LC/MS/MS analysis 
Compound Predicted 
molecular ion m/z 
[M+H] 
CE value 
(V) 
DP value 
(V) 
Injection 
volume (µl) 
Galanthamine 288.1 35 70 10 
 Norbelladine* 260.1 15 60 10 
4’-O-Methylnorbelladine* 274.1 35 60 10 
N-Methylnorbelladine 274.1 20 60 10 
4’-O-Methyl-N-methylnorbelladine* 
 
288.2 20 60 10 
Dopamine* 154.1 20 70 20 
3’-O-Methyldopamine 168.1 
 
20 70 20 
Methylated dopamine product 168.1 20 70 20 
Papaverine 340.2 52 70 10 
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Figure C.1. NpN4OMT1 product 4’-O-methylnorbelladine proton NMR spectra with peak assignments. 
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Figure C.2. NpN4OMT1 product 4’-O-methylnorbelladine COSY spectra. 
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Figure C.3. NpN4OMT1 product 4’-O-methylnorbelladine HMBC spectra. 
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Figure C.4. NpN4OMT1 product 4’-O-methylnorbelladine ROESY spectra. 
[161] 
 
 
Figure C.5. NpN4OMT1 product 4’-O-methylnorbelladine HSQC spectra. 
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Figure C.6. Effect of divalent cations, temperature, and pH on NpN4OMT1 enzyme activity. (A) Divalent cations 
tested with 5 min assays with 5 µM of cation Ca2+, Co2+, Zn2+, Mg2+ or Mn2+. (B) pH optimum 15 min assays with 5 
µM Mg2+. (C) Temperature optimum 15 min assays with 5 µM Mg2+. Divalent cation and pH testing reactions are 100 
µl reactions at 37⁰C. The divalent cation test contained 4 µM norbelladine, while pH and temperature optimum tests 
contained 100 µM norbelladine in the assay mix. 
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Appendix D: Supplementary Material for 
Chapter 4 
D.1  Figures and Tables 
Table D. 1. Oxidoreductases used in BLASTP search 
Accession 
number 
Short name Species Reference 
Q9SE94  Maize (Roje et al., 1999) 
AAW60421.1  Gluconobacter oxydans 
621H 
(Chen et al., 2010; 
Schweiger et al., 2010)  
Q9SQ70 NADPH-dependent codeinone 
reductase 
Papaver somniferum (Unterlinner et al., 1999) 
ABO93462.1 SalR P. somniferum, Papaver 
bracteatum 
 
(Ziegler et al., 2006; 
Geissler et al., 2007) 
P51102 Dihydroflavonol-4-reductase Arabidopsis thaliana (Saito et al., 2013) 
Q40316 Vestitone reductase Medicago sativa (Guo and Paiva, 1995) 
3H7U Akr4c9 
 
Arabidopsis thaliana (Simpson et al., 2009) 
AAD37373.1 Quinone oxidoreductase Arabidopsis thaliana (Sparla et al., 1999) 
B5WWZ8 FAO1 Lotus japonicus (Zhao et al., 2008) 
O23240 D-2-Hydroxyglutarate 
dehydrogenase 
Arabidopsis thaliana (Engqvist et al., 2009) 
O24562 Probable cinnamyl alcohol 
dehydrogenase 
Zea mays (Halpin et al., 1998) 
O24648 2-Oxoglutarate-dependent 
dioxygenase 
Pisum sativum (Lester et al., 1997) 
O48741 Protochlorophyllide reductase 
C, chloroplastic 
Arabidopsis thaliana (Oosawa et al., 2000) 
O49213 GDP-L-fucose synthase 1 Arabidopsis thaliana 
 
(Bonin and Reiter, 2000) 
O49482 Cinnamyl alcohol 
dehydrogenase 5 
Arabidopsis thaliana (Sibout et al., 2005) 
O80944 Aldo-keto reductase family 4 
member C8 
Arabidopsis thaliana (Simpson et al., 2009) 
O81852 Bifunctional 
aspartokinase/homoserine 
dehydrogenase 2 
Arabidopsis thaliana (Paris et al., 2002) 
P06525 Alcohol dehydrogenase class-
P 
Arabidopsis thaliana (Chang and Meyerowitz, 
1986) 
P16972 Ferredoxin-2, chloroplastic Arabidopsis thaliana (Somers et al., 1990) 
Q05431 Ascorbate peroxidase 1, 
cytosolic 
Arabidopsis thaliana (Davletova et al., 2005) 
Q0PGJ6 Aldo-keto reductase family 4 
member C9 
Arabidopsis thaliana (Simpson et al., 2009) 
Q39219 Ubiquinol oxidase 1a, 
mitochondrial 
Arabidopsis thaliana (Berthold, 1998) 
[166] 
 
Q39659 Glyoxysomal fatty acid beta-
oxidation multifunctional 
protein MFP-a 
Cucumis sativus (Preisig-Müller et al., 1994) 
Q43727 Glucose-6-phosphate 1-
dehydrogenase 1, chloroplastic 
Arabidopsis thaliana  
Q56Y42 Pyridoxal reductase, 
chloroplastic 
Arabidopsis thaliana (Herrero et al., 2011) 
Q56YU0 Aldehyde dehydrogenase 
family 2 member C4 
Arabidopsis thaliana  
Q5C9I9 (-)-Isopiperitenol/(-)-carveol 
dehydrogenase, mitochondrial 
Mentha piperita (Ringer et al., 2005) 
Q5N800 Probable chlorophyll(ide) b 
reductase NYC1 chloroplastic 
Oryza sativa subsp. Japonica (Sato et al., 2009) 
Q6ZHS4 Cinnamyl alcohol 
dehydrogenase 2 
Oryza sativa subsp. japonica  
Q8GWA1 Internal alternative NAD(P)H-
ubiquinone oxidoreductase A1, 
mitochondrial 
Arabidopsis thaliana (Michalecka et al., 2003) 
Q8GXR9  Alternative NAD(P)H-
ubiquinone oxidoreductase C1, 
chloroplastic/mitochondrial 
Arabidopsis thaliana  
Q8L799 Inositol oxygenase 1 Arabidopsis thaliana  
Q8L9C4 Very-long-chain 3-oxoacyl-
CoA reductase 1 
Arabidopsis thaliana (Beaudoin et al., 2009) 
Q8LEU3 Chlorophyll(ide) b reductase 
NOL, chloroplastic 
Arabidopsis thaliana (Horie et al., 2009) 
Q949Q0 Glycerol-3-phosphate 
dehydrogenase [NAD(+)] 2, 
chloroplastic 
Arabidopsis thaliana (Nandi et al., 2004) 
Q94AX4 lactate dehydrogenase 
[cytochrome], mitochondrial 
Arabidopsis thaliana  
Q9C9W5 Glycerate dehydrogenase 
HPR, peroxisomal 
Arabidopsis thaliana  
Q9CA90 Glyoxylate/hydroxypyruvate 
reductase A HPR2 
Arabidopsis thaliana  
Q9FJ95 Sorbitol dehydrogenase Arabidopsis thaliana  
Q9LKA3 Malate dehydrogenase 2, 
mitochondrial 
Arabidopsis thaliana  
Q9LW56 Long-chain-alcohol oxidase Arabidopsis thaliana  
Q9SA18 Bifunctional 
aspartokinase/homoserine 
dehydrogenase 1, chloroplastic 
Arabidopsis thaliana  
Q9SJ10 Cinnamyl alcohol 
dehydrogenase 3 
Arabidopsis thaliana  
Q9SQT8 Bifunctional 3-dehydroquinate 
dehydratase/shikimate 
dehydrogenase, chloroplastic 
Arabidopsis thaliana  
Q9ST62 External alternative NADPH-
ubiquinone oxidoreductase B1, 
mitochondrial 
Solanum tuberosum  
Q9ST63 Internal alternative NADPH-
ubiquinone oxidoreductase A1, 
mitochondrial 
Solanum tuberosum  
[167] 
 
Q9SU56 Galactono-1,4-lactone 
dehydrogenase, mitochondrial 
Arabidopsis thaliana  
Q9SZB3 Putative uncharacterized 
protein 
Arabidopsis thaliana  
Q9ZP06 Malate dehydrogenase 1, 
mitochondrial 
Arabidopsis thaliana  
Q9ZPI5 Peroxisomal fatty acid beta-
oxidation multifunctional 
protein MFP2 
Arabidopsis thaliana  
*the end list contains all sequences in this table plus all plant AKRs listed on the 
http://www.med.upenn.edu/akr/members.shtml web page and all sequences minus 
GRMZM2G086773 from (Moummou et al., 2012) Table #3 were included. 
Table D.2. Imine oxidoreductases used in BLASTP search 
Accession 
number 
Short name Species Reference 
AED92078.1 Pyrroline-5-carboxylate reductase Arabidopsis thaliana (Funck et al., 2012) 
Q05762 Bifunctional dihydrofolate 
reductase-thymidylate synthase 1 
Arabidopsis thaliana (Lazar et al., 1993) 
F4JVY8 Lysine-ketoglutarate 
reductase/saccharopine 
dehydrogenase bifunctional 
enzyme 
Arabidopsis thaliana (Stepansky et al., 2005) 
O22213 
 
Cytokinin dehydrogenase 1 Arabidopsis thaliana (Bilyeu et al., 2001) 
Q4ADV8 Cytokinin dehydrogenase 2 Oryza sativa subsp. 
japonica 
 
Q6NKX1 Proline dehydrogenase 2, 
mitochondrial 
Arabidopsis thaliana (Funck et al., 2010) 
Q8H191 Probable polyamine oxidase 4 Arabidopsis thaliana (Tavladoraki et al., 2006) 
Q9FNA2 Polyamine oxidase 1 Arabidopsis thaliana  
Q9FUJ3 Cytokinin dehydrogenase 2 Arabidopsis thaliana  
Q9LYT1 Polyamine oxidase 3 Arabidopsis thaliana (Tavladoraki et al., 2006) 
Q9SJA7 Probable sarcosine oxidase Arabidopsis thaliana  
Q9SKX5 Probable polyamine oxidase 2 Arabidopsis thaliana  
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Table D.3. Primers used 
Primer name  Primer sequence 
NNR forward outer GGAAAGCCTTCAGAGGAGATT 
NNR forward inner aattGGATCCATGTCGTTGGAGAAGAGATGGT 
NNR reverse outer AGATAGCACCGTGGAGAT 
NNR reverse inner aattGCGGCCGCTCAACCATTTATGGTCCGTCCT 
 
Table D.4. Product MS/MS parameters 
Substrate Product Parameters (parent ion 
m/z)(CE)(DP) 
3,4-Dihydroxybenzaldehyde 
and tyramine 
Norbelladine (260.0)(15)(50) 
Noroxomaritidine Oxomaritinamine (274.3)(35)(70) 
Vanillin and tyramine 3’-O-Methylnorbelladine (274.3)(20)(60) 
Isovanillin and tyramine 4’-O-Methylnorbelladine (274.3)(20)(60) 
Piperonal and tyramine 4-(2-((1,3-Benzodioxol-5-
ylmethyl)amino)ethyl)phenol 
(272.1)(20)(60) 
8-O-,9-O-
Didemethyloxomaritidine 
9-O-Demethyloxomaritinamine (260.1)(35)(70) 
Collision energy=CE 
Declustering potential=DP 
 
  
[169] 
 
Table D.5. NNR crystal structure parameters 
Crystal NNR•NADP+ NNR•NADP+•Piperonal NNR•NADP+•Tyramine 
Space group P 42 2 2  P 31 2 1  P 21 21 21 
Cell dimensions a = b = 60.377, c = 
136.142Å 
a = b = 73.386, c = 167.892Å a = 61.8, b = 86.964, c = 
186.115 Å 
Data collection    
Wavelength (Å) 0.98 0.98 0.98 
Resolution range (Å) 
(highest shell resolution) 
45.17  - 1.73 (1.792  - 
1.73) 
35.85-1.501 (1.554-1.501) 39.39  - 1.814 (1.879  - 1.814) 
Reflections 
(total/unique) 
27,098/2,606 84,467/8,243 90,854/8,266 
Completeness (highest 
shell) 
99.73% (98.60%) 99.86% (98.67%) 99.17% (91.62%) 
〈I/σ〉 (highest shell) 21.96 (2.39) 17.55 (2.30) 23.73 (2.30) 
Model and refinement    
Rcryst/Rfree 18.1/21.5% 14.9/16.0% 18.3/21.3% 
No. of protein atoms 1870 3971 7,650 
No. of water molecules 136 644 443 
No. of ligand atoms 48 107 174 
Root mean square 
deviation, bond lengths 
(Å) 
0.013 0.007 0.008 
Root mean square 
deviation, bond angles 
(°) 
1.21 1.18 1.13 
Average B-factor (Å2), 
protein, solvent 
37.9, 37.7, 41.8 20.2,18.2,33.1 41.2, 41.2, 42.4 
Stereochemistry, most favored,  
allowed, outliers 
  
Figure 0.1Figure A. 2Figure B. 2Figure C. 7 
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Figure D.1. Alignment, generated with CLC main workbench version 6.9.1, of the original sequence 
(medp_9narc_20101112|58880), the full length homologue (medp_9narc_20101112|12438), and the cloned sequence 
(NNR). Dots indicate identical base pairs, identical amino acids are not shown, altered amino acids are shown in red 
below the corresponding sequence, black arrows are over outer primer sequences, and red arrows are over inner primer 
sequences. 
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Figure D.2. pH and temperature optima for NNR using MRM based quantification of norbelladine. (A) pH optimum 
for NNR. (B) Temperature optimum for NNR. (C) NNR product:vector control background ratio with pH on the x-
axis. (D) NNR product:vector control background ratio with temperature on the x-axis. Abbreviations counts per 
second (CPS) and noroxomaritidine/norcraugsodine reductase (NNR). 
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